# BugSigDB 2024-10-14_03:07_UTC, License: Creative Commons Attribution 4.0 International, URL: https://bugsigdb.org
bsdb:1/1/1_Colorectal-adenoma:conventional-adenoma-cases_vs_controls_UP	NA	1654	1716	1301	162289	189330	33024	40544	1386
bsdb:1/1/2_Colorectal-adenoma:conventional-adenoma-cases_vs_controls_DOWN	NA	100883
bsdb:1/2/1_Hyperplastic-Polyp:hyperplastic-polyp-cases_vs_controls_UP	NA	207244
bsdb:1/2/2_Hyperplastic-Polyp:hyperplastic-polyp-cases_vs_controls_DOWN	NA	100883
bsdb:2/1/1_Head-and-neck-squamous-cell-carcinoma:squamous-cell-carcinoma-tissues_vs_normal-adjacent-tissues_UP	NA	543311
bsdb:2/1/2_Head-and-neck-squamous-cell-carcinoma:squamous-cell-carcinoma-tissues_vs_normal-adjacent-tissues_DOWN	NA	1654
bsdb:2/2/1_Head-and-neck-squamous-cell-carcinoma:T3-T4-high-tumor-stages-patients_vs_T0-T2-low-tumor-stages-patients_UP	NA	543311
bsdb:2/2/2_Head-and-neck-squamous-cell-carcinoma:T3-T4-high-tumor-stages-patients_vs_T0-T2-low-tumor-stages-patients_DOWN	NA	1654
bsdb:3/1/1_Colorectal-cancer:adenocarcinoma-of-colon-and-rectum-patients_vs_controls_UP	NA	848	836
bsdb:4/1/1_Hepatitis:HCV-stage-4-male-patients_vs_male-healthy-controls_UP	NA	469	838	29465	33024
bsdb:4/1/2_Hepatitis:HCV-stage-4-male-patients_vs_male-healthy-controls_DOWN	NA	375288	1263	574697	1678	53246	39948
bsdb:5/1/1_Chronic-obstructive-pulmonary-disease:Chronic-obstructive-pulmonary-disease_vs_controls_UP	NA	46123	1654	642	653683	1380	1678	118747	830	194	1016	43996	82202	84162	893	39948	156973	1730	848	52228	32067	186650	1839	133925	265975	543311	1257	838	32207	970	613	123375	1301	195950	29465
bsdb:5/1/2_Chronic-obstructive-pulmonary-disease:Chronic-obstructive-pulmonary-disease_vs_controls_DOWN	NA	1485	88138	2023	544	1663
bsdb:5/2/1_Chronic-obstructive-pulmonary-disease:Severe_vs_moderate-Chronic-obstructive-pulmonary-disease_UP	NA	1839	289201	1485	186650	642
bsdb:7/1/1_Autism:severely-autistic_vs_non-sibling-control_UP	NA	191303	816	286729	872	258514	375288
bsdb:7/1/2_Autism:severely-autistic_vs_non-sibling-control_DOWN	NA	114627	52784	109326	1678	1485	102106	39948	253238	31983	1578	1243	113286	1263	1301	46255
bsdb:10/1/1_Cervical-glandular-intraepithelial-neoplasia:Cervical-Intraepithelial-Lesion-HIV-patients_vs_Normal-tissue-HIV-patients_UP	NA	437755
bsdb:10/2/1_Cervical-glandular-intraepithelial-neoplasia:Cervical-Intraepithelial-Lesion-HIV-patients_vs_Normal-tissue-HIV-patients_UP	NA	1375
bsdb:14/1/1_Halitosis:Oral-Halitosis_vs_Control_UP	NA	194	195950	39948	1257	970	32067	2740	543311	157	1016	416916	838
bsdb:14/1/2_Halitosis:Oral-Halitosis_vs_Control_DOWN	NA	416916	724	437755	265975	838	1301	2740	32067
bsdb:15/1/1_Gestational-diabetes:Gestational-diabetes-mellitus_vs_controls_UP	NA	33057
bsdb:15/1/2_Gestational-diabetes:Gestational-diabetes-mellitus_vs_controls_DOWN	NA	55080	935200	1578	231454	44675
bsdb:16/1/1_Obesity:high-fat-diet_vs_normal-chow-diet_UP	NA	31980	1263	248744	239759	572511
bsdb:16/1/2_Obesity:high-fat-diet_vs_normal-chow-diet_DOWN	NA	816	283168	109326	574697	209	990721	35832	459786
bsdb:16/2/1_Obesity:high-fat-diet-+-melatonin_vs_high-fat-diet_UP	NA	583	283168	209	109326	872	574697	239934	1920251
bsdb:16/2/2_Obesity:high-fat-diet-+-melatonin_vs_high-fat-diet_DOWN	NA	239759	244127
bsdb:17/1/1_Anxiety-disorder:treatment-active-Generalized-Anxiety-disorder_vs_healthy-controls_UP	NA	848	816	946234	1432051	1505663
bsdb:17/1/2_Anxiety-disorder:treatment-active-Generalized-Anxiety-disorder_vs_healthy-controls_DOWN	NA	35832	580596	39948	216851	28050	46205	841	292632	40544
bsdb:17/2/1_Anxiety-disorder:treatment-naiive-Generalized-Anxiety-disorder_vs_healthy-controls_UP	NA	1578	848	816	561	620	375288	1505663	946234
bsdb:17/2/2_Anxiety-disorder:treatment-naiive-Generalized-Anxiety-disorder_vs_healthy-controls_DOWN	NA	244127	397864	580596	574697	102106	216851	1407607	28050	437755	846	577310	2740	841	292632
bsdb:18/1/1_Obesity:Sv129--Low-Fat_vs_BL6--Low-Fat_UP	NA	244127	816	572511	830	1485	189330	1730	216851	1578	459786	1017280	841	1263	292632
bsdb:18/1/2_Obesity:Sv129--Low-Fat_vs_BL6--Low-Fat_DOWN	NA	239934	239759	283168	375288	838	195950
bsdb:18/2/1_Obesity:Sv129-High-Fat-without-enomithacin_vs_BL6-High-Fat-without-enomithacin_UP	NA	1485	841
bsdb:18/2/2_Obesity:Sv129-High-Fat-without-enomithacin_vs_BL6-High-Fat-without-enomithacin_DOWN	NA	239934
bsdb:19/1/1_Schizophrenia:Schizophrenia_vs_Healthy-controls_UP	NA	838	83770	848	906	1578	544	33024	904	872
bsdb:19/1/2_Schizophrenia:Schizophrenia_vs_Healthy-controls_DOWN	NA	1301	33042	841	572511
bsdb:20/1/1_Non-alcoholic-fatty-liver-disease:NASH_vs_Non-NASH_UP	NA	816
bsdb:20/1/2_Non-alcoholic-fatty-liver-disease:NASH_vs_Non-NASH_DOWN	NA	838
bsdb:20/2/1_Non-alcoholic-fatty-liver-disease:significant-fibrosis-(F>2)_vs_mild-fibrosis-(F-0-1)_UP	NA	1263	816
bsdb:20/2/2_Non-alcoholic-fatty-liver-disease:significant-fibrosis-(F>2)_vs_mild-fibrosis-(F-0-1)_DOWN	NA	838
bsdb:21/1/1_Obesity:Cameron-County-Hispanic-Cohort-samples_vs_Human-Microbiome-Project-samples_UP	NA	838	102106	841	1301	39948
bsdb:21/1/2_Obesity:Cameron-County-Hispanic-Cohort-samples_vs_Human-Microbiome-Project-samples_DOWN	NA	816	375288	239759
bsdb:22/1/1_Parkinson's-disease:Parkinson's_vs_Healthy-controls_UP	NA	1578	990721	270497	119852	1678
bsdb:22/1/2_Parkinson's-disease:Parkinson's_vs_Healthy-controls_DOWN	NA	189330	816	838	216851
bsdb:23/1/1_Alzheimer's-disease:Alzheimer's_vs_Healhty-controls_UP	NA	239759	816	572511	1378	33024	35832
bsdb:23/1/2_Alzheimer's-disease:Alzheimer's_vs_Healhty-controls_DOWN	NA	447020	1678	1485	39948	86331
bsdb:24/1/1_Chronic-fatigue-syndrome:Chronic-Fatigue-patients_vs_Healthy-controls_UP	NA	331654	816	194	848	1378
bsdb:24/1/2_Chronic-fatigue-syndrome:Chronic-Fatigue-patients_vs_Healthy-controls_DOWN	NA	29465	724	836	475	286
bsdb:25/1/1_Psoriasis:Psoriasis-Male_vs_Female_UP	NA	1301	150022	165779	29465	360541	1716	43668	32207	33882	57495	1016	469	36739	171412
bsdb:25/1/2_Psoriasis:Psoriasis-Male_vs_Female_DOWN	NA	1578	1743	2701	212791	1696
bsdb:26/1/1_Sex-design:female_vs_male_UP	NA	35832
bsdb:26/2/1_Obesity:BMI->33-female_vs_male_UP	NA	816
bsdb:27/1/1_Obesity:foster-mother-wild-type-pre-HFD_vs_foster-mother-fat1-pre-HFD_UP	NA	1485	191303	2740	946234	574697	580596	375288
bsdb:27/1/2_Obesity:foster-mother-wild-type-pre-HFD_vs_foster-mother-fat1-pre-HFD_DOWN	NA	816	239759	397864	209	283168	872	174708	28138	1331051
bsdb:27/2/1_Obesity:foster-mother-wild-type-post-HFD_vs_foster-mother-fat1-post-HFD_UP	NA	172900	256846	1485	28138	244127	459786	946234	1578	2740	574697	375288
bsdb:27/2/2_Obesity:foster-mother-wild-type-post-HFD_vs_foster-mother-fat1-post-HFD_DOWN	NA	209	816	283168	1331051
bsdb:28/1/1_Chronic-fatigue-syndrome:CFS-cases_vs_Healthy-controls_UP	NA	119852	84111	1357	244127	100883
bsdb:28/1/2_Chronic-fatigue-syndrome:CFS-cases_vs_Healthy-controls_DOWN	NA	2740	724	1380	1485	216851	1263	416916	1678	102106	40544
bsdb:29/1/1_Unipolar-depression:Active-Major-Depressive-Disorder_vs_Healthy-Controls_UP	NA	946234	574697	375288	239759
bsdb:29/1/2_Unipolar-depression:Active-Major-Depressive-Disorder_vs_Healthy-Controls_DOWN	NA	216851	39948	1263	724	561	620
bsdb:29/2/1_Unipolar-depression:Responded-Major-Depressive-Disorder_vs_Healthy-Controls_UP	NA	574697
bsdb:29/2/2_Unipolar-depression:Responded-Major-Depressive-Disorder_vs_Healthy-Controls_DOWN	NA	1263	724	1485
bsdb:30/1/1_Chronic-fatigue-syndrome:Norweigan-controls_vs_Belgian-controls_UP	NA	841	61170
bsdb:30/1/2_Chronic-fatigue-syndrome:Norweigan-controls_vs_Belgian-controls_DOWN	NA	816	239759	397864	838	375288
bsdb:30/2/1_Chronic-fatigue-syndrome:Norweigan-CFS/ME-patients_vs_Norweigan-controls_UP	NA	239759	420345
bsdb:30/2/2_Chronic-fatigue-syndrome:Norweigan-CFS/ME-patients_vs_Norweigan-controls_DOWN	NA	841	61170	39948	84036
bsdb:31/1/1_Chronic-fatigue-syndrome:CFS/ME-patients_vs_controls_UP	NA	207244	1485	100883	1017280
bsdb:31/1/2_Chronic-fatigue-syndrome:CFS/ME-patients_vs_controls_DOWN	NA	33042	189330	216851	1378	724	841
bsdb:31/2/1_Chronic-fatigue-syndrome:CFS/ME-patients-with-IBS_vs_controls_UP	NA	1485	207244
bsdb:31/2/2_Chronic-fatigue-syndrome:CFS/ME-patients-with-IBS_vs_controls_DOWN	NA	33042	189330	216851	841
bsdb:32/1/2_Anorexia-nervosa:Aonerxia-Nervosa-patients_vs_Controls_DOWN	NA	1263	841	1485
bsdb:34/1/2_Bipolar-disorder:Bipolar-disorder_vs_Controls_DOWN	NA	216851
bsdb:34/2/1_Bipolar-disorder:Bipolar-patients-with-high-IL-6_vs_low-IL-6_UP	NA	1578	1301
bsdb:35/1/1_Sjogren-syndrome:PSS_vs_Controls_UP	NA	29465
bsdb:35/1/2_Sjogren-syndrome:PSS_vs_Controls_DOWN	NA	1654	724	482	32207	836	1257
bsdb:36/1/1_Obesity:obese-adolescent_vs_control-adult_UP	NA	1654
bsdb:36/1/2_Obesity:obese-adolescent_vs_control-adult_DOWN	NA	119852
bsdb:36/2/1_Obesity:obese-adult_vs_control-adolescent_UP	NA	1301
bsdb:36/2/2_Obesity:obese-adult_vs_control-adolescent_DOWN	NA	119852
bsdb:37/1/1_Colorectal-cancer:CRC-patients_vs_Healthy-controls_UP	NA	165779	194	1730	236752	848	1378	61170	32257	32067	283168	459786	375288	543311	1257	836	123375
bsdb:37/1/2_Colorectal-cancer:CRC-patients_vs_Healthy-controls_DOWN	NA	1243	1301
bsdb:38/1/1_Body-odor-measurement:head-of-teenager_vs_head-of-child_UP	NA	1912216
bsdb:38/1/2_Body-odor-measurement:head-of-teenager_vs_head-of-child_DOWN	NA	55193	1279
bsdb:38/2/1_Body-odor-measurement:teen-neck_vs_child-neck_UP	NA	1912216	55193
bsdb:38/2/2_Body-odor-measurement:teen-neck_vs_child-neck_DOWN	NA	1279
bsdb:39/1/2_Body-odor-measurement:youth-underarm-after-exercise_vs_youth-underarm-before_DOWN	NA	265
bsdb:39/2/1_Body-odor-measurement:youth-Neck-before_vs_after-excercise_DOWN	NA	469
bsdb:40/1/1_Attention-deficit-hyperactivity-disorder:ADHD_vs_Controls_UP	NA	1678	84111	283168	375288	239759
bsdb:40/1/2_Attention-deficit-hyperactivity-disorder:ADHD_vs_Controls_DOWN	NA	292632	1263	35829	33042
bsdb:41/1/1_Psychosis:FIrst-episode-Psychosis_vs_Controls_UP	NA	2038	528	316625	56688	1578	53572	109262
bsdb:41/1/2_Psychosis:FIrst-episode-Psychosis_vs_Controls_DOWN	NA	1163	96	35798
bsdb:42/1/1_Extrahepatic-cholestasis:cholestasis-infants_vs_healthy-infants_UP	NA	1301	1350	1279	906	28100	158846
bsdb:42/1/2_Extrahepatic-cholestasis:cholestasis-infants_vs_healthy-infants_DOWN	NA	1678	816	572511	216851	841	207244	102106
bsdb:43/1/1_Behcet's-syndrome:behcet's-disease_vs_controls_UP	NA	1283313
bsdb:43/2/1_Behcet's-syndrome:immunosuppressant-users_vs_non-immunosuppressent-users-among-behcet's-patients_UP	NA	59735	838
bsdb:44/1/2_Obesity:pediatric-obese_vs_controls_DOWN	NA	816
bsdb:45/1/1_Obesity:Rats-fed--HFHS_vs_control-rats_UP	NA	572511	1678	33024	174708
bsdb:46/1/1_Obesity:pediatric-obese_vs_controls_DOWN	NA	816	838
bsdb:46/1/2_Obesity:pediatric-obese_vs_controls_DOWN	NA	838
bsdb:47/1/1_Obesity:low_vs_high-dietary-fiber_UP	NA	1263
bsdb:47/2/2_Obesity:low_vs_hight-moderate-to-vigrous-physical-activity_DOWN	NA	189330	28050	577309
bsdb:48/1/1_Obesity:obese-adolescent_vs_control-adolescent_UP	NA	838
bsdb:48/1/2_Obesity:obese-adolescent_vs_control-adolescent_DOWN	NA	816	239759	216851	459786
bsdb:48/2/1_Obesity:high-BMI-zscore_vs_low-BMI-zscores_UP	NA	838
bsdb:48/2/2_Obesity:high-BMI-zscore_vs_low-BMI-zscores_DOWN	NA	816	239759
bsdb:49/1/1_Obesity:Obesity-group_vs_controls_UP	NA	43996	117563	86331	1257	838	123375
bsdb:49/1/2_Obesity:Obesity-group_vs_controls_DOWN	NA	724	2717	1016	47670	1716	1279	40323
bsdb:50/1/1_Colorectal-cancer:Colrectal-cancer-patients_vs_healthy-controls_UP	NA	836	561	620	1350	1301	1257
bsdb:50/1/2_Colorectal-cancer:Colrectal-cancer-patients_vs_healthy-controls_DOWN	NA	816	841	239759	1730	577310
bsdb:51/1/1_Colorectal-cancer:Carcinoma-patients_vs_postoperation-patients_UP	NA	1578	838	150022	48736	1380	404402	1283313	1716	135858	1573535	543311	286	1378	1257	836	46255	117563	1654
bsdb:51/1/2_Colorectal-cancer:Carcinoma-patients_vs_postoperation-patients_DOWN	NA	32067	196082	1678	33882	1847725	1573534	40544	28050	1506577	570
bsdb:51/2/1_Colorectal-cancer:NDA(new-dev.-adenoma)_vs_CIT(cleain-intestine)_UP	NA	46123	1380	581	838	123375
bsdb:51/2/2_Colorectal-cancer:NDA(new-dev.-adenoma)_vs_CIT(cleain-intestine)_DOWN	NA	574697	1263	1485	33042	150022	437755	459786	872	244127
bsdb:52/1/1_Substance-related-disorder:Substance-use-disorder-patients_vs_Healthy-controls_UP	NA	838	265	1485	33057
bsdb:52/1/2_Substance-related-disorder:Substance-use-disorder-patients_vs_Healthy-controls_DOWN	NA	35832	189330	375288	1301	207244	906	1407607	239759	204475	816	1263
bsdb:52/2/1_Substance-related-disorder:Substance-use-disorder-patients_vs_adjusted-Healthy-controls_UP	NA	33057	265	838
bsdb:52/2/2_Substance-related-disorder:Substance-use-disorder-patients_vs_adjusted-Healthy-controls_DOWN	NA	207244	375288	204475	35832	1301	906	1407607
bsdb:55/1/1_Stimulus-or-stress-design:grid-floor-induced-stress_vs_control_UP	NA	283168	239759
bsdb:56/1/1_Type-II-diabetes-mellitus:Healthy-baby-meconium_vs_adult-stool_UP	NA	283	561	570	583	620
bsdb:56/2/1_Gestational-diabetes:Baby-meconium-with-GDM-mothers_vs_Healthy-baby-meconium_DOWN	NA	507	106589	283	80865	40323
bsdb:57/1/1_Irritable-bowel-syndrome:irritable-bowel-syndrome_vs_control_UP	NA	838	1485	79206	1257	507	32008	482
bsdb:57/1/2_Irritable-bowel-syndrome:irritable-bowel-syndrome_vs_control_DOWN	NA	1716	1743	1301	13687	286
bsdb:57/2/1_Irritable-bowel-syndrome:overweight-irritable-bowel-syndrome_vs_control_UP	NA	1716	1678	1380	133925	1386	162291	1578	113286	265975	177971	39948	906	970	92793	80865	194	286	157	838	1279
bsdb:57/2/2_Irritable-bowel-syndrome:overweight-irritable-bowel-syndrome_vs_control_DOWN	NA	396388	59732	109244	670486	1378	1301	482	724	838	1279
bsdb:58/1/1_High-fat-diet:newborns-of-maternal-high-fat-diet_vs_nebowrns-of-maternal-control_UP	NA	1357	117563	1350
bsdb:58/1/2_High-fat-diet:newborns-of-maternal-high-fat-diet_vs_nebowrns-of-maternal-control_DOWN	NA	40544	375288	816	283
bsdb:58/2/1_High-fat-diet:6-months-babies-of-maternal-high-fat-diet_vs_6-months-babies-control_UP	NA	1301	561
bsdb:58/2/2_High-fat-diet:6-months-babies-of-maternal-high-fat-diet_vs_6-months-babies-control_DOWN	NA	816
bsdb:60/1/1_Type-II-diabetes-mellitus:Type-2-DM-cases_vs_controls_UP	NA	458839	111142	504481	255204
bsdb:60/1/2_Type-II-diabetes-mellitus:Type-2-DM-cases_vs_controls_DOWN	NA	92793	338	1847
bsdb:60/2/1_Type-II-diabetes-mellitus:Type-2-DM-cariers-of-pathogens_vs_carier-of-pathogens-controls_UP	NA	504481
bsdb:60/2/2_Type-II-diabetes-mellitus:Type-2-DM-cariers-of-pathogens_vs_carier-of-pathogens-controls_DOWN	NA	816
bsdb:61/1/1_Obesity:infants-of-overweight-mothers_vs_infants-of-normal-weight-mother-at-age-1-month_DOWN	NA	816	838
bsdb:62/1/1_Parkinson's-disease:Cognitively-Unimpaired-PD-(PD-NC)_vs_Control-Subjects_UP	NA	244127	1678	1649459	596767	2172
bsdb:62/1/2_Parkinson's-disease:Cognitively-Unimpaired-PD-(PD-NC)_vs_Control-Subjects_DOWN	NA	1485	838	1501226	841
bsdb:63/2/1_Cesarean-section:C-section-delivery_vs_vaginal-delivery-after-3-months-of-delivery_DOWN	NA	1578
bsdb:64/1/2_Periodontitis:periodontitis_vs_No-Periodontitis-within-negative-diabetic-background-only_DOWN	NA	416916	32067
bsdb:65/1/1_Type-II-diabetes-mellitus:Diabetic_vs_Non-diabetic_UP	NA	416916	482	1378	538	1654	1016	848	29465	1301	970
bsdb:65/1/2_Type-II-diabetes-mellitus:Diabetic_vs_Non-diabetic_DOWN	NA	1730	44259	836	195950	157
bsdb:66/1/1_Neonatal-jaundice:cesarean-infants-with-jaundice_vs_control_UP	NA	106589
bsdb:66/2/2_Neonatal-jaundice:infants-with-jaundice_vs_control_DOWN	NA	1301
bsdb:67/2/1_Autism:autistic_vs_neurotypical_UP	NA	1578	102106	1716	189330
bsdb:67/2/2_Autism:autistic_vs_neurotypical_DOWN	NA	239759	39948	375288	29465	35832
bsdb:68/1/1_Obesity:obese_vs_normal-weight_UP	NA	35832	572511	1485	33042	140625	1578	1263	1301
bsdb:68/1/2_Obesity:obese_vs_normal-weight_DOWN	NA	1485	33042	51514	189330	119852	375288
bsdb:68/2/1_Obesity:overweight_vs_normal-weight_UP	NA	816	1578	1301	1485	572511	140625	1263	35832
bsdb:68/2/2_Obesity:overweight_vs_normal-weight_DOWN	NA	51514	119852	375288
bsdb:69/1/1_Sex-design:female_vs_male_UP	NA	1263
bsdb:69/2/1_Obesity:female-obese_vs_female-normal-weight_DOWN	NA	33024
bsdb:70/1/1_Obesity:pediatric-obese_vs_pediatric-normal-weight_UP	NA	39948	816	838
bsdb:70/1/2_Obesity:pediatric-obese_vs_pediatric-normal-weight_DOWN	NA	207244	40544	816
bsdb:70/2/2_Obesity:female-pediatric-obese_vs_female-pediatric-normal-weight_DOWN	NA	283168
bsdb:71/1/1_Cesarean-section:C-section_vs_vaginal-delivery_UP	NA	1243	909928	2737	830
bsdb:71/2/1_Premature-birth:infants-<33-weeks-gestational-age_vs_>/=33-weeks_UP	NA	1386	1279	1350	2737	1578	1243	1485	29465	909928	1678	547	544	551	570	160674	53335	29487	195950
bsdb:71/2/2_Premature-birth:infants-<33-weeks-gestational-age_vs_>/=33-weeks_DOWN	NA	223927
bsdb:72/1/2_Autism:autism_vs_typically-developing-controls_DOWN	NA	1301	29465	561	1654	543311	118747	162289
bsdb:73/1/1_Obesity:obese_vs_normal-weight_UP	NA	216851	841	28050	33042
bsdb:73/1/2_Obesity:obese_vs_normal-weight_DOWN	NA	816
bsdb:73/2/1_Obesity:obese-+-metabolic-syndrome_vs_normal-weight_UP	NA	216851	841	28050	33042
bsdb:73/2/2_Obesity:obese-+-metabolic-syndrome_vs_normal-weight_DOWN	NA	816
bsdb:74/1/2_Obesity:obese_vs_non-obese_DOWN	NA	239759	195950
bsdb:74/2/2_Obesity:obese_vs_Nonobese-microbiota-cluster_DOWN	NA	239759
bsdb:75/1/1_Smoking-behavior:right-oropharynx-of-smokers_vs_right-oropharynx-of-nonsmokers_UP	NA	1016	1257	848	12916	724	482
bsdb:75/1/2_Smoking-behavior:right-oropharynx-of-smokers_vs_right-oropharynx-of-nonsmokers_DOWN	NA	906	29465	52228	1301
bsdb:75/2/1_Smoking-behavior:left-oropharynx-of-smokers_vs_left-oropharynx-of-nonsmokers_UP	NA	1016	848	482	416916
bsdb:75/2/2_Smoking-behavior:left-oropharynx-of-smokers_vs_left-oropharynx-of-nonsmokers_DOWN	NA	1654	84111	906	29465	34104
bsdb:76/1/1_Type-I-diabetes-mellitus:type-I-diabetes-mellitus-children_vs_controls_UP	NA	572511	904
bsdb:76/1/2_Type-I-diabetes-mellitus:type-I-diabetes-mellitus-children_vs_controls_DOWN	NA	39948	724	1392389
bsdb:77/1/2_Bipolar-disorder:atypical-antipsychotic-users_vs_non-users_DOWN	NA	239934
bsdb:78/1/1_Stimulus-or-stress-design:limited-nesting-stress_vs_controls_UP	NA	1350	1301	2740	1375	227979	66831	1485	1716	872	117563	32207	583	100883	1357	191303	2316
bsdb:78/1/2_Stimulus-or-stress-design:limited-nesting-stress_vs_controls_DOWN	NA	1263	841	33042	1573535	1279	375288	28050	244127	724	283168
bsdb:79/1/1_Obesity:Laparoscopic-sleeve-gastrectomy-baseline_vs_Laparoscopic-sleeve-gastrectomy-after-3-months-and-6-Months-combined_UP	NA	33042	189330	1263
bsdb:79/2/1_Obesity:Very-low-calorie-diet-baseline_vs_very-low-calorie-diet-after-3-months-and-6-months_DOWN	NA	100883	1350	61170	1578	265975	1263
bsdb:80/1/1_Type-I-diabetes-mellitus:Type-I-diabetic-children-at-onset_vs_controls_UP	NA	816
bsdb:80/1/2_Type-I-diabetes-mellitus:Type-I-diabetic-children-at-onset_vs_controls_DOWN	NA	838	904	158846
bsdb:83/1/1_Obesity:before-surgery_vs_after-surgery_UP	NA	207244	33042	216851	209	5782	40637
bsdb:83/1/2_Obesity:before-surgery_vs_after-surgery_DOWN	NA	544	547	590	29465	5140
bsdb:85/1/1_Cesarean-section:two-day-aged-babies-c-section_vs_vaginal-delivery_UP	NA	570	1266
bsdb:85/2/1_Cesarean-section:two-day-aged-babies-c-section_vs_vaginal-delivery_DOWN	NA	816
bsdb:86/1/1_Cesarean-section:c-section_vs_vaginal-delivery-at-day-3_UP	NA	1279	1578
bsdb:87/1/1_Type-I-diabetes-mellitus:Type-I-Diabetics_vs_maturity-onset-diabetes-of-the-young-2-(MODY2)-and-healthy-Controls_UP	NA	572511	816	29465	1263	1301	547	40544
bsdb:87/2/1_Type-I-diabetes-mellitus:Type-I-Diabetics-and-maturity-onset-diabetes-of-the-young-2-(MODY2)_vs_healthy-Controls_DOWN	NA	28050	841	207244	216851
bsdb:88/1/1_Schizophrenia:schizophrenia_vs_non-psychiatric-controls_UP	NA	165779	906	572511
bsdb:88/1/2_Schizophrenia:schizophrenia_vs_non-psychiatric-controls_DOWN	NA	724	40544	1485
bsdb:89/1/1_Crohn's-disease:CD-patients_vs_Healthy-controls_UP	NA	1654	1678
bsdb:89/1/2_Crohn's-disease:CD-patients_vs_Healthy-controls_DOWN	NA	698776	1730	61170	375288	841	1017280	292632
bsdb:90/1/1_Cesarean-section:transitional-stool_vs_mecomium-in-vaginal-delivery_UP	NA	209
bsdb:90/1/2_Cesarean-section:transitional-stool_vs_mecomium-in-vaginal-delivery_DOWN	NA	469	70774	1301	13687	1716	42255	165695	129337	482	165779	407	29465	1269	1357	357	212791	29580	80865
bsdb:90/2/1_Cesarean-section:transitional-stool_vs_mecomium-in-C-section-delivery_UP	NA	29465	1350
bsdb:90/2/2_Cesarean-section:transitional-stool_vs_mecomium-in-C-section-delivery_DOWN	NA	286	400634	1716	1301	106589	32067	1654	848	13687	42255	2745	157	724	41275	2717	165695
bsdb:91/1/1_Cesarean-section:C-section_vs_vaginal-delivery_UP	NA	1386	1298	1730	216851	40323
bsdb:91/1/2_Cesarean-section:C-section_vs_vaginal-delivery_DOWN	NA	1743	283	286
bsdb:92/2/1_Non-alcoholic-fatty-liver-disease:non-alcoholic-fatty-liver-disease-patients_vs_healthy-controls_UP	NA	838
bsdb:93/1/1_Cesarean-section:C-section_vs_vaginal-delivery_DOWN	NA	1279
bsdb:93/2/1_Cesarean-section:Antimicrobials-use-during-delivery-(yes)_vs_Antimicrobials-use-during-delivery-(no)_UP	NA	1678
bsdb:95/1/1_Obesity:overweight/obese-babies_vs_control-babies-at-the-age-of-3_UP	NA	189330	841
bsdb:95/1/2_Obesity:overweight/obese-babies_vs_control-babies-at-the-age-of-3_DOWN	NA	375288
bsdb:96/1/1_Obesity:obese_vs_controls_UP	NA	239759	165779	33042	848	543311
bsdb:96/1/2_Obesity:obese_vs_controls_DOWN	NA	816	872	216851	150022	1164882	133925	292632
bsdb:97/2/1_Obesity:Roux-en-Y-gastric-bypass-(RYGB)_vs_healthy-controls_UP	NA	1678	906
bsdb:98/1/1_Chronic-kidney-disease:CKD_vs_controls_UP	NA	469	1386	81	445	68	1664383	286	504481	613	629
bsdb:98/1/2_Chronic-kidney-disease:CKD_vs_controls_DOWN	NA	1705353	911113	1716	1210119	265	13687	40323	1506577
bsdb:99/1/2_Obesity:obese_vs_controls_DOWN	NA	816	239759
bsdb:100/1/1_Obesity:High-BMI_vs_low-BMI_UP	NA	613	838
bsdb:100/2/1_Obesity:Abdominal-obesity_vs_non-abdominal-obesity_UP	NA	613	838
bsdb:100/2/2_Obesity:Abdominal-obesity_vs_non-abdominal-obesity_DOWN	NA	119852
bsdb:101/1/1_Obesity:obese_vs_lean-controls_UP	NA	1578
bsdb:102/1/1_Type-II-diabetes-mellitus:Women-with-gestational-DM_vs_normoglycemic-controls_UP	NA	838	1263
bsdb:102/1/2_Type-II-diabetes-mellitus:Women-with-gestational-DM_vs_normoglycemic-controls_DOWN	NA	572511	239759
bsdb:103/1/1_Unipolar-depression:depressed-female_vs_Healthy-Controls_UP	NA	572511	1654	1678	553372	1380	84111	644652	133925	1730	207244	841	216851	872
bsdb:103/1/2_Unipolar-depression:depressed-female_vs_Healthy-Controls_DOWN	NA	404402	40544	638847
bsdb:103/2/1_Unipolar-depression:depressed-male_vs_Healthy-Controls_UP	NA	1380	816	29465
bsdb:103/2/2_Unipolar-depression:depressed-male_vs_Healthy-Controls_DOWN	NA	644652	109326	638847
bsdb:104/1/1_Unipolar-depression:major-depressive-disorder-(visit-1)_vs_healthy-controls_UP	NA	838	570	1301
bsdb:104/2/1_Unipolar-depression:major-depressive-disorder-(visit-2)_vs_healthy-controls_UP	NA	838	1301
bsdb:105/1/1_Bipolar-disorder:Bipolar_vs_Healthy-controls_DOWN	NA	216851
bsdb:106/1/1_Bipolar-disorder:bipolar-disorder-patients_vs_healthy-controls_UP	NA	946234
bsdb:107/1/2_Anorexia-nervosa:Anorexia-patients-at-T1_vs_Healthy-comparison-group-(HCG)_DOWN	NA	207244	216851
bsdb:107/2/1_Anorexia-nervosa:Anorexia-patients-at-T2_vs_Healthy-comparison-group-(HCG)_UP	NA	375288
bsdb:108/1/1_Anorexia-nervosa:anorexia-nervosa-patients_vs_healthy-controls_DOWN	NA	1301
bsdb:109/1/1_Anorexia-nervosa:anorexia-patients-before-weight-gain_vs_normal-weight-participants_UP	NA	207244	244127	1678	1485
bsdb:109/1/2_Anorexia-nervosa:anorexia-patients-before-weight-gain_vs_normal-weight-participants_DOWN	NA	204475	841
bsdb:109/2/1_Anorexia-nervosa:anorexia-patients-after-weight-gain_vs_HC_UP	NA	207244	1678	1578	1357	1017280	1263	44748	1485
bsdb:109/2/2_Anorexia-nervosa:anorexia-patients-after-weight-gain_vs_HC_DOWN	NA	816	1485
bsdb:110/1/1_Schizophrenia:schizophrenia_vs_healthy-controls_DOWN	NA	1678	1578
bsdb:111/1/1_Attention-deficit-hyperactivity-disorder:ADHD_vs_healthy-control_UP	NA	469	990721	100883	1573534	1473205	40323	1505652
bsdb:111/1/2_Attention-deficit-hyperactivity-disorder:ADHD_vs_healthy-control_DOWN	NA	39948	1506553	216851	40544	904	1508657	1506577
bsdb:112/1/1_Attention-deficit-hyperactivity-disorder:ADHD-males_vs_controls_UP	NA	482	816
bsdb:112/1/2_Attention-deficit-hyperactivity-disorder:ADHD-males_vs_controls_DOWN	NA	838	375288
bsdb:113/1/1_Unipolar-depression:MDD_vs_controls_DOWN	NA	1678
bsdb:114/1/1_Unipolar-depression:MDD_vs_controls_UP	NA	846	543311	118747	286	1257	1378
bsdb:114/1/2_Unipolar-depression:MDD_vs_controls_DOWN	NA	216851	33042	572511	189330
bsdb:115/1/1_Unipolar-depression:MDD_vs_controls_UP	NA	1485	1678	459786	1301	970	906	904	838
bsdb:115/1/2_Unipolar-depression:MDD_vs_controls_DOWN	NA	816	283168	195950
bsdb:115/2/1_Bipolar-disorder:bipolar_vs_healthy-controls_DOWN	NA	816	283168	195950
bsdb:116/1/1_Type-I-diabetes-mellitus:children-with-type-1-diabetes_vs_healthy-controls_UP	NA	1485	816	29465
bsdb:116/1/2_Type-I-diabetes-mellitus:children-with-type-1-diabetes_vs_healthy-controls_DOWN	NA	838	1678	1578
bsdb:117/1/1_Pneumonia:elderly-pneumonia-patients_vs_elderly-controls_UP	NA	1578	32207
bsdb:117/1/2_Pneumonia:elderly-pneumonia-patients_vs_elderly-controls_DOWN	NA	32067	196082
bsdb:117/2/1_Pneumonia:adult-pneumonia-patients_vs_adult-controls_UP	NA	1578	32207
bsdb:117/2/2_Pneumonia:adult-pneumonia-patients_vs_adult-controls_DOWN	NA	724	32067	482
bsdb:118/1/1_Cesarean-section:cesarean-born_vs_vaginal-born-children_UP	NA	1578
bsdb:118/1/2_Cesarean-section:cesarean-born_vs_vaginal-born-children_DOWN	NA	1678
bsdb:118/2/1_Cesarean-section:cesarean-born-and-mixed-fed_vs_cesarean-born-and-breastfed_UP	NA	29465	1350
bsdb:118/2/2_Cesarean-section:cesarean-born-and-mixed-fed_vs_cesarean-born-and-breastfed_DOWN	NA	1506577	838	216851
bsdb:119/1/1_Type-II-diabetes-mellitus:Metaformin-positive_vs_Metaformin-negative-among-Opoid-negative_UP	NA	1678
bsdb:119/2/1_Type-II-diabetes-mellitus:Metaformin-positive_vs_Metaformin-negative-among-Opoid-positive_UP	NA	838
bsdb:119/2/2_Type-II-diabetes-mellitus:Metaformin-positive_vs_Metaformin-negative-among-Opoid-positive_DOWN	NA	1678
bsdb:120/1/1_Physical-activity:Activity-Based-Anorexia-group_vs_exercise-group_UP	NA	838	1485	1350	816
bsdb:120/1/2_Physical-activity:Activity-Based-Anorexia-group_vs_exercise-group_DOWN	NA	816	1678	1578
bsdb:120/2/1_Physical-activity:Ad-libitum-group_vs_exercise-group_UP	NA	816	838	1350	1485
bsdb:120/2/2_Physical-activity:Ad-libitum-group_vs_exercise-group_DOWN	NA	1678	1578
bsdb:121/1/1_Gingivitis:gingivitis_vs_healthy-controls_UP	NA	836	195950	157
bsdb:121/1/2_Gingivitis:gingivitis_vs_healthy-controls_DOWN	NA	1016
bsdb:122/1/1_Breast-carcinoma:tumor-tissue_vs_normal-tissue_UP	NA	237	407
bsdb:122/1/2_Breast-carcinoma:tumor-tissue_vs_normal-tissue_DOWN	NA	13687	914	374
bsdb:123/1/1_Diet:high-fat-diet_vs_low-fat-diet_UP	NA	1357	117563	1486725	109326	1485	33042	1730	216851	946234	119852	100175	1017280	44748	1506577	1505663	61170	32207	447020	102106
bsdb:123/1/2_Diet:high-fat-diet_vs_low-fat-diet_DOWN	NA	544	397864	816	588605
bsdb:124/1/2_Diet:body-builders-(high-protein)_vs_distance-runners-(high-carb)_DOWN	NA	1678	561	1357
bsdb:124/2/1_Diet:body-builders-(high-protein)_vs_control_UP	NA	40544	216851	1485	724	1432051
bsdb:124/2/2_Diet:body-builders-(high-protein)_vs_control_DOWN	NA	1678	577310	1243
bsdb:125/1/1_Squamous-cell-carcinoma:Oral-Squamous-Cell-Cancer-patients_vs_noncancer-individuals_UP	NA	1257	848	1283313	1016
bsdb:125/1/2_Squamous-cell-carcinoma:Oral-Squamous-Cell-Cancer-patients_vs_noncancer-individuals_DOWN	NA	32207	724
bsdb:126/1/1_Oral-leukoplakia:Oral-leukoplakia_vs_healthy-controls_UP	NA	724	1386
bsdb:126/1/2_Oral-leukoplakia:Oral-leukoplakia_vs_healthy-controls_DOWN	NA	1301	46123
bsdb:126/2/1_Oral-squamous-cell-carcinoma:Oral-Squamous-Cell-Cancer-patients_vs_healthy-controls_UP	NA	724	1386
bsdb:126/2/2_Oral-squamous-cell-carcinoma:Oral-Squamous-Cell-Cancer-patients_vs_healthy-controls_DOWN	NA	1301	46123
bsdb:127/1/1_Alcohol-drinking:alcohol-overconsumers_vs_controls_UP	NA	1485	61170	40544
bsdb:127/1/2_Alcohol-drinking:alcohol-overconsumers_vs_controls_DOWN	NA	216851
bsdb:127/2/1_Alcohol-drinking:alcohol-overconsumers_vs_controls_UP	NA	904	118747	1485	2383	561	61170	570	158846	581	32207	40544
bsdb:127/2/2_Alcohol-drinking:alcohol-overconsumers_vs_controls_DOWN	NA	447020	102106	216851	52225	283168	265975	838	1279	674963
bsdb:128/1/1_Gastric-cancer:gastric-cancer_vs_intestinal-metaplasia_UP	NA	1283313	43996	39948	848	543311	1578	437755	2740	1257	838	84108	1301
bsdb:128/1/2_Gastric-cancer:gastric-cancer_vs_intestinal-metaplasia_DOWN	NA	469	57739	378210	235572
bsdb:128/2/1_Gastric-cancer:gastric-cancer_vs_atrophic-gastric_UP	NA	1301	1257	1378	848	543311	1578	1730	1283313	838	39948	84108	2740	43996	437755
bsdb:128/2/2_Gastric-cancer:gastric-cancer_vs_atrophic-gastric_DOWN	NA	57739	235572
bsdb:129/1/1_Multiple-sclerosis:Multiple-sclerosis_vs_Healthy-controls_UP	NA	572511	189330	237	13159	84567	286
bsdb:129/1/2_Multiple-sclerosis:Multiple-sclerosis_vs_Healthy-controls_DOWN	NA	447020	572511	102106	100883	724	1578	2093	375288
bsdb:130/1/1_Diet:high-Southern-European-Atlantic-Diet_vs_low-Southern-European-Atlantic-Diet_UP	NA	1678
bsdb:130/2/1_Diet:intermediate-Southern-European-Atlantic-Diet_vs_low-Southern-European-Atlantic-Diet_UP	NA	1678
bsdb:131/1/1_Diet:Time-7-days_vs_Time-0-days-controls_DOWN	NA	119852
bsdb:131/2/2_Diet:Time-7-days_vs_Time-0-days-Cara-Cara_DOWN	NA	283168
bsdb:132/1/1_Diet:Meat_vs_mushroom_UP	NA	189330
bsdb:132/1/2_Diet:Meat_vs_mushroom_DOWN	NA	816	375288	33042	207244	40544
bsdb:134/1/1_Diet:6-months-after-Average-Danish-Diet_vs_before-Average-Danish-Diet_UP	NA	872
bsdb:134/2/1_Diet:6-months-after--New-Nordic-Diet_vs_before--New-Nordic-Diet_UP	NA	1485	872
bsdb:134/2/2_Diet:6-months-after--New-Nordic-Diet_vs_before--New-Nordic-Diet_DOWN	NA	239759
bsdb:135/1/1_Diet:High-animal-protein_vs_low-animal-protein_UP	NA	816
bsdb:136/1/2_Diet:Low-vegetable,-fruit,-grains,_vs_high-vegetable,-fruit,-grain_DOWN	NA	1485	1730	459786
bsdb:136/2/1_Diet:two-weeks-after-a-dietry-intervention_vs_before-dietary-intervention_UP	NA	84111	1357	1301	1350	1730	102106	1485	1678	572511
bsdb:136/2/2_Diet:two-weeks-after-a-dietry-intervention_vs_before-dietary-intervention_DOWN	NA	872	39948	216851	1263	84108	29465
bsdb:137/1/1_Colorectal-cancer:CRC_vs_controls_UP	NA	642	848
bsdb:137/1/2_Colorectal-cancer:CRC_vs_controls_DOWN	NA	816	35832	544	413496	189330	1730	841
bsdb:138/1/1_Lung-cancer:lung-cancer_vs_controls_UP	NA	1654	1380	1350	1505663	1573535	1392389	69965	160674
bsdb:138/1/2_Lung-cancer:lung-cancer_vs_controls_DOWN	NA	447020	226	1678	102106	1348911	189330	28050	175304	437755	162289	1257	46205	1508657	40544
bsdb:139/1/2_Head-and-neck-squamous-cell-carcinoma:HNSCC_vs_controls_DOWN	NA	1716	32257
bsdb:140/1/1_Multiple-sclerosis:multiple-sclerosis_vs_healthy-controls_UP	NA	2172	239934	84593
bsdb:140/1/2_Multiple-sclerosis:multiple-sclerosis_vs_healthy-controls_DOWN	NA	574697
bsdb:140/2/1_Multiple-sclerosis:multiple-sclerosis-patients_vs_controls_UP	NA	84593	2172	239934
bsdb:140/2/2_Multiple-sclerosis:multiple-sclerosis-patients_vs_controls_DOWN	NA	574697
bsdb:141/1/1_Preterm-premature-rupture-of-the-membranes:PPROM_vs_controls_UP	NA	165779	39948	162289	543311	43996	838	1301
bsdb:141/1/2_Preterm-premature-rupture-of-the-membranes:PPROM_vs_controls_DOWN	NA	1578
bsdb:142/1/1_Oral-squamous-cell-carcinoma:HNSCC_vs_Controls_UP	NA	1578	543311	1257	1279	1301	195950	29465
bsdb:142/1/2_Oral-squamous-cell-carcinoma:HNSCC_vs_Controls_DOWN	NA	416916	47670	724	482	32067
bsdb:144/1/1_Air-pollution:moderately-polluted-region-(B)_vs_lightly-poluuted-region-(A)_UP	NA	32207	265975	482	1654
bsdb:144/1/2_Air-pollution:moderately-polluted-region-(B)_vs_lightly-poluuted-region-(A)_DOWN	NA	848	475	1257	836	838	29465
bsdb:144/2/2_Air-pollution:heavily-polluted-region-(C)_vs_lightly-poluuted-region-(A)_DOWN	NA	194	1016	848	475	1257	836	838	29465
bsdb:146/1/1_Oral-squamous-cell-carcinoma:oral-squamous-cell-carcinoma-(OSCC)_vs_Controls_UP	NA	2093	157	194	538	82202	1283313	848	970	39948	1257	44259	2740	43996	543311	1016
bsdb:146/1/2_Oral-squamous-cell-carcinoma:oral-squamous-cell-carcinoma-(OSCC)_vs_Controls_DOWN	NA	906	1213720	117563	47670	29465	1301	196081	32207	1654
bsdb:147/1/1_Squamous-cell-carcinoma:laryngeal-squamous-cell-carcinoma-(LSCC)_vs_controls_UP	NA	848	838	543311	1257	39948	43996	970	157	32008
bsdb:147/1/2_Squamous-cell-carcinoma:laryngeal-squamous-cell-carcinoma-(LSCC)_vs_controls_DOWN	NA	1301	32207
bsdb:148/1/1_Polycystic-ovary-syndrome:NIR-PCOS---NIR(Non-Insulin-Resistance)_vs_HC---Healthy-Controls_UP	NA	816	28050
bsdb:148/1/2_Polycystic-ovary-syndrome:NIR-PCOS---NIR(Non-Insulin-Resistance)_vs_HC---Healthy-Controls_DOWN	NA	838
bsdb:148/2/1_Polycystic-ovary-syndrome:IR-PCOS-IR-(Insulin-Resistance)_vs_HC---Healthy-Controls_UP	NA	816	28050
bsdb:148/2/2_Polycystic-ovary-syndrome:IR-PCOS-IR-(Insulin-Resistance)_vs_HC---Healthy-Controls_DOWN	NA	838
bsdb:149/1/1_Obesity:Obese-children_vs_Normal-weight-children_UP	NA	158846
bsdb:149/1/2_Obesity:Obese-children_vs_Normal-weight-children_DOWN	NA	207244	61170	459786
bsdb:150/1/1_Head-and-neck-carcinoma:Throat-cancer_vs_Healthy-controls_UP	NA	286	416916	216851	1508657	47670	909656	816
bsdb:150/1/2_Head-and-neck-carcinoma:Throat-cancer_vs_Healthy-controls_DOWN	NA	713	109326	59735	194	1716	1730	848	724	1506553	32067	475	482	543311	1257	836	838	841	32207	970	157	29465
bsdb:150/2/1_Head-and-neck-carcinoma:Cancer_vs_Vocal-cord-polyp_UP	NA	547	416916	286
bsdb:150/2/2_Head-and-neck-carcinoma:Cancer_vs_Vocal-cord-polyp_DOWN	NA	848	838	44259	713	209	1730	841	109326	872	43994
bsdb:152/1/1_Cervical-cancer:cervical-cancer_vs_healthy-controls_UP	NA	189330	581	583	1263	22	83770
bsdb:152/1/2_Cervical-cancer:cervical-cancer_vs_healthy-controls_DOWN	NA	2745	33024
bsdb:153/1/1_Prostate-cancer:prostate-cancer_vs_non-prostate-cancer_UP	NA	2747	129337	1357	1301
bsdb:153/1/2_Prostate-cancer:prostate-cancer_vs_non-prostate-cancer_DOWN	NA	114627	413496	1350	44249
bsdb:154/1/1_Colorectal-cancer:colorectal-cancer_vs_healthy-controls_UP	NA	46913	44249	59732
bsdb:154/1/2_Colorectal-cancer:colorectal-cancer_vs_healthy-controls_DOWN	NA	838	1730	570	32067	33024	86331	613
bsdb:155/1/1_Esophageal-cancer:Esophageal-Adenocarcinoma-(EAC)_vs_controls_UP	NA	29465	970
bsdb:155/1/2_Esophageal-cancer:Esophageal-Adenocarcinoma-(EAC)_vs_controls_DOWN	NA	1283313	265975	123375	482	724
bsdb:155/2/1_Esophageal-cancer:Esophageal-Squamous-cell-carcinoma-(ESCC)_vs_controls_UP	NA	59735
bsdb:155/2/2_Esophageal-cancer:Esophageal-Squamous-cell-carcinoma-(ESCC)_vs_controls_DOWN	NA	838
bsdb:156/1/1_Gastric-adenocarcinoma:Gastric-cancer_vs_healthy-controls_UP	NA	838	561	620	570	1578	1301	239759	29465	1678	990721	375288
bsdb:156/1/2_Gastric-adenocarcinoma:Gastric-cancer_vs_healthy-controls_DOWN	NA	216851	841	28050	1506553
bsdb:156/2/1_Gastric-adenocarcinoma:Gastric-cancer_vs_healthy-controls_UP	NA	1729679	838	561	620	570	1301	1578	239759	1678	29465
bsdb:156/2/2_Gastric-adenocarcinoma:Gastric-cancer_vs_healthy-controls_DOWN	NA	841	28050	1506553
bsdb:157/1/1_Esophageal-cancer:Esophageal-Squamous-cell-carcinoma-(ESCC)_vs_Dysplasia_UP	NA	44259	1578	836	838	1301	46123
bsdb:157/1/2_Esophageal-cancer:Esophageal-Squamous-cell-carcinoma-(ESCC)_vs_Dysplasia_DOWN	NA	416916	1380	118747	194	43996	1716	44259	848	724	963	47670	32067	482	265975	2740	32207	29465	2717
bsdb:157/2/1_Esophageal-cancer:Esophageal-Squamous-cell-carcinoma-(ESCC)_vs_Healthy-controls_UP	NA	816	1016	308865	836	838	1301	830
bsdb:157/2/2_Esophageal-cancer:Esophageal-Squamous-cell-carcinoma-(ESCC)_vs_Healthy-controls_DOWN	NA	2147	1654	416916	1380	118747	830	194	2717	43996	1716	39948	44259	724	47670	32067	906	482	265975	2740	1257	32207	970	157	29465
bsdb:158/1/1_Lung-cancer:lung-cancer-patients_vs_healthy-volunteers_UP	NA	816	29465	848	33024
bsdb:158/1/2_Lung-cancer:lung-cancer-patients_vs_healthy-volunteers_DOWN	NA	579	216851	547	39948	561	620
bsdb:158/2/1_Lung-cancer:lung-cancer-patients_vs_healthy-volunteers_UP	NA	848	570	816
bsdb:158/2/2_Lung-cancer:lung-cancer-patients_vs_healthy-volunteers_DOWN	NA	39948	547	561	216851	620
bsdb:159/1/1_Gingival-disease:1-month-after-the-placement-of-the-brackets_vs_before_UP	NA	713	1016
bsdb:159/2/1_Gingival-disease:3-months-after-the-placement-of-the-brackets_vs_before_UP	NA	1016
bsdb:159/2/2_Gingival-disease:3-months-after-the-placement-of-the-brackets_vs_before_DOWN	NA	117563
bsdb:160/1/1_Head-and-neck-carcinoma:OCC-&-OPC_vs_High-risk-individuals_DOWN	NA	346096	1716	836	1654	713	1016	848	416916	47670
bsdb:160/2/1_Head-and-neck-carcinoma:OCC-&-OPC_vs_Normal-Healthy-Controls_UP	NA	265975
bsdb:160/2/2_Head-and-neck-carcinoma:OCC-&-OPC_vs_Normal-Healthy-Controls_DOWN	NA	32207	724	1716	346096	836	1016
bsdb:161/1/1_Lung-cancer:NSCLC_vs_Healthy-controls_UP	NA	1301	47670
bsdb:161/1/2_Lung-cancer:NSCLC_vs_Healthy-controls_DOWN	NA	838
bsdb:163/1/1_Squamous-cell-carcinoma:Oropharyngeal-Squamous-Cell-Carcinoma_vs_Healthy-Controls_UP	NA	1654	1678	872	437755	55506	970	157
bsdb:163/1/2_Squamous-cell-carcinoma:Oropharyngeal-Squamous-Cell-Carcinoma_vs_Healthy-Controls_DOWN	NA	43996	724	482	838	1301	29465
bsdb:163/2/1_Squamous-cell-carcinoma:Oropharyngeal-Squamous-Cell-Carcinoma_vs_Healthy-Controls_UP	NA	146	29465
bsdb:163/2/2_Squamous-cell-carcinoma:Oropharyngeal-Squamous-Cell-Carcinoma_vs_Healthy-Controls_DOWN	NA	1213720
bsdb:164/1/1_Gastric-cancer:gastric-cancer_vs_controls_UP	NA	838	1301	29465	1654	32067
bsdb:164/1/2_Gastric-cancer:gastric-cancer_vs_controls_DOWN	NA	482	848	724	836	1301
bsdb:165/1/1_Chronic-kidney-disease:chronic-kidney-disease-patients_vs_healthy-controls_UP	NA	1283313	1485	872	407	577309
bsdb:165/1/2_Chronic-kidney-disease:chronic-kidney-disease-patients_vs_healthy-controls_DOWN	NA	239934	174708	580024	1730	209	1578	1357	1243	248038	133925	265975	577310	1427376	638847	32207	2753
bsdb:166/1/1_Chronic-kidney-disease:chronic-kidney-disease_vs_healthy-controls_UP	NA	816	84111	1505663	561	946234	375288	1508657	1769710	620	46255
bsdb:166/1/2_Chronic-kidney-disease:chronic-kidney-disease_vs_healthy-controls_DOWN	NA	1506577	102106	580596	1501226	1263	841	33042	292632	28050	2747	39948
bsdb:167/1/1_Squamous-cell-carcinoma:Stage-4_vs_healthy-controls_UP	NA	82202
bsdb:168/1/1_Chronic-hepatitis-B-virus-infection:chronic-hepatitis-B-yellow-tongue-coating-patients_vs_healthy-controls_UP	NA	283	47670	482
bsdb:168/1/2_Chronic-hepatitis-B-virus-infection:chronic-hepatitis-B-yellow-tongue-coating-patients_vs_healthy-controls_DOWN	NA	194	1331051	543311	1481960	196081
bsdb:168/2/1_Chronic-hepatitis-B-virus-infection:chronic-hepatitis-B-yellow-tongue-coating-patients_vs_chronic-hepatitis-B-white-tongue-coating-patients_UP	NA	2093	482
bsdb:168/2/2_Chronic-hepatitis-B-virus-infection:chronic-hepatitis-B-yellow-tongue-coating-patients_vs_chronic-hepatitis-B-white-tongue-coating-patients_DOWN	NA	43996	838
bsdb:169/1/1_Gastric-cancer:white-thin-tongue-coating-GC-patient_vs_other-coatings_UP	NA	47670	50729
bsdb:169/1/2_Gastric-cancer:white-thin-tongue-coating-GC-patient_vs_other-coatings_DOWN	NA	1213720
bsdb:170/1/1_Lung-cancer:cancerous-site_vs_controls_UP	NA	1301
bsdb:170/1/2_Lung-cancer:cancerous-site_vs_controls_DOWN	NA	1279
bsdb:170/2/1_Lung-cancer:paired-contralateral-non-cancerous-site-in-lung-cancer-patients_vs_controls_UP	NA	1016	237	724	32067	482	970	1301
bsdb:170/2/2_Lung-cancer:paired-contralateral-non-cancerous-site-in-lung-cancer-patients_vs_controls_DOWN	NA	469
bsdb:171/1/1_Digestive-system-cancer:digestive-tract-cancer-patients_vs_controls_UP	NA	1716	848	482	29465
bsdb:171/1/2_Digestive-system-cancer:digestive-tract-cancer-patients_vs_controls_DOWN	NA	836	838	32207
bsdb:171/2/1_Tongue-neoplasm:tongue/pharyngeal-cancer-patients_vs_controls_UP	NA	1716	32067	482	838
bsdb:171/2/2_Tongue-neoplasm:tongue/pharyngeal-cancer-patients_vs_controls_DOWN	NA	1301
bsdb:172/1/1_Cannabis-use:marijuana-usage-group_vs_controls-(lateral-border-of-tongue)_UP	NA	85413	80865	88	86331	32207
bsdb:172/1/2_Cannabis-use:marijuana-usage-group_vs_controls-(lateral-border-of-tongue)_DOWN	NA	59735	1016	848	836
bsdb:172/2/1_Cannabis-use:marijuana-usage-group_vs_controls-(oral-pharynx)_UP	NA	86331	970	29465
bsdb:172/2/2_Cannabis-use:marijuana-usage-group_vs_controls-(oral-pharynx)_DOWN	NA	59735	1301
bsdb:173/1/1_Pancreatic-carcinoma:pancreatic-cancer_vs_healthy-controls_UP	NA	904	416916	194	135858	82202	413496	547	52228	570	1578	32067	200903	838	970	29465
bsdb:173/1/2_Pancreatic-carcinoma:pancreatic-cancer_vs_healthy-controls_DOWN	NA	239934	239759	207244	244127	1678	35832	572511	41275	580596	1485	33042	189330	84111	946234	204475	158846	906	86331	651554	577310	583	379	44748
bsdb:173/2/1_Pancreatic-carcinoma:pancreatic-head-cancer-with-obstruction_vs_pancreatic-head-cancer-without-obstruction_UP	NA	283	117563	140625	32067	115543	46205	1200657	1301
bsdb:173/2/2_Pancreatic-carcinoma:pancreatic-head-cancer-with-obstruction_vs_pancreatic-head-cancer-without-obstruction_DOWN	NA	118966	561	620
bsdb:174/1/1_Gastric-cancer:cancer-tissue_vs_adjacent-normal-tissue_UP	NA	970	838	1164882	1301	1257	13687	469	1386
bsdb:174/1/2_Gastric-cancer:cancer-tissue_vs_adjacent-normal-tissue_DOWN	NA	613	209	1543704	1357
bsdb:174/2/1_Gastric-cancer:H-pylori-sequencing-positive_vs_H-pylori-sequencing-negative_UP	NA	416916	111142	292480
bsdb:174/2/2_Gastric-cancer:H-pylori-sequencing-positive_vs_H-pylori-sequencing-negative_DOWN	NA	286
bsdb:175/1/1_Pancreatic-carcinoma:pancreatic-cancer-cases_vs_controls_UP	NA	1283313
bsdb:175/1/2_Pancreatic-carcinoma:pancreatic-cancer-cases_vs_controls_DOWN	NA	32067
bsdb:176/1/1_Leukemia:survivors-of-acute-lymphoblastic-leukemia_vs_controls_UP	NA	1716	162289	150022	1279	1654
bsdb:176/1/2_Leukemia:survivors-of-acute-lymphoblastic-leukemia_vs_controls_DOWN	NA	216851	1263	28050
bsdb:177/1/1_Colorectal-cancer:colon-cancer-patients_vs_control-group_UP	NA	35832	1485	39948	848	2172	119852	1257
bsdb:177/1/2_Colorectal-cancer:colon-cancer-patients_vs_control-group_DOWN	NA	1301
bsdb:177/2/1_Colorectal-cancer:colon-cancer-patients-(tumor-samples)_vs_control-group_UP	NA	2172	1257	970
bsdb:178/1/1_Gastric-cancer:gastric-cancer-peritumor-group_vs_normal_UP	NA	2745	22	1350	41275	1663	1763
bsdb:178/1/2_Gastric-cancer:gastric-cancer-peritumor-group_vs_normal_DOWN	NA	106589	445
bsdb:178/2/1_Gastric-cancer:gastric-cancer-tumor-group_vs_peritumor_UP	NA	1350	970	2745	1678	239759	1263	39948	459786	33042	841	906	1279	572511
bsdb:178/2/2_Gastric-cancer:gastric-cancer-tumor-group_vs_peritumor_DOWN	NA	379	158846	22	1763	1578
bsdb:179/1/1_Esophageal-squamous-cell-carcinoma:Oesophageal-cancer_vs_Healthy-controls_UP	NA	1654	1380	2717
bsdb:179/1/2_Esophageal-squamous-cell-carcinoma:Oesophageal-cancer_vs_Healthy-controls_DOWN	NA	848	836
bsdb:179/2/1_Esophageal-squamous-cell-carcinoma:Oesophageal-cancer_vs_Healthy-controls_UP	NA	1654	1380
bsdb:179/2/2_Esophageal-squamous-cell-carcinoma:Oesophageal-cancer_vs_Healthy-controls_DOWN	NA	848	836
bsdb:181/1/1_Irritable-bowel-syndrome:IBS_vs_Healthy-control_UP	NA	239934	572511	946234	283168	459786	375288	29465
bsdb:181/1/2_Irritable-bowel-syndrome:IBS_vs_Healthy-control_DOWN	NA	838
bsdb:184/1/1_Prostate-cancer:prostate-cancer-patients_vs_controls_UP	NA	816
bsdb:184/1/2_Prostate-cancer:prostate-cancer-patients_vs_controls_DOWN	NA	216851	28050	258514
bsdb:185/1/1_Gastric-cancer:gastric-cancer_vs_controls_UP	NA	561	620	1485	29465
bsdb:185/1/2_Gastric-cancer:gastric-cancer_vs_controls_DOWN	NA	816
bsdb:185/2/1_Gastric-cancer:gastric-cancer_vs_healthy-gastric-cancer-(post-surgery)_UP	NA	570
bsdb:185/2/2_Gastric-cancer:gastric-cancer_vs_healthy-gastric-cancer-(post-surgery)_DOWN	NA	239934	620	1578	39948
bsdb:187/1/1_Medroxyprogesterone-acetate:naive-black-participants-(baseline-visit)_vs_depot-medroxyprogesterone-acetate-vaginal-microbiome-(visit-2)-among-black-participants_UP	NA	838
bsdb:187/2/1_Medroxyprogesterone-acetate:white-naiive-vaginal-microbiome-(baseline)_vs_black-naive-vaginal-microbiome-(baseline-visit-)_UP	NA	150022
bsdb:187/2/2_Medroxyprogesterone-acetate:white-naiive-vaginal-microbiome-(baseline)_vs_black-naive-vaginal-microbiome-(baseline-visit-)_DOWN	NA	1485	177971
bsdb:188/1/1_Cervical-cerclage:Vaginal-microbiome-of-symptomatic-women-prior-ro-cerclage_vs_Vaginal-microbiome-of-asymptomatic-women-prior-to-cerclage_UP	NA	2701
bsdb:189/1/1_Chronic-hepatitis-B-virus-infection:chronic-hepatitis-B-patients_vs_healthy-controls_UP	NA	158846	1654
bsdb:189/1/2_Chronic-hepatitis-B-virus-infection:chronic-hepatitis-B-patients_vs_healthy-controls_DOWN	NA	816	574697	375288	553372	239759	1263
bsdb:190/1/1_Environmental-exposure-measurement:one-month-age-infants-exposed-to-high-chemical-breast-milk_vs_one-month-age-infants-exposed-to-low-chemical-breast-milk-(<20th-percentile)_UP	NA	1485	1350
bsdb:190/1/2_Environmental-exposure-measurement:one-month-age-infants-exposed-to-high-chemical-breast-milk_vs_one-month-age-infants-exposed-to-low-chemical-breast-milk-(<20th-percentile)_DOWN	NA	1578	29465
bsdb:192/1/2_Irritable-bowel-syndrome:diarrhea-predominant-irritable-bowel-syndrome_vs_healthy-controls_DOWN	NA	216851
bsdb:192/2/1_Irritable-bowel-syndrome:diarrhea-predominant-irritable-bowel-syndrome_vs_healthy-controls_UP	NA	253238
bsdb:194/1/1_Ovarian-cancer:ovarian-cancer_vs_normal-tissue_UP	NA	212791	283	1279	165695	407	106589	586	196013	504481	12916	13687	469
bsdb:194/1/2_Ovarian-cancer:ovarian-cancer_vs_normal-tissue_DOWN	NA	236752	1357
bsdb:195/1/1_Chronic-hepatitis-B-virus-infection:chronic-hepatitis-B_vs_healthy-controls_UP	NA	629	44259
bsdb:195/1/2_Chronic-hepatitis-B-virus-infection:chronic-hepatitis-B_vs_healthy-controls_DOWN	NA	32067	1016
bsdb:196/1/1_Henoch-Schoenlein-purpura:Henoch-Schönlein-Purpura_vs_controls_UP	NA	29465	1350	158846	375288
bsdb:196/1/2_Henoch-Schoenlein-purpura:Henoch-Schönlein-Purpura_vs_controls_DOWN	NA	39948	724	570	28050	577310	841	1508657	1263	1301
bsdb:197/1/1_Asthma:severe-asthma_vs_non-asthma_UP	NA	239759	207244	816	1016	1432051	1730	216851	946234	5277	283168	459786	375288	4753	5533	1501226	841	1263
bsdb:197/1/2_Asthma:severe-asthma_vs_non-asthma_DOWN	NA	5206	237557	583	5615
bsdb:198/1/1_Henoch-Schoenlein-purpura:Henoch-Schönlein-Purpura_vs_controls_UP	NA	482	29465	838
bsdb:198/1/2_Henoch-Schoenlein-purpura:Henoch-Schönlein-Purpura_vs_controls_DOWN	NA	724	469
bsdb:199/1/2_Ovarian-cancer:ovarian-cancer_vs_controls_DOWN	NA	44249	2251
bsdb:200/1/2_Postmenopausal:Post-menopausal-patients_vs_Pre-menopausal-patients_UP	NA	1380	816	572511	194	1485	39948	216851	162290	33983	2740	162289	836	285105	72763	184869	165779	419014	1654	437755
bsdb:201/1/1_Leukemia:induction_vs_repeat-therapy_UP	NA	816	216851	459786	375288	1263
bsdb:201/1/2_Leukemia:induction_vs_repeat-therapy_DOWN	NA	1654	84111	1350	1573536	1578	292632	29465
bsdb:202/1/1_Autism:children-with-autism-mental-regression-(AMR)_vs_children-with-autism-non-mental-regression-(ANMR)_UP	NA	1350
bsdb:202/2/1_Autism:children-with-autism-non-mental-regression-(ANMR)_vs_healthy-controls_UP	NA	1678	1350
bsdb:204/1/1_Premature-birth:mothers-whose-newborns-were-delivered-at-<34-gestational-week_vs_mothers-whose-newborns-were-delivered-at-≥37-getastional-weeks_DOWN	NA	1678
bsdb:207/1/1_Vulvovaginitis:Women-with-BV_vs_Normal-controls_UP	NA	1380	118747	39948	2701	2050	836	168808
bsdb:207/1/2_Vulvovaginitis:Women-with-BV_vs_Normal-controls_DOWN	NA	1578
bsdb:208/1/1_Food-allergy:infants-with-food-allergies_vs_healthy-controls_UP	NA	207244	1485	1350	216851	946234	1578	838	1279
bsdb:208/1/2_Food-allergy:infants-with-food-allergies_vs_healthy-controls_DOWN	NA	816	572511	158846	906	1301	29465
bsdb:208/2/1_Food-allergy:infants-with-food-allergies_vs_healthy-controls_UP	NA	580596	1485
bsdb:208/2/2_Food-allergy:infants-with-food-allergies_vs_healthy-controls_DOWN	NA	906	68287	222	84111	237	40323	86331	59732	283
bsdb:209/1/1_Cesarean-section:C-section_vs_vaginal-delivery_UP	NA	29465	407	544	1279	1716	1301	12916	1743	117563	469	374	80865	1302778	1578	222	65551	28209	40323	114248	724	88	283	28067	504481	1357	547	150247	357
bsdb:209/1/2_Cesarean-section:C-section_vs_vaginal-delivery_DOWN	NA	561	816	1485	1678	1350	544	570	158851	620	1279	1716	1301
bsdb:210/1/1_Food-allergy:children-with-food-sensitization_vs_healthy-controls_UP	NA	239934	1678	102106	1350	216851	1578	841	1263	13687	292632	40544
bsdb:210/1/2_Food-allergy:children-with-food-sensitization_vs_healthy-controls_DOWN	NA	239759	816	375288	838	1301	29465
bsdb:211/1/1_Anemia:gestational-anemia-(GA1-group)_vs_healthy-controls(HC1-group)_UP	NA	244127	265975	543311	191303
bsdb:211/2/1_Anemia:gestational-anemia-(GA3-group)_vs_healthy-controls-(HC3-group)_UP	NA	1380	135858	84111
bsdb:211/2/2_Anemia:gestational-anemia-(GA3-group)_vs_healthy-controls-(HC3-group)_DOWN	NA	216851	1263	86331	207244	204475	447020
bsdb:212/1/1_Diet:Higher-quartile-of-TOTAL-fiber-intake_vs_low-quartile-of-TOTAL-fiber-intake_DOWN	NA	1654	283168	119852
bsdb:212/1/2_Diet:Higher-quartile-of-TOTAL-fiber-intake_vs_low-quartile-of-TOTAL-fiber-intake_DOWN	NA	216851	28050
bsdb:214/1/1_Milk-allergic-reaction:children-with-milk-allergy-persistence_vs_milk-allergy-resolution_UP	NA	547	590	158851
bsdb:214/1/2_Milk-allergic-reaction:children-with-milk-allergy-persistence_vs_milk-allergy-resolution_DOWN	NA	572511	1730	1263
bsdb:215/1/1_Eczema:infants-with-eczema_vs_healthy-control-infants_UP	NA	239934	207244	35832	33042	872	547	216851	946234	204475	44249	375288	577309	33024	836	379	841	29465	561	620	1485
bsdb:215/1/2_Eczema:infants-with-eczema_vs_healthy-control-infants_DOWN	NA	904	209879	156454	244127	1678	43668	1696	580596	1485	102106	1716	39948	189330	538	117563	724	570	1578	906	459786	838	1263	1301	40544	191303
bsdb:216/1/1_Cesarean-section:C-section_vs_vaginal-delivery_DOWN	NA	1380	1350
bsdb:218/1/1_Hepatocellular-carcinoma:non-HBV-non-HCV-related-HCC_vs_healthy-controls_UP	NA	244127
bsdb:218/1/2_Hepatocellular-carcinoma:non-HBV-non-HCV-related-HCC_vs_healthy-controls_DOWN	NA	28050	158846
bsdb:218/2/1_Hepatocellular-carcinoma:HBV-related-HCC-patients_vs_healthy-controls_UP	NA	244127	33024	838
bsdb:219/2/1_Diet:lower-fiber-(cracker)---8-wk-after-intervention_vs_higher-fiber-(almonds)---8-wk-after-intervention_UP	NA	28050
bsdb:219/2/2_Diet:lower-fiber-(cracker)---8-wk-after-intervention_vs_higher-fiber-(almonds)---8-wk-after-intervention_DOWN	NA	239759	574697	283168
bsdb:220/1/1_Age:older-age-European-women_vs_younger-age_UP	NA	1663	168808	1716	2745
bsdb:220/1/2_Age:older-age-European-women_vs_younger-age_DOWN	NA	1743
bsdb:221/1/1_Urinary-tract-infection:urinary-tract-infection_vs_healthy-controls_UP	NA	547
bsdb:221/1/2_Urinary-tract-infection:urinary-tract-infection_vs_healthy-controls_DOWN	NA	39948	150022	724	149698
bsdb:223/1/1_HIV-infection:HIV-infected-patients_vs_healthy-controls_UP	NA	1350	1506553	1578	1301
bsdb:223/1/2_HIV-infection:HIV-infected-patients_vs_healthy-controls_DOWN	NA	816	39948	216851	158846	33024	838	292632
bsdb:224/1/1_Diet:barley-(WGB)_vs_baseline_UP	NA	572511
bsdb:224/1/2_Diet:barley-(WGB)_vs_baseline_DOWN	NA	283168	841	39948
bsdb:225/1/1_Atopic-eczema:infant-with-atopic-eczema_vs_healthy-infant_UP	NA	1350
bsdb:225/2/1_Atopic-eczema:infant-with-atopic-eczema_vs_healthy-infant_DOWN	NA	816
bsdb:226/1/1_HIV-infection:HIV-1-infected-patients_vs_healthy-controls_UP	NA	580596	135858	189330	547	1350	216851	158846	577310	838
bsdb:226/1/2_HIV-infection:HIV-1-infected-patients_vs_healthy-controls_DOWN	NA	33042	397864	39948	816
bsdb:227/1/2_Atopic-eczema:infant-with-transient-atopic-dermatitis_vs_healthy-control_UP	NA	1678	239934
bsdb:227/2/1_Atopic-eczema:infants-with-persistent-atopic-dermatitis_vs_healthy-controls_UP	NA	1301
bsdb:227/2/2_Atopic-eczema:infants-with-persistent-atopic-dermatitis_vs_healthy-controls_DOWN	NA	1485
bsdb:228/1/1_Diet:day-3-of-PECTIN-spike-in_vs_day-6-of-PECTIN-spike-in_DOWN	NA	841	816	44748
bsdb:229/1/1_Diet:early-pectin-incubation-time_vs_late-pectin-incubation-time_UP	NA	1678	100883	846	283168	33042	574697	1263	207244	572511	375288	33024	841	816
bsdb:229/1/2_Diet:early-pectin-incubation-time_vs_late-pectin-incubation-time_DOWN	NA	28050	40544	189330	1485
bsdb:230/1/1_Food-allergy:infant-with-food-allergy_vs_non-allergy_DOWN	NA	1243	46255	29465
bsdb:230/1/2_Food-allergy:infant-with-food-allergy_vs_non-allergy_UP	NA	1485
bsdb:231/1/1_Diet:Renatta-canada-apple---at-10-hr_vs_Poorly-fermentable-fiber-(cellulose)_DOWN	NA	35832	119852	375288	1263	86331
bsdb:231/1/2_Diet:Renatta-canada-apple---at-10-hr_vs_Poorly-fermentable-fiber-(cellulose)_UP	NA	1678
bsdb:232/1/1_HIV-infection:HIV-infected-cART-negative_vs_Healthy-controls_UP	NA	165779	848	1257	836
bsdb:232/1/2_HIV-infection:HIV-infected-cART-negative_vs_Healthy-controls_DOWN	NA	239759	33042	1730	28050	841	1263
bsdb:233/1/1_HIV-infection:HIV-infected-subjects_vs_uninfected-controls_UP	NA	469	838
bsdb:233/1/2_HIV-infection:HIV-infected-subjects_vs_uninfected-controls_DOWN	NA	816	572511	33042
bsdb:236/1/1_Diet:before-walnut-diet_vs_after-walnut-diet_UP	NA	207244
bsdb:236/1/2_Diet:before-walnut-diet_vs_after-walnut-diet_DOWN	NA	1678	572511
bsdb:236/2/1_Diet:carbohydrate-replacement-(with-walnuts)_vs_replace-both_DOWN	NA	204475	1407607	816
bsdb:237/1/1_Chronic-hepatitis-C-virus-infection:cirrhosis-patients_vs_healthy-controls_UP	NA	239934	1283313	544	724	1578	1269	1253	1301	29465	46255	1485
bsdb:237/1/2_Chronic-hepatitis-C-virus-infection:cirrhosis-patients_vs_healthy-controls_DOWN	NA	35829	35832	574697	52225	1017280	213484	172900
bsdb:237/2/1_Chronic-hepatitis-C-virus-infection:cirrhosis-patients_vs_no-cirrhosis_UP	NA	1578	29465	1678	239934	724	1269	46255
bsdb:237/2/2_Chronic-hepatitis-C-virus-infection:cirrhosis-patients_vs_no-cirrhosis_DOWN	NA	213484
bsdb:238/1/1_Cervical-cancer:cervical-cancer-patient_vs_healthy-controls_UP	NA	838	836	39948	1506553	40544	1505663	437755	946234	459786	1301
bsdb:238/1/2_Cervical-cancer:cervical-cancer-patient_vs_healthy-controls_DOWN	NA	239759	207244	816	572511	547	561	1407607	1505657	375288	1501226	620	574697
bsdb:238/2/1_Cervical-cancer:cervical-cancer-patient_vs_healthy-controls_UP	NA	838	836	39948	1506553	1505663	946234	437755
bsdb:238/2/2_Cervical-cancer:cervical-cancer-patient_vs_healthy-controls_DOWN	NA	1501226	207244	572511	239759
bsdb:239/1/1_Egg-allergy:children-with-egg-allergy_vs_healthy-control_UP	NA	1263	1357
bsdb:239/1/2_Egg-allergy:children-with-egg-allergy_vs_healthy-control_DOWN	NA	1243
bsdb:239/2/1_Egg-allergy:children-with-egg-sensitization_vs_healthy-control_UP	NA	216851	841
bsdb:241/1/2_Iron-deficiency-anemia:iron-deficiency-anemia_vs_healthy-control_DOWN	NA	39948
bsdb:242/1/1_Iron-deficiency-anemia:iron-deficiency-anemia_vs_healthy-control_UP	NA	475	1357	286	1350	57493	1578
bsdb:242/1/2_Iron-deficiency-anemia:iron-deficiency-anemia_vs_healthy-control_DOWN	NA	1716	482	416916	2717
bsdb:243/1/1_Gastric-cancer:current-H.pylori-infection_vs_non-current-H.pylori-infection_UP	NA	1378
bsdb:243/1/2_Gastric-cancer:current-H.pylori-infection_vs_non-current-H.pylori-infection_DOWN	NA	12916	1827
bsdb:243/2/1_Gastric-cancer:current-H.pylori-infection-patients_vs_past-H.pylori-infection_UP	NA	838	40544
bsdb:244/1/1_Age:18-62-years_vs_2-12-years_UP	NA	1743	1716	1279	1578	150022	165779
bsdb:244/1/2_Age:18-62-years_vs_2-12-years_DOWN	NA	32207	1301	117563	1378	724
bsdb:244/2/1_Atopic-eczema:lesional-skin_vs_non-lesional-skin_UP	NA	1279
bsdb:244/2/2_Atopic-eczema:lesional-skin_vs_non-lesional-skin_DOWN	NA	1301	1743
bsdb:245/1/1_Urolithiasis,Nephrolithiasis:kidney-stone-group_vs_healthy-control_UP	NA	469	1283313	85413	561	1730	1573534	1506553	158846	620
bsdb:245/1/2_Urolithiasis,Nephrolithiasis:kidney-stone-group_vs_healthy-control_DOWN	NA	1508657	39948	61170	168934	638847	1678	841	577310	547
bsdb:245/2/1_Urolithiasis,Nephrolithiasis:kidney-stone-group_vs_healthy-control_UP	NA	1283313	1505663	33024	158846	469	561	620	40544
bsdb:245/2/2_Urolithiasis,Nephrolithiasis:kidney-stone-group_vs_healthy-control_DOWN	NA	189330	1508657	207244	1407607	292632	1573535	39948	1263	577310	35832
bsdb:246/1/1_Asthma:maternal-asthma/male-caucasian-infants_vs_no-asthma_UP	NA	1654	1357	158846
bsdb:246/1/2_Asthma:maternal-asthma/male-caucasian-infants_vs_no-asthma_DOWN	NA	158851	1578
bsdb:246/2/1_Asthma:maternal-asthma_vs_no-asthma_UP	NA	816	286
bsdb:246/2/2_Asthma:maternal-asthma_vs_no-asthma_DOWN	NA	906
bsdb:247/1/1_Diet:Placebo_vs_Prebiotic_UP	NA	33042	189330	119852
bsdb:247/1/2_Diet:Placebo_vs_Prebiotic_DOWN	NA	1678
bsdb:247/2/1_Diet:placebo_vs_prebiotic-(inulin-type-fructan)---in-participants-with-low-dietary-fiber_DOWN	NA	1678
bsdb:248/1/1_Human-papilloma-virus-infection:high-risk-hpv_vs_low-risk-hpv_UP	NA	33870
bsdb:248/1/2_Human-papilloma-virus-infection:high-risk-hpv_vs_low-risk-hpv_DOWN	NA	724	28100
bsdb:248/2/1_Human-papilloma-virus-infection:HPV_vs_no-HPV_UP	NA	2701
bsdb:248/2/2_Human-papilloma-virus-infection:HPV_vs_no-HPV_DOWN	NA	286	28100
bsdb:249/1/1_Hepatitis,-Alcoholic:alcoholics_vs_NAC_UP	NA	374	33882	1843210	1716
bsdb:249/1/2_Hepatitis,-Alcoholic:alcoholics_vs_NAC_DOWN	NA	2053	1839	53387	1678	816	397864	577309	838	239759	237	182709	94008	572511	1263	186650	265	780	114248	12916	47420	215579	29580	70774	642
bsdb:249/2/1_Hepatitis,-Alcoholic:HDC_vs_NAC_UP	NA	469	165779	374	59732	57493	33882	482	20	1883	1060
bsdb:249/2/2_Hepatitis,-Alcoholic:HDC_vs_NAC_DOWN	NA	2053	1839	1678	816	397864	838	237	1301	1485	114248	12916	70774
bsdb:250/1/1_Severe-aplastic-anemia:hematopoietic-stem-cell-transplantation-engraftment_vs_baseline_UP	NA	482	1213720
bsdb:250/2/1_Severe-aplastic-anemia:hematopoietic-stem-cell-transplantation-engraftment_vs_baseline_DOWN	NA	482
bsdb:251/1/1_Milk-allergic-reaction:cow’s-milk-allergic-(CMA)-infants-colonized-mice_vs_healthy-Infants-colonised-mice_UP	NA	572511	100883	1350	375288	1263
bsdb:251/1/2_Milk-allergic-reaction:cow’s-milk-allergic-(CMA)-infants-colonized-mice_vs_healthy-Infants-colonised-mice_DOWN	NA	590	1301
bsdb:252/1/1_Pemphigus-vulgaris:Pemphigus-vulgaris-(PV)--Patients_vs_healthy-control_UP	NA	46123	100883	946234	117563
bsdb:252/1/2_Pemphigus-vulgaris:Pemphigus-vulgaris-(PV)--Patients_vs_healthy-control_DOWN	NA	102106	33042
bsdb:253/1/1_Asthma:asthma_vs_healthy-control_UP	NA	1279	838
bsdb:253/1/2_Asthma:asthma_vs_healthy-control_DOWN	NA	724
bsdb:253/2/1_Asthma:asthma-remission_vs_healthy-control_UP	NA	848	838	543311
bsdb:253/2/2_Asthma:asthma-remission_vs_healthy-control_DOWN	NA	724
bsdb:254/1/1_Nephrolithiasis,Urolithiasis:kidney-stone-patient_vs_healthy-control_UP	NA	239759	816	375288
bsdb:254/1/2_Nephrolithiasis,Urolithiasis:kidney-stone-patient_vs_healthy-control_DOWN	NA	150022	162289	838	184869
bsdb:255/1/1_Human-papilloma-virus-infection:high-grade-squamous-intraepithelial-lesions_vs_negative-for-intraepithelial-lesion-or-malignancy_UP	NA	1279
bsdb:255/1/2_Human-papilloma-virus-infection:high-grade-squamous-intraepithelial-lesions_vs_negative-for-intraepithelial-lesion-or-malignancy_DOWN	NA	150022
bsdb:256/1/1_Gastric-cancer:peritumoral-tissues_vs_normal-tissues_UP	NA	45402	2745	209	1578	407	1257	970	22	1301	29465
bsdb:256/1/2_Gastric-cancer:peritumoral-tissues_vs_normal-tissues_DOWN	NA	1386	816	1716	216851	848	33024	838	1743	286	13687
bsdb:256/2/1_Gastric-cancer:tumoral-tissues_vs_peritumoral-tissues_UP	NA	1386	838	1743	286
bsdb:256/2/2_Gastric-cancer:tumoral-tissues_vs_peritumoral-tissues_DOWN	NA	216851	2745	33024	22	13687
bsdb:257/1/1_Colorectal-cancer:colorectal-cancer_vs_healthy-control_UP	NA	239934	35832	574697	990721	1485	51514	848	283168	119852	846	375288	1257	836	1263	970	1730
bsdb:257/1/2_Colorectal-cancer:colorectal-cancer_vs_healthy-control_DOWN	NA	158846	52225
bsdb:258/1/1_Colorectal-cancer:carcinoma_vs_Healthy-Controls_UP	NA	848	836	1485
bsdb:258/1/2_Colorectal-cancer:carcinoma_vs_Healthy-Controls_DOWN	NA	816	1279	1485
bsdb:260/1/2_Food-allergy:Allergic-Estonian-children._vs_Nonallergic--Estonian-children._DOWN	NA	1678	1578
bsdb:260/2/2_Food-allergy:Allergic-Swedish-children_vs_Non-allergic-Swedish-children._DOWN	NA	1578	1678
bsdb:262/1/1_Atopic-asthma:nasal-brush-speciments_vs_bronchial-brush-specimens_UP	NA	1651	1716	475	1279
bsdb:262/1/2_Atopic-asthma:nasal-brush-speciments_vs_bronchial-brush-specimens_DOWN	NA	1654	32067	836	838	1301
bsdb:263/1/1_Crohn's-disease:crohn's-disease_vs_healthy-controls_UP	NA	1654	572511	84111	1573536	1378	1505657	32207	1301
bsdb:263/1/2_Crohn's-disease:crohn's-disease_vs_healthy-controls_DOWN	NA	553372	1485	33042	216851	1407607	204475	28050	86331	459786	1501226	1263	44748	292632	191303
bsdb:263/2/1_Ulcerative-colitis:ulcerative-colitis_vs_healthy-controls_UP	NA	1654	264995	1678	84111	1573536	1378	1301
bsdb:263/2/2_Ulcerative-colitis:ulcerative-colitis_vs_healthy-controls_DOWN	NA	204475	644652	28050	86331	1263	44748
bsdb:264/1/1_Human-papilloma-virus-infection:HPV+/HIV-_vs_HPV-/HIV-_UP	NA	28263	39948	906	162289	1257	838	168808
bsdb:264/1/2_Human-papilloma-virus-infection:HPV+/HIV-_vs_HPV-/HIV-_DOWN	NA	56688	1578
bsdb:265/1/1_Human-papilloma-virus-infection,Age:two-months_vs_at-birth_UP	NA	32207	1301	29465	724	150022
bsdb:265/1/2_Human-papilloma-virus-infection,Age:two-months_vs_at-birth_DOWN	NA	357	816	80865	1578	906	1743	286	1279
bsdb:266/1/1_Diet:Healthy-vegetarian_vs_Healthy-non-vegetarian_UP	NA	1301	838	570	216851	841	572511
bsdb:266/1/2_Diet:Healthy-vegetarian_vs_Healthy-non-vegetarian_DOWN	NA	239934	239759	816	1678	1485	33042	39948	158846	459786	375288	33024	590
bsdb:267/1/1_Atopic-asthma:atopic-asthma_vs_healthy-control_UP	NA	1654	109326	194	848	724	32257	482	836	838	165697	157	29465
bsdb:267/1/2_Atopic-asthma:atopic-asthma_vs_healthy-control_DOWN	NA	713	1578	32067	407	1257
bsdb:268/1/1_Cervical-glandular-intraepithelial-neoplasia:before_vs_after-loop-electrosurgical-excision-procedure_UP	NA	1485	102106	1716	168808	29465
bsdb:268/1/2_Cervical-glandular-intraepithelial-neoplasia:before_vs_after-loop-electrosurgical-excision-procedure_DOWN	NA	1279	48736
bsdb:269/1/1_Leukemia:Acute-Lymphoblastic-Leukemia-diagnosis-and-Pre--Chemotherapy-treatment_vs_healthy-control_UP	NA	816
bsdb:269/1/2_Leukemia:Acute-Lymphoblastic-Leukemia-diagnosis-and-Pre--Chemotherapy-treatment_vs_healthy-control_DOWN	NA	194	1716	1678	1380	162289	1279	838	165779	836
bsdb:269/1/3_Leukemia:Acute-Lymphoblastic-Leukemia-diagnosis-and-Pre--Chemotherapy-treatment_vs_healthy-control_UP	NA	1678
bsdb:269/1/4_Leukemia:Acute-Lymphoblastic-Leukemia-diagnosis-and-Pre--Chemotherapy-treatment_vs_healthy-control_DOWN	NA	1380	816	838	848	1716
bsdb:270/1/1_Human-papilloma-virus-infection:HPV+_vs_HPV-_UP	NA	168808	906	1253	1696	286
bsdb:270/1/2_Human-papilloma-virus-infection:HPV+_vs_HPV-_DOWN	NA	83618	1654	213484	222991
bsdb:270/2/1_Human-papilloma-virus-infection:HPV+-(persistance)_vs_HPV+-(clearance)_UP	NA	1380	216851
bsdb:270/2/2_Human-papilloma-virus-infection:HPV+-(persistance)_vs_HPV+-(clearance)_DOWN	NA	28065
bsdb:271/1/1_Acute-lymphoblastic-leukemia:Minimal-Residual-Disease--(negativity)-with-Allogenic-Stem-Cell-Transplant_vs_Minimal-Residual-Disease+-(positivity)-with-Allogenic-Stem-Cell-Transplant_UP	NA	216851	253238	44748
bsdb:271/1/2_Acute-lymphoblastic-leukemia:Minimal-Residual-Disease--(negativity)-with-Allogenic-Stem-Cell-Transplant_vs_Minimal-Residual-Disease+-(positivity)-with-Allogenic-Stem-Cell-Transplant_DOWN	NA	32207
bsdb:272/1/1_Pneumonia:S.pneumoniae-positive_vs_negative_UP	NA	475	1301
bsdb:272/1/2_Pneumonia:S.pneumoniae-positive_vs_negative_DOWN	NA	1716	1279
bsdb:273/1/1_Acute-lymphoblastic-leukemia:Infectious-complications-(IC)_vs_non-infectious-complications-(NIC)_DOWN	NA	1678	816	838	239759	189330	216851
bsdb:273/1/2_Acute-lymphoblastic-leukemia:Infectious-complications-(IC)_vs_non-infectious-complications-(NIC)_UP	NA	357	507	41275	517
bsdb:274/1/1_Human-papilloma-virus-infection:HPV+_vs_HPV-_UP	NA	838
bsdb:274/1/2_Human-papilloma-virus-infection:HPV+_vs_HPV-_DOWN	NA	1654	1678	39948	2701	1578
bsdb:274/2/1_Cervical-glandular-intraepithelial-neoplasia:low-grade-dysplasia_vs_HPV-_UP	NA	543311
bsdb:274/2/2_Cervical-glandular-intraepithelial-neoplasia:low-grade-dysplasia_vs_HPV-_DOWN	NA	71655	561	1578	162289	620	1301
bsdb:275/1/1_Acute-lymphoblastic-leukemia:adolescent-ALL-patient_vs_healthy-sibling-control_UP	NA	816
bsdb:275/1/2_Acute-lymphoblastic-leukemia:adolescent-ALL-patient_vs_healthy-sibling-control_DOWN	NA	841
bsdb:276/2/1_Multiple-myeloma:Multiple-Myeloma-patient_vs_healthy-control_UP	NA	816	191303	413496
bsdb:276/2/2_Multiple-myeloma:Multiple-Myeloma-patient_vs_healthy-control_DOWN	NA	1508657	1730	207244	84108	135858	904
bsdb:277/1/1_Crohn's-disease:crohn's-disease_vs_healthy-control_DOWN	NA	216851	1263	841	239759	1730	46239	206664	836	28138	375288	830
bsdb:278/1/1_Non-alcoholic-fatty-liver-disease:NAFLD--[non-alcoholic-fatty-liver-disease]_vs_Healthy-control_UP	NA	1578
bsdb:278/1/2_Non-alcoholic-fatty-liver-disease:NAFLD--[non-alcoholic-fatty-liver-disease]_vs_Healthy-control_DOWN	NA	239759	207244	816	572511	189330	216851	33042	841	375288
bsdb:279/1/2_Acute-myeloid-leukemia:High-Intensity-Chemotherapy_vs_Low-Intensity-Chemotherapy_DOWN	NA	55193
bsdb:279/2/1_Acute-myeloid-leukemia:Patients-with-bacterial-infections-at-T3_vs_Patients-without-bacterial-infections-at-T3_UP	NA	1535326
bsdb:280/1/1_Cervical-glandular-intraepithelial-neoplasia:high-grade-squamus-intraepithelial-lesion_vs_low-grade-squamus-intraepithelial-lesion_UP	NA	165779	168808
bsdb:281/1/1_Acute-lymphoblastic-leukemia:Fecal-bacterial-composition-in-small-intestines-of-leukemia-mice_vs_Healthy-Control_UP	NA	239934	2086	207244	572511	830	1485	33042	189330	119852	1263
bsdb:281/1/2_Acute-lymphoblastic-leukemia:Fecal-bacterial-composition-in-small-intestines-of-leukemia-mice_vs_Healthy-Control_DOWN	NA	447020	1578	191303
bsdb:282/1/2_Graft-versus-host-disease:Grades-II-IV-(acute-graft-host-disease)_vs_Grades-0-I-(non-acute-graft-host-disease)_DOWN	NA	1506553	572511
bsdb:283/1/1_Human-papilloma-virus-infection:HPV+_vs_HPV-_UP	NA	84111	1378
bsdb:284/1/1_Chronic-kidney-disease:Chronic-kidney-disease_vs_healthy-controls_UP	NA	1654	59735	1716	32207	1301	1578
bsdb:284/1/2_Chronic-kidney-disease:Chronic-kidney-disease_vs_healthy-controls_DOWN	NA	848	836
bsdb:285/1/1_Multiple-sclerosis:pediatric-multiple-sclerosis_vs_healthy-controls_UP	NA	35832	1678	872	135858	33024
bsdb:285/1/2_Multiple-sclerosis:pediatric-multiple-sclerosis_vs_healthy-controls_DOWN	NA	28050	577309	816	119852
bsdb:286/1/2_Graves-ophthalmopathy:graves-orbitopathy_vs_Healthy-controls_DOWN	NA	207244	572511	574697	102106	1407607	1263
bsdb:288/1/1_Phenylketonuria:phenylketonuric-with-Phe-restricted-diet_vs_mild-hyperphenylalaninemic-with-unrestricted-diet_DOWN	NA	841	1578
bsdb:289/1/1_Health-trait:suboptimal-health-status_vs_healthy-controls_UP	NA	59732	119852	841	1263
bsdb:289/1/2_Health-trait:suboptimal-health-status_vs_healthy-controls_DOWN	NA	581	48736	40544
bsdb:290/1/1_Oral-mucositis:ulcerative-oral-mucositis_vs_no-ulcerative-oral-mucositis_UP	NA	29465	1350	1301	1279	848	838
bsdb:290/1/2_Oral-mucositis:ulcerative-oral-mucositis_vs_no-ulcerative-oral-mucositis_DOWN	NA	1301	1654
bsdb:290/2/1_Oral-mucositis:pre--and-three-month-after-auto-stem-cell-transplant_vs_one-and-two-weeks-after-stem-cell-transplant_UP	NA	838	32067
bsdb:290/2/2_Oral-mucositis:pre--and-three-month-after-auto-stem-cell-transplant_vs_one-and-two-weeks-after-stem-cell-transplant_DOWN	NA	1578
bsdb:291/1/1_Graves-disease:graves-disease_vs_healthy-controls_UP	NA	838	724
bsdb:291/1/2_Graves-disease:graves-disease_vs_healthy-controls_DOWN	NA	239759	216851	39948
bsdb:292/1/2_Response-to-allogeneic-hematopoietic-stem-cell-transplant:allogeneic-hematopoietic-stem-cell-transplant_vs_community-dwelling-controls_DOWN	NA	1283313	724	32067	482	265975	838	1301
bsdb:293/1/1_Human-papilloma-virus-infection:Baseline-HPV+_vs_Baseline-HPV-_UP	NA	2129
bsdb:293/1/2_Human-papilloma-virus-infection:Baseline-HPV+_vs_Baseline-HPV-_DOWN	NA	1582879	216851	848	873565
bsdb:293/2/1_Human-papilloma-virus-infection:new-acquisition-of-HPV-within-a-year_vs_no-new-acquisition-of-HPV-within-a-year_DOWN	NA	1654
bsdb:295/1/1_Human-papilloma-virus-infection:low-risk-HPV_vs_negative-control_UP	NA	1654	239759	1678	35832	572511	574697	1485	1348911	33042	39948	1407607	204475	70774	906	745	1257	33024	841	1263	1200657	168808	40544
bsdb:295/1/2_Human-papilloma-virus-infection:low-risk-HPV_vs_negative-control_DOWN	NA	209	68	497726
bsdb:297/1/1_Human-papilloma-virus-infection:non-pregnant-high-risk-HPV_vs_non-pregnant-no-HPV_UP	NA	1678	1386
bsdb:297/1/2_Human-papilloma-virus-infection:non-pregnant-high-risk-HPV_vs_non-pregnant-no-HPV_DOWN	NA	1578
bsdb:297/2/1_Human-papilloma-virus-infection:pregnant-high-risk-HPV_vs_pregnant-no-HPV_UP	NA	12916
bsdb:297/2/2_Human-papilloma-virus-infection:pregnant-high-risk-HPV_vs_pregnant-no-HPV_DOWN	NA	1301
bsdb:298/2/1_Acute-myeloid-leukemia:infection_vs_no-infection_UP	NA	40323
bsdb:298/2/2_Acute-myeloid-leukemia:infection_vs_no-infection_DOWN	NA	1301
bsdb:301/1/1_Human-papilloma-virus-infection:HPV+_vs_HPV-_UP	NA	39948	906	168808	848
bsdb:301/1/2_Human-papilloma-virus-infection:HPV+_vs_HPV-_DOWN	NA	1578
bsdb:301/2/1_Human-papilloma-virus-infection:HPV+_vs_HPV-_UP	NA	168808
bsdb:303/1/1_Non-Hodgkins-lymphoma:post-chemotherapy_vs_pre-chemotherapy_UP	NA	544	1350	375288	1380	570
bsdb:303/1/2_Non-Hodgkins-lymphoma:post-chemotherapy_vs_pre-chemotherapy_DOWN	NA	447020	165779	1380	1678	572511	1485	102106	33042	189330	570	28050	119852	841	1263
bsdb:304/1/1_Antimicrobial-agent:oral-intake-of-vancomycin-(directed-against-Gram-positive-bacteria)_vs_or-placebo-(microcrystalline-cellulose)_UP	NA	1380	1678	102106
bsdb:305/1/1_Genital-neoplasm,-female:women-with-gynecological-cancer_vs_healthy-controls_UP	NA	165779	39948	1582879	848	2050	437755	2093	543311	162289	1257	836	838	168808
bsdb:305/1/2_Genital-neoplasm,-female:women-with-gynecological-cancer_vs_healthy-controls_DOWN	NA	1678	1578	177971
bsdb:307/1/1_Antimicrobial-agent:moxifloxacin-treated-group-(MXF)_vs_Negative-control-group-(CLT)_UP	NA	572511
bsdb:307/1/2_Antimicrobial-agent:moxifloxacin-treated-group-(MXF)_vs_Negative-control-group-(CLT)_DOWN	NA	239759	572511	574697	135858	1485	100883	1730	216851	459786
bsdb:308/1/1_Air-pollution:PM-2.5-air-exposed-group_vs_Filtered-air-group_UP	NA	1578
bsdb:308/1/2_Air-pollution:PM-2.5-air-exposed-group_vs_Filtered-air-group_DOWN	NA	1578	1279
bsdb:309/1/1_Cervical-glandular-intraepithelial-neoplasia:CIN2+_vs_CIN1_UP	NA	816	574697	1578	375288	59195
bsdb:310/1/1_Non-Hodgkins-lymphoma:post-chemotherapy_vs_pre-chemotherapy_UP	NA	816	561
bsdb:310/1/2_Non-Hodgkins-lymphoma:post-chemotherapy_vs_pre-chemotherapy_DOWN	NA	572511	216851	841	1678
bsdb:312/2/1_Antimicrobial-agent:Infants-born-by-mothers-positive-to-GBS-and-received-IAP_vs_infants-born-by-mothers-negative-to-GBS_DOWN	NA	1678
bsdb:313/1/1_Non-Hodgkins-lymphoma:bloodstream-infection_vs_non-bloodstream-infection_UP	NA	29465
bsdb:313/1/2_Non-Hodgkins-lymphoma:bloodstream-infection_vs_non-bloodstream-infection_DOWN	NA	574697	51514	216851	119852	40544
bsdb:314/1/1_Cervical-glandular-intraepithelial-neoplasia:CIN-non-regression_vs_CIN-regression_UP	NA	1380	168808	906	543311	838
bsdb:314/1/2_Cervical-glandular-intraepithelial-neoplasia:CIN-non-regression_vs_CIN-regression_DOWN	NA	1578
bsdb:317/1/1_Obsessive-compulsive-disorder:OCD-T0-(Baseline)_vs_Control-(healthy-group)_UP	NA	239759	207244	1348911	946234	1649459	459786
bsdb:317/1/2_Obsessive-compulsive-disorder:OCD-T0-(Baseline)_vs_Control-(healthy-group)_DOWN	NA	1766253	580596	135858	1485	33042	39948	404402	28050	577309	1501226
bsdb:317/2/1_Obsessive-compulsive-disorder:OCD-T0_vs_Control-(healthy-group)_UP	NA	265975	1654	1380	1164882	86331
bsdb:318/2/1_Graft-versus-host-disease:acute-graft-versus-host-disease_vs_non-acute-graft-versus-host-disease_UP	NA	216851	1730
bsdb:319/1/1_Air-pollution:mice-exposed-to-filtered-air-(FA)_vs_mice-exposed-to-PM-2.5-(CAP)_UP	NA	248744	2093
bsdb:319/1/2_Air-pollution:mice-exposed-to-filtered-air-(FA)_vs_mice-exposed-to-PM-2.5-(CAP)_DOWN	NA	209	1501226	100175	174708	191303
bsdb:320/1/1_Antimicrobial-agent:infants(6-weeks)-to-mothers-exposed-to-intrapartum-antibiotic_vs_infants-(6-weeks)-to-mothers-unexposed-to--intrapartum-antibiotic_UP	NA	119852	113286	184869
bsdb:320/1/2_Antimicrobial-agent:infants(6-weeks)-to-mothers-exposed-to-intrapartum-antibiotic_vs_infants-(6-weeks)-to-mothers-unexposed-to--intrapartum-antibiotic_DOWN	NA	816	1678	572511	841	1263
bsdb:320/2/1_Antimicrobial-agent:infants(1-year)-to-mothers-exposed-to-intrapartum-antibiotic_vs_infants-(1-year)-to-mothers-unexposed-to--intrapartum-antibiotic_UP	NA	119852	113286	184869
bsdb:320/2/2_Antimicrobial-agent:infants(1-year)-to-mothers-exposed-to-intrapartum-antibiotic_vs_infants-(1-year)-to-mothers-unexposed-to--intrapartum-antibiotic_DOWN	NA	816	1678	572511	841
bsdb:321/1/1_Antimicrobial-agent:10-d-old-7-10-day-treatment-infants_vs_10-d-old-2-day-treatment-infants_DOWN	NA	816	1357
bsdb:322/1/1_Oral-mucositis:patients-with-newly-diagnosed-malignancies_vs_reference_UP	NA	46123	1357	203697
bsdb:322/1/2_Oral-mucositis:patients-with-newly-diagnosed-malignancies_vs_reference_DOWN	NA	1716	346096	1378	848	22	2745	713
bsdb:323/1/1_Necrotizing-enterocolitis:NEC_vs_non-NEC_UP	NA	1485	1279
bsdb:323/1/2_Necrotizing-enterocolitis:NEC_vs_non-NEC_DOWN	NA	28196	150022	29330	1654	286	59732	283	1301	1716
bsdb:324/1/1_Thyroid-carcinoma:patients-with-thyroid-carcinoma_vs_healthy-controls_UP	NA	207244	33042	561	1505657	570	1578	620	1301	292632	191303	1357	239759
bsdb:324/1/2_Thyroid-carcinoma:patients-with-thyroid-carcinoma_vs_healthy-controls_DOWN	NA	1283313	816	1506553	158846	33024	838	841
bsdb:325/1/1_Psoriasis:psoriasis_vs_healthy-controls_UP	NA	572511	1263	216851	1678	33042	86331	189330	990721	1654	102106
bsdb:325/1/2_Psoriasis:psoriasis_vs_healthy-controls_DOWN	NA	574697	35832	283168	375288	838	40544	28050	577309
bsdb:326/1/1_Non-small-cell-lung-carcinoma,Renal-cell-carcinoma,Disease-progression-measurement:Responders-(partial-response-or-stable-disease)_vs_Non-Responders-(progression-or-death)_UP	NA	239759	816	1392389	838
bsdb:326/1/2_Non-small-cell-lung-carcinoma,Renal-cell-carcinoma,Disease-progression-measurement:Responders-(partial-response-or-stable-disease)_vs_Non-Responders-(progression-or-death)_DOWN	NA	572511	838
bsdb:326/2/1_Non-small-cell-lung-carcinoma,Renal-cell-carcinoma,Disease-progression-measurement:Progressive--Free--Survival-more-than-30-days_vs_Progressive--Free--Survival-more-less-than-30-days_UP	NA	239759	572511	946234	1392389	1263
bsdb:327/1/1_Antimicrobial-agent:infants-who-received-short-term-or-long-term-antibiotic-treatment---week-1_vs_control-(no-treatment)---week-1_UP	NA	1578
bsdb:327/1/2_Antimicrobial-agent:infants-who-received-short-term-or-long-term-antibiotic-treatment---week-1_vs_control-(no-treatment)---week-1_DOWN	NA	561	1301
bsdb:327/2/1_Antimicrobial-agent:infants-received-long-term(>5days)-antibiotic-treatment---week-2_vs_control(no-treatment)---week-2_UP	NA	1350
bsdb:328/1/1_Psoriatic-arthritis:psoriatic-arthiritis_vs_healthy-controls_DOWN	NA	239934	33042	46205	1263
bsdb:329/1/1_Antimicrobial-agent:Postnatal-antibiotic-group-(2-day-old-infant)_vs_control-group_UP	NA	1578
bsdb:329/1/2_Antimicrobial-agent:Postnatal-antibiotic-group-(2-day-old-infant)_vs_control-group_DOWN	NA	816
bsdb:329/2/1_Antimicrobial-agent:IAP-group-(4-day-old-infant)_vs_control-group_DOWN	NA	816
bsdb:330/1/1_Human-papilloma-virus-infection:HPV+_vs_HPV-_UP	NA	1578	2129
bsdb:330/2/1_Human-papilloma-virus-infection:HPV+_vs_HPV-_UP	NA	1578	2129
bsdb:330/2/2_Human-papilloma-virus-infection:HPV+_vs_HPV-_DOWN	NA	724	1257
bsdb:331/1/1_Hashimoto's-thyroiditis:hashimoto's-thyroiditis-patients_vs_healthy-controls_UP	NA	207244	572511	580596	33042	189330	1407607	724	1501226	841	1301	292632	1485
bsdb:331/1/2_Hashimoto's-thyroiditis:hashimoto's-thyroiditis-patients_vs_healthy-controls_DOWN	NA	816	216851	838	1283313	33024	1506553	375288	577309	1154586
bsdb:333/1/1_Antimicrobial-agent:infants-with-(Abx)_vs_without-(non-Abx)-use-of-maternal-antimicrobial-agents-at-delivery_DOWN	NA	1678
bsdb:334/1/1_Antimicrobial-agent:infants(14-d-old)-exposed-to-prenatal-antibiotic-therapy-(PAT-group)_vs_prenatal-antibiotic-free-group-(PAF-group)_UP	NA	1618113
bsdb:334/1/2_Antimicrobial-agent:infants(14-d-old)-exposed-to-prenatal-antibiotic-therapy-(PAT-group)_vs_prenatal-antibiotic-free-group-(PAF-group)_DOWN	NA	1678
bsdb:336/1/1_Antimicrobial-agent:combination-of-penicillin-and-moxalactam-group-(postnatal-day-3)_vs_Antibiotic-free-group-(postnatal-day-3)_UP	NA	816	1578	13687
bsdb:336/1/2_Antimicrobial-agent:combination-of-penicillin-and-moxalactam-group-(postnatal-day-3)_vs_Antibiotic-free-group-(postnatal-day-3)_DOWN	NA	1485
bsdb:337/1/1_Antimicrobial-agent:3-month-old-infants-exposed-to-antibiotics-in-the-second-trimester_vs_3-month-old-infants-not-exposed-to-antibiotics-during-the-second-trimester_UP	NA	1407607	1350
bsdb:337/1/2_Antimicrobial-agent:3-month-old-infants-exposed-to-antibiotics-in-the-second-trimester_vs_3-month-old-infants-not-exposed-to-antibiotics-during-the-second-trimester_DOWN	NA	816	1279	1301	29465
bsdb:338/1/1_Obesity:obese-children_vs_normal-weight-children_UP	NA	216851	724	28050	158846	33024
bsdb:338/1/2_Obesity:obese-children_vs_normal-weight-children_DOWN	NA	39948	119852
bsdb:338/2/1_Obesity:obese-children_vs_normal-weight-children_UP	NA	713	416916	194	848	117563	724	28050	158846	33024	32207	1301	40544	191303	29465
bsdb:338/2/2_Obesity:obese-children_vs_normal-weight-children_DOWN	NA	447020	239759	244127	1678	35832	990721	1485	102106	1185408	872	1730	1769729	61170	119852	846	838	1263	44748
bsdb:340/1/1_Inflammatory-bowel-disease:Pouchitis_vs_Normal-pouch_UP	NA	469	10	629	100883	561	586	84108	29465
bsdb:340/1/2_Inflammatory-bowel-disease:Pouchitis_vs_Normal-pouch_DOWN	NA	773	189330	2745	1253
bsdb:341/1/1_Smoking-behavior:patients-with-FD,-ID,or-CD-who-currently-smoked_vs_never-smoked_UP	NA	32207	1301	29465
bsdb:341/2/1_Smoking-behavior:patients-with-FD,-ID,or-CD-who-currently-smokes_vs_never-smoked_DOWN	NA	482	838
bsdb:342/1/1_Asthma:Children-who-experienced-exacerbation_vs_children-who-did-not-experience-asthma-exacerbation_DOWN	NA	724
bsdb:343/1/1_Leukemia:Acute-anti-leukemia-treatment_vs_Allogeneic-Hematopoetic-Stem-Cell-Transplant_UP	NA	816	239934	216851
bsdb:343/1/2_Leukemia:Acute-anti-leukemia-treatment_vs_Allogeneic-Hematopoetic-Stem-Cell-Transplant_DOWN	NA	1485
bsdb:344/1/1_Air-pollution:mice-exposed-to-Pm-2.5-suspension_vs_mice-exposed-suspension-from-extracts-of-“blank”-filter_UP	NA	946234	848	459786
bsdb:344/1/2_Air-pollution:mice-exposed-to-Pm-2.5-suspension_vs_mice-exposed-suspension-from-extracts-of-“blank”-filter_DOWN	NA	1386	80865	173479	55968	248038	283168	286	970	13687	1301
bsdb:345/1/1_Response-to-diet:Female-hamsters-Low-protein-diet-(LPD)-group_vs_Female-hamsters-Normal-protein-diet-(NPD)-group_UP	NA	2086	816	156973	690621
bsdb:345/1/2_Response-to-diet:Female-hamsters-Low-protein-diet-(LPD)-group_vs_Female-hamsters-Normal-protein-diet-(NPD)-group_DOWN	NA	469	174708	308865	204475	1159323	264147	248038	2093	217063	119852	146	577309
bsdb:350/1/1_Obesity:Obese-children-(O)_vs_Normal-weight-(NW)_UP	NA	836
bsdb:350/1/2_Obesity:Obese-children-(O)_vs_Normal-weight-(NW)_DOWN	NA	33024
bsdb:351/1/1_Obesity:overweight/obesity_vs_normal_UP	NA	1578
bsdb:351/1/2_Obesity:overweight/obesity_vs_normal_DOWN	NA	1678
bsdb:352/1/1_Human-papilloma-virus-infection,Cervical-glandular-intraepithelial-neoplasia:Low-Grade-Squamous-Intraepithelial-Lesion_vs_Atypical-Squamous-Cells-of-Undetermined-Significance_DOWN	NA	4930
bsdb:352/2/1_Human-papilloma-virus-infection,Cervical-glandular-intraepithelial-neoplasia:High-risk-HPV_vs_Low-risk-HPV_UP	NA	55193
bsdb:354/1/2_Obesity:overweight/obese_vs_control-(BMI-at-normal-range)_DOWN	NA	872
bsdb:356/1/1_Air-pollution:ICR-male-mice-exposed-to-PM-2.5_vs_mice-dams-exposed-to-filtered-blanks-PND-3_UP	NA	841	239759
bsdb:356/1/2_Air-pollution:ICR-male-mice-exposed-to-PM-2.5_vs_mice-dams-exposed-to-filtered-blanks-PND-3_DOWN	NA	66831	482
bsdb:357/1/1_Air-pollution:post-smog-swabs_vs_pre-smog-swabs_UP	NA	32067
bsdb:357/1/2_Air-pollution:post-smog-swabs_vs_pre-smog-swabs_DOWN	NA	838
bsdb:358/1/1_Cervical-glandular-intraepithelial-neoplasia,Cervical-cancer:CIN2/3-CC_vs_Healthy-controls_UP	NA	1912216	212791	1269	1279	1301	46255	29465	286	1716	149698	2129	13687	2701
bsdb:358/1/2_Cervical-glandular-intraepithelial-neoplasia,Cervical-cancer:CIN2/3-CC_vs_Healthy-controls_DOWN	NA	2701
bsdb:360/1/1_Air-pollution:mice-exposed-to-MVE_vs_mice-exposed-to-Filtered-Air_UP	NA	191303	1485
bsdb:360/1/2_Air-pollution:mice-exposed-to-MVE_vs_mice-exposed-to-Filtered-Air_DOWN	NA	1578	119852
bsdb:360/2/2_Air-pollution:mice-exposed-to-WS_vs_mice-exposed-to-Filtered-Air_DOWN	NA	1485	1578	119852
bsdb:361/1/1_Air-pollution:male-mice-exposed-to-cigarette-smoke_vs_all-other-mice_UP	NA	239934
bsdb:361/2/1_Air-pollution:female-mice-exposed-to-cigarette-smoke_vs_all-other-mice_UP	NA	816
bsdb:363/1/1_Smoking-behavior:current-smokers_vs_never-smokers_UP	NA	32207	1301	1380	906	1716	346096	109326	195950	44259	2093
bsdb:363/1/2_Smoking-behavior:current-smokers_vs_never-smokers_DOWN	NA	2740	1016	482	2717	47670	1257	43996	848	1283313	836	1164882	32067	265975	1730	194	123375	724	1213720	1378
bsdb:364/1/1_Smoking-behavior:smokers_vs_non-smokers_UP	NA	1654	29465
bsdb:365/1/1_Methionine-measurement:mice-fed-American-Diet_vs_mice-fed-control-rodent-diet._UP	NA	33042	119852	1263	1386	1357
bsdb:365/1/2_Methionine-measurement:mice-fed-American-Diet_vs_mice-fed-control-rodent-diet._DOWN	NA	1485	838
bsdb:366/1/1_Non-alcoholic-fatty-liver-disease:nonalcoholic-fatty-liver-disease_vs_healthy-controls_UP	NA	1578	588605	841	189330
bsdb:366/1/2_Non-alcoholic-fatty-liver-disease:nonalcoholic-fatty-liver-disease_vs_healthy-controls_DOWN	NA	459786
bsdb:367/1/2_Obesity:obese_vs_normal-weight_DOWN	NA	119852
bsdb:368/1/1_Smoking-behavior:shammah-users_vs_non-shammah-users_UP	NA	1301	32207	1578	419014
bsdb:368/1/2_Smoking-behavior:shammah-users_vs_non-shammah-users_DOWN	NA	538	1257	265975	47
bsdb:369/1/1_Obesity:obese_vs_normal-weight_UP	NA	816	28050	841
bsdb:369/1/2_Obesity:obese_vs_normal-weight_DOWN	NA	84108	838	119852
bsdb:370/1/1_Air-pollution:Spring/Summer-individuals_vs_Winter-individuals_DOWN	NA	1378	117563	724	2745	1301
bsdb:372/1/1_Air-pollution:Diesel-exhaust-particle-(DEP)-exposed-mice_vs_mice-exposed-to-FRA_UP	NA	1578
bsdb:372/1/2_Air-pollution:Diesel-exhaust-particle-(DEP)-exposed-mice_vs_mice-exposed-to-FRA_DOWN	NA	816	1485
bsdb:373/1/1_Obesity:overweight-children_vs_normal-weight-children_UP	NA	33042
bsdb:373/1/2_Obesity:overweight-children_vs_normal-weight-children_DOWN	NA	239759
bsdb:374/1/1_Cervical-glandular-intraepithelial-neoplasia:cervical-intraepithelial-neoplasia-cases_vs_normal-controls_UP	NA	114627	1643951	953
bsdb:374/1/2_Cervical-glandular-intraepithelial-neoplasia:cervical-intraepithelial-neoplasia-cases_vs_normal-controls_DOWN	NA	53246	497
bsdb:374/2/1_Cervical-cancer:cervical-cancer_vs_normal-control_UP	NA	114627	1643951	953
bsdb:374/2/2_Cervical-cancer:cervical-cancer_vs_normal-control_DOWN	NA	1578	1279	1263978
bsdb:375/1/1_Obesity:obese_vs_normal-weight_UP	NA	1578
bsdb:375/1/2_Obesity:obese_vs_normal-weight_DOWN	NA	838
bsdb:376/1/1_Antimicrobial-agent:patients-that-took-amoxiclav_vs_before-antibiotic-exposure_UP	NA	816
bsdb:376/2/1_Antimicrobial-agent:patients-that-took-levofloxacin_vs_before-antibiotic-exposure_UP	NA	816	33042
bsdb:376/2/2_Antimicrobial-agent:patients-that-took-levofloxacin_vs_before-antibiotic-exposure_DOWN	NA	572511
bsdb:378/1/1_Graft-versus-host-disease:Severe-acute-graft-versus-host-disease_vs_controls_UP	NA	1357	47670	40323
bsdb:378/1/2_Graft-versus-host-disease:Severe-acute-graft-versus-host-disease_vs_controls_DOWN	NA	207244	572511	1505663	946234	1378	1392389	1506553	459786	1508657	1769710
bsdb:378/2/1_Graft-versus-host-disease:Severe-acute-graft-versus-host-disease_vs_controls_UP	NA	40323	838
bsdb:378/2/2_Graft-versus-host-disease:Severe-acute-graft-versus-host-disease_vs_controls_DOWN	NA	572511	946234	1506553	1769710
bsdb:379/1/1_Obesity:non-obese_vs_obese_UP	NA	1678	1578
bsdb:379/2/1_Obesity:obese_vs_non-obese_UP	NA	1378	117563
bsdb:379/2/2_Obesity:obese_vs_non-obese_UP	NA	419014	156454
bsdb:381/1/1_Response-to-allogeneic-hematopoietic-stem-cell-transplant:hematopoietic-stem-cell-transplant-recipients_vs_healthy-volunteers_UP	NA	1350
bsdb:381/1/2_Response-to-allogeneic-hematopoietic-stem-cell-transplant:hematopoietic-stem-cell-transplant-recipients_vs_healthy-volunteers_DOWN	NA	46205	292632
bsdb:381/2/1_Response-to-allogeneic-hematopoietic-stem-cell-transplant:high-fecal-butyrate-levels_vs_low-fecal-butyrate-levels_UP	NA	84111	1508657	1506553	572511	46205	1505663
bsdb:381/2/2_Response-to-allogeneic-hematopoietic-stem-cell-transplant:high-fecal-butyrate-levels_vs_low-fecal-butyrate-levels_DOWN	NA	1578	1350
bsdb:382/1/1_Chlamydia-trachomatis-infectious-disease:patient-with-chlamydia-infection_vs_healthy-control_UP	NA	1375
bsdb:382/1/2_Chlamydia-trachomatis-infectious-disease:patient-with-chlamydia-infection_vs_healthy-control_DOWN	NA	1578
bsdb:382/2/1_Chlamydophila-infectious-disease,Human-papilloma-virus-infection:patient-with-chlamydia-infection_vs_HPV-positive-women_UP	NA	810
bsdb:382/2/2_Chlamydophila-infectious-disease,Human-papilloma-virus-infection:patient-with-chlamydia-infection_vs_HPV-positive-women_DOWN	NA	1578
bsdb:383/1/1_Food-allergy:child-with-food-sensitization_vs_no-food-sensitization_DOWN	NA	724	39948	189330	1485
bsdb:383/2/1_Food-allergy:child-with-food-allergy_vs_no-food-allergy_DOWN	NA	544	119852	1357	189330
bsdb:384/1/1_Schizophrenia:FSCZ_vs_healthy-controls_UP	NA	561	620	29465	1350
bsdb:384/1/2_Schizophrenia:FSCZ_vs_healthy-controls_DOWN	NA	848	906	713
bsdb:384/2/1_Schizophrenia:TSCZ_vs_healthy-controls_UP	NA	561	1350	1578	620	1301	29465
bsdb:384/2/2_Schizophrenia:TSCZ_vs_healthy-controls_DOWN	NA	713	906
bsdb:385/1/1_Gastric-adenocarcinoma:Gastric-adenocarcinoma-(GC)_vs_Superficial-gastritis-(SG)_UP	NA	416916	1283313	482	836
bsdb:385/1/2_Gastric-adenocarcinoma:Gastric-adenocarcinoma-(GC)_vs_Superficial-gastritis-(SG)_DOWN	NA	1654	1380	150203	561	165695
bsdb:386/1/1_Pulmonary-tuberculosis:Tuberculosis-(TB)-patients_vs_healthy-controls_UP	NA	33042
bsdb:387/1/1_Antimicrobial-agent:after-ciprofloxacin-exposure_vs_before-ciprofloxacin-exposure_UP	NA	816
bsdb:387/1/2_Antimicrobial-agent:after-ciprofloxacin-exposure_vs_before-ciprofloxacin-exposure_DOWN	NA	239759	216851
bsdb:387/2/1_Antimicrobial-agent:after-clindamycin-exposure_vs_Before-clindamycin-exposure_DOWN	NA	33042	189330	28050	841	1263
bsdb:388/1/1_Oral-squamous-cell-carcinoma:cancerous--lesions_vs_paracancerous-tissues_UP	NA	2747	44259	848	543311	1257	1301	195950	157
bsdb:388/1/2_Oral-squamous-cell-carcinoma:cancerous--lesions_vs_paracancerous-tissues_DOWN	NA	1663	41275	872	33882	248038	44249
bsdb:389/1/1_Schizophrenia:schizophrenia_vs_healthy-controls_UP	NA	1301
bsdb:389/1/2_Schizophrenia:schizophrenia_vs_healthy-controls_DOWN	NA	838
bsdb:389/2/1_Schizophrenia:mania_vs_healthy-controls_UP	NA	1301	215579
bsdb:389/2/2_Schizophrenia:mania_vs_healthy-controls_DOWN	NA	838
bsdb:390/1/1_Schizophrenia:acute-schizphrenia_vs_healthy-controls_UP	NA	258514	1654	244127	35832	946234	1505657	1508657	191303
bsdb:390/1/2_Schizophrenia:acute-schizphrenia_vs_healthy-controls_DOWN	NA	1774107	1432051	1392389
bsdb:390/2/1_Schizophrenia:scizophrenia-during-remission_vs_healthy-controls_UP	NA	1654	264995	244127	1380	35832	2383	1485	283	946234	61170	1505657	420345	375288	838	123375	191303
bsdb:390/2/2_Schizophrenia:scizophrenia-during-remission_vs_healthy-controls_DOWN	NA	580596	1774107	1432051	1392389	577309	3025755
bsdb:391/1/1_Neuromyelitis-optica:neuromyelitis-optica-spectrum-disorder_vs_healthy-controls_UP	NA	561	620	265975	1486725	156454	946234	1301
bsdb:391/1/2_Neuromyelitis-optica:neuromyelitis-optica-spectrum-disorder_vs_healthy-controls_DOWN	NA	40544	1407607	33042	1501226	572511	841	216851	838
bsdb:392/1/1_Milk-allergic-reaction:non-IgE-mediated-cow's-milk-allergy_vs_healthy-controls_UP	NA	239759	816	1266
bsdb:392/2/1_Milk-allergic-reaction:infant-with-non-IgE-mediated-cow's-milk-allergy-treated-with-EHCF_vs_infant-with-non-IgE-mediated-cow's-milk-allergy-at-diagnosis_DOWN	NA	816	239759
bsdb:393/1/1_Milk-allergic-reaction:infant-with-non-IgE-mediated-cow's-milk-allergy-tolerant-to-cow's-milk-protein_vs_infant-with-non-IgE-mediated-cow's-milk-allergy-non-tolerant-to-cow's-milk-protein_UP	NA	1678
bsdb:393/2/2_Milk-allergic-reaction:infant-with-non-IgE-mediated-cow's-milk-allergy_vs_healthy-control_DOWN	NA	816
bsdb:394/1/1_Asthma:child-with-asthma-at-age-6_vs_healthy-control_UP	NA	838	29465
bsdb:396/1/1_Atopic-eczema:atopic-dermatitis_vs_healthy-control_UP	NA	1279
bsdb:396/1/2_Atopic-eczema:atopic-dermatitis_vs_healthy-control_DOWN	NA	47670	106589
bsdb:396/2/1_Atopic-eczema:atopic-dermatitis-after-treatment-with-TCS-+-Bleach_vs_baseline_UP	NA	469	1716	838
bsdb:396/2/2_Atopic-eczema:atopic-dermatitis-after-treatment-with-TCS-+-Bleach_vs_baseline_DOWN	NA	1279
bsdb:397/1/1_Atopic-eczema:severe-atopic-dermatitis_vs_healthy-control_UP	NA	1279	1827	1651	114248
bsdb:397/1/2_Atopic-eczema:severe-atopic-dermatitis_vs_healthy-control_DOWN	NA	357	1380	32067	131079	836	838	32207	1301	29465	117563
bsdb:398/1/1_Atopic-eczema:atopic-dermatitis_vs_healthy-control_DOWN	NA	1279
bsdb:399/1/1_Age:non-healthy-aging-(NHA)_vs_healthy-aging-(HA)_UP	NA	32207	1301	29465	1578	1678
bsdb:399/1/2_Age:non-healthy-aging-(NHA)_vs_healthy-aging-(HA)_DOWN	NA	1016	848	724	482	195950	157	538	47670	43994	2717	283	44259	1743	1716	836	1481960
bsdb:399/2/1_Age:non-healthy-aging-(NHA)_vs_healthy-aging-(HA)_UP	NA	561	1578	620	1301	244127	46205	1508657
bsdb:399/2/2_Age:non-healthy-aging-(NHA)_vs_healthy-aging-(HA)_DOWN	NA	239934	816	84108
bsdb:400/1/1_Asthma:asthma_vs_healthy-control_UP	NA	1485	1350	561	1730	1578
bsdb:400/1/2_Asthma:asthma_vs_healthy-control_DOWN	NA	39948	216851	841
bsdb:401/1/1_Asthma:asthma_vs_healthy-control_UP	NA	970
bsdb:401/1/2_Asthma:asthma_vs_healthy-control_DOWN	NA	830	543311
bsdb:402/2/1_Atopic-eczema:Mothers-whose-infants-developed-IgE-associated-eczema_vs_mothers-whose-infants-remained-non-allergic_UP	NA	1301
bsdb:403/1/1_Eczema:child-with-eczema_vs_healthy-control_UP	NA	841	551
bsdb:403/1/2_Eczema:child-with-eczema_vs_healthy-control_DOWN	NA	1678	547
bsdb:403/2/2_Eczema:child-with-eczema_vs_healthy-control_DOWN	NA	1678
bsdb:404/1/1_Atopic-eczema:patient-with-atopic-dermatitis_vs_healthy-control_UP	NA	1263	375288	216851	292632	140625	158846	207244	239759
bsdb:404/1/2_Atopic-eczema:patient-with-atopic-dermatitis_vs_healthy-control_DOWN	NA	561	620
bsdb:404/2/1_Atopic-eczema:patient-with-atopic-dermatitis_vs_healthy-control_UP	NA	1263
bsdb:404/2/2_Atopic-eczema:patient-with-atopic-dermatitis_vs_healthy-control_DOWN	NA	191303	100883
bsdb:405/1/1_Asthma:child-with-asthma-at-5-years-old_vs_no-asthma-at-5-years-old_UP	NA	29465	1301
bsdb:405/1/2_Asthma:child-with-asthma-at-5-years-old_vs_no-asthma-at-5-years-old_DOWN	NA	841	239759	946234	216851	1678	572511	375288	207244	1263	39948	838
bsdb:405/2/1_Asthma:child-with-asthma-at-5-years-old-among-mothers-with-asthma_vs_no-asthma-at-5-years-old_UP	NA	29465
bsdb:405/2/2_Asthma:child-with-asthma-at-5-years-old-among-mothers-with-asthma_vs_no-asthma-at-5-years-old_DOWN	NA	239759	1678	39948	216851	841	1263	572511	375288	1301	838	946234	239934
bsdb:406/1/1_Lung-cancer:non-smoking-female-lung-cancer-patients_vs_healthy-controls_UP	NA	150203	963	13687
bsdb:406/1/2_Lung-cancer:non-smoking-female-lung-cancer-patients_vs_healthy-controls_DOWN	NA	469	59732	283	1301
bsdb:407/1/1_Peptic-esophagitis:reflux-esophagus-patients_vs_healthy-controls_UP	NA	1380	1730	1164882	906	265975	1257	838	123375	29465	356797
bsdb:407/1/2_Peptic-esophagitis:reflux-esophagus-patients_vs_healthy-controls_DOWN	NA	416916	194	1716	538	44259	2701	1378	940557	52228	43994	1508421	482	113286	32207	1301	157	843
bsdb:408/2/1_Asthma:asthma-at-1-year_vs_healthy-controls_UP	NA	32207
bsdb:409/1/1_Milk-allergic-reaction:IgE-mediated-cow's-milk-allergy_vs_healthy-controls_UP	NA	216851	1263
bsdb:409/1/2_Milk-allergic-reaction:IgE-mediated-cow's-milk-allergy_vs_healthy-controls_DOWN	NA	1678	561
bsdb:410/1/1_HIV-infection:ART-treated-HIV-infected-MSM_vs_HIV-uninfected-MSM_UP	NA	165779	194	150022	162289
bsdb:410/1/2_HIV-infection:ART-treated-HIV-infected-MSM_vs_HIV-uninfected-MSM_DOWN	NA	838
bsdb:411/1/1_HIV/AIDS-pre-exposure-prophylaxis:HIV-negative-MSM-on-PrEP_vs_HIV-negative-MSM-not-on-PrEP_UP	NA	1301	848	52225
bsdb:411/1/2_HIV/AIDS-pre-exposure-prophylaxis:HIV-negative-MSM-on-PrEP_vs_HIV-negative-MSM-not-on-PrEP_DOWN	NA	561	620
bsdb:411/2/1_HIV/AIDS-pre-exposure-prophylaxis:HIV-negative-MSM-on-PrEP_vs_HIV-negative-MSM-not-on-PrEP_UP	NA	1301
bsdb:412/1/1_HIV-infection,Methamphetamine-dependence:HIV-positive-MA-users_vs_HIV-positive-non-MA-users_UP	NA	1654	75984	909928	34104
bsdb:413/1/1_Obsessive-compulsive-disorder:OCD_vs_healthy-controls_DOWN	NA	119852	283168	207244
bsdb:414/1/1_Epilepsy:before-keto-diet_vs_after-keto-diet_UP	NA	1678	39948
bsdb:414/1/2_Epilepsy:before-keto-diet_vs_after-keto-diet_DOWN	NA	561
bsdb:415/1/1_HIV-infection:HIV-positive-women-who-have-been-taking-ART-for-more-than-1-year_vs_Age-matched-HIV-uninfected-women_UP	NA	265975	437755
bsdb:415/2/1_HIV-infection,Oral-candidiasis:HIV-positive-women-with-oral-candidiasis_vs_Age-matched-HIV-uninfected-womenn_UP	NA	29465
bsdb:417/1/1_HIV-infection,Diabetes-mellitus:Women-with-diabetes_vs_Women-without-diabetes_DOWN	NA	165779	150022	168808	447020
bsdb:418/1/1_HIV-infection:immunological-non-responders-assigned-to-treatment-for-12-weeks_vs_baseline_UP	NA	872	158846
bsdb:418/1/2_HIV-infection:immunological-non-responders-assigned-to-treatment-for-12-weeks_vs_baseline_DOWN	NA	135858
bsdb:418/2/1_HIV-infection:immunological-responders-assigned-to-treatment-for-12-weeks_vs_baseline_UP	NA	872	158846
bsdb:418/2/2_HIV-infection:immunological-responders-assigned-to-treatment-for-12-weeks_vs_baseline_DOWN	NA	135858
bsdb:419/1/1_HIV-infection:combination-antiretroviral-therapy-treated-individuals-after-taking-LGG-probiotic-for-8-weeks_vs_baseline_UP	NA	1508657
bsdb:420/1/1_HIV-infection:Probiotic-group-after-8-weeks-of-intervention_vs_baseline-probiotic-group_UP	NA	1678
bsdb:420/1/2_HIV-infection:Probiotic-group-after-8-weeks-of-intervention_vs_baseline-probiotic-group_DOWN	NA	816
bsdb:421/1/1_HIV-infection:Vertically-HIV-infected-children_vs_HIV-uninfected-siblings-or-children-born-to-HIV-infected-mothers_UP	NA	239934	100883	561	848	838
bsdb:421/1/2_HIV-infection:Vertically-HIV-infected-children_vs_HIV-uninfected-siblings-or-children-born-to-HIV-infected-mothers_DOWN	NA	244127	207244	51514	1357	189330	33042	28050	216851	1678
bsdb:422/1/1_HIV-infection:Perinatally-HIV-infected-children_vs_uninfected-age-matched-controls_UP	NA	838	906	970	1485	32067	53335
bsdb:422/1/2_HIV-infection:Perinatally-HIV-infected-children_vs_uninfected-age-matched-controls_DOWN	NA	816	51514	216851	724	475961	48463	1263
bsdb:423/1/2_Amyotrophic-lateral-sclerosis:Amyotrophic-lateral-sclerosis---ALS-patients_vs_Healthy-controls_DOWN	NA	158846
bsdb:424/1/1_Pancreatic-carcinoma:Pancreatic-cancer-patients_vs_Healthy-control_UP	NA	239934	906	283168
bsdb:424/1/2_Pancreatic-carcinoma:Pancreatic-cancer-patients_vs_Healthy-control_DOWN	NA	207244	216851	292632
bsdb:426/1/1_Autoimmune-Hepatitis:autoimmune-hepatits-cases_vs_healthy-controls_UP	NA	570	1578	1301	29465
bsdb:426/1/2_Autoimmune-Hepatitis:autoimmune-hepatits-cases_vs_healthy-controls_DOWN	NA	33042	119852	375288
bsdb:427/1/1_Diet:omnivores_vs_vegetarians_DOWN	NA	28050
bsdb:427/1/2_Diet:omnivores_vs_vegetarians_UP	NA	1263
bsdb:427/2/1_Diet:omnivores_vs_vegans_DOWN	NA	841	28050	838
bsdb:427/2/2_Diet:omnivores_vs_vegans_UP	NA	1263	119852
bsdb:428/1/2_COVID-19:COVID-19-cases_vs_Healthy-controls_DOWN	NA	292632
bsdb:428/2/2_COVID-19:Recovered-COVID-19-cases_vs_Healthy-controls_DOWN	NA	292632
bsdb:429/1/1_Gastric-cancer:gastric-cancer-patients_vs_healthy-controls_UP	NA	1301
bsdb:429/1/2_Gastric-cancer:gastric-cancer-patients_vs_healthy-controls_DOWN	NA	1301
bsdb:431/1/1_Cervical-glandular-intraepithelial-neoplasia:persistent-HPV+-with-HSIL_vs_persistent-HPV+-with-LSIL_DOWN	NA	222	283	1079922	162290	2745	1357	1243	68	149698	407	1839	265	33024	1522432	286	207599	152161	84036	270
bsdb:432/1/1_Human-papilloma-virus-infection:HPV+_vs_HPV-_UP	NA	2093
bsdb:432/1/2_Human-papilloma-virus-infection:HPV+_vs_HPV-_DOWN	NA	2077
bsdb:433/1/1_Cervical-glandular-intraepithelial-neoplasia:CIN-2+_vs_healthy-controls_UP	NA	2701
bsdb:433/1/2_Cervical-glandular-intraepithelial-neoplasia:CIN-2+_vs_healthy-controls_DOWN	NA	1578
bsdb:434/1/1_Human-papilloma-virus-infection:HPV-+_vs_healthy-control_UP	NA	906
bsdb:435/1/1_Human-papilloma-virus-infection:HPV+-persistence_vs_HPV--controls-and-HPV+-transient-patients_UP	NA	28100	13687	165779	838	836	39948	162289
bsdb:435/1/2_Human-papilloma-virus-infection:HPV+-persistence_vs_HPV--controls-and-HPV+-transient-patients_DOWN	NA	1578
bsdb:437/1/1_Human-papilloma-virus-infection:HPV-16+_vs_Healthy-control_UP	NA	78156	1578
bsdb:437/1/2_Human-papilloma-virus-infection:HPV-16+_vs_Healthy-control_DOWN	NA	333750
bsdb:438/1/2_Antimicrobial-agent:Antibiotic-treated-(week-4)_vs_Untreated-controls-(week-4)_DOWN	NA	1678	1578
bsdb:439/1/2_Type-II-diabetes-mellitus:Individuals-diagnosed-with-Type-2-Diabetes-Mellitus_vs_Healthy-controls_UP	NA	838
bsdb:441/1/1_COVID-19:COVID-19-cases_vs_Healthy-controls_UP	NA	1301	32207	29465	1505663	1654
bsdb:441/1/2_COVID-19:COVID-19-cases_vs_Healthy-controls_DOWN	NA	1766253	207244	189330	216851	1407607	1505657	570	1501226	191303	1485
bsdb:442/1/1_Type-II-diabetes-mellitus:Individuals-diagnosed-with-Type-2-Diabetes-Mellitus_vs_Healthy-controls_DOWN	NA	5598	5498	5453	41254	95729	5644
bsdb:443/1/1_Irritable-bowel-syndrome:IBS_vs_Healthy-Control_UP	NA	816	29465
bsdb:443/1/2_Irritable-bowel-syndrome:IBS_vs_Healthy-Control_DOWN	NA	1678
bsdb:444/1/2_Physical-activity:Inactive-patients_vs_Active-patients_DOWN	NA	83770	40840
bsdb:447/1/1_Gestational-diabetes:Individuals-with-gestational-diabetes_vs_Healthy-controls_UP	NA	724
bsdb:447/1/2_Gestational-diabetes:Individuals-with-gestational-diabetes_vs_Healthy-controls_DOWN	NA	239759	33024
bsdb:448/1/1_Influenza-A-(H1N1):Pneumonia-patients-with-pH1N1-infection_vs_Pneumonia-patients-without-any-influenza-A-infection_UP	NA	469	286	1386
bsdb:448/1/2_Influenza-A-(H1N1):Pneumonia-patients-with-pH1N1-infection_vs_Pneumonia-patients-without-any-influenza-A-infection_DOWN	NA	482	838	29465
bsdb:448/1/5_Influenza-A-(H1N1):Pneumonia-patients-with-pH1N1-infection_vs_Pneumonia-patients-without-any-influenza-A-infection_UP	NA	469	1386	286
bsdb:448/1/6_Influenza-A-(H1N1):Pneumonia-patients-with-pH1N1-infection_vs_Pneumonia-patients-without-any-influenza-A-infection_DOWN	NA	482	838	29465
bsdb:452/1/1_Gestational-diabetes:Pregnant-women-with-Gestational-Diabetes-Mellitus_vs_euglycemic-(control)-singleton-pregnant-women_UP	NA	244127	33042	189330	577309	838	1263
bsdb:452/1/2_Gestational-diabetes:Pregnant-women-with-Gestational-Diabetes-Mellitus_vs_euglycemic-(control)-singleton-pregnant-women_DOWN	NA	29465
bsdb:453/1/1_COVID-19:SARS-CoV-2-infected-patients_vs_Non-infected-patients-with-unrelated-respiratory-medical-conditions_UP	NA	1716	194	150022	2050	165779	1582879	836	838	1161127	236752	66831	162290	1279	1380	990721	39948	577310	1649459	1392389
bsdb:453/1/2_COVID-19:SARS-CoV-2-infected-patients_vs_Non-infected-patients-with-unrelated-respiratory-medical-conditions_DOWN	NA	1578	1505657	189330	572511	32207	216851	561	2039302	292632	1301	29465	841	1407607	1766253	570
bsdb:454/1/1_Colorectal-cancer:colorectal-cancer-(CRC)_vs_healthy-controls_UP	NA	1654	239759	209879	816	1678	39948	1350	848	1378	117563	86331	459786	543311	1257	33024	286	841	1263	1279	1301	172900	1485	258514	194	1730	404402	836	838
bsdb:454/1/2_Colorectal-cancer:colorectal-cancer-(CRC)_vs_healthy-controls_DOWN	NA	118966	207244	816	572511	580596	33042	39948	189330	216851	204475	61170	570	841	1485
bsdb:455/1/1_Pregnancy:pregnant-women-without-gingivitis_vs_non-pregnant-women-without-gingivitis_UP	NA	816	848	157
bsdb:455/1/2_Pregnancy:pregnant-women-without-gingivitis_vs_non-pregnant-women-without-gingivitis_DOWN	NA	59735	1378	724	1301	217201
bsdb:456/1/1_Diabetes-mellitus:Individuals-diagnosed-with-Type-2-Diabetes-Mellitus_vs_Healthy-controls_DOWN	NA	207244	816	35832	572511	1485	33042	216851	28050	248744	283168	577310	33024	46205	841	1263	13687	40544
bsdb:456/1/2_Diabetes-mellitus:Individuals-diagnosed-with-Type-2-Diabetes-Mellitus_vs_Healthy-controls_UP	NA	1654	239934	244127	1678	544	102106	84111	1350	570	1578	906	375288	160674	1301	292632	46255
bsdb:457/1/1_Periodontitis:Individuals-diagnosed-with-Periodontitis-group_vs_Healthy-controls-group_UP	NA	40544
bsdb:458/1/1_COVID-19:COVID-19-patients_vs_Non-intubated-patients-with-non-incubation-viral-pneumonia-or-non-incubation-non-infectious-diseases_UP	NA	469	570	48736	13687
bsdb:458/1/2_COVID-19:COVID-19-patients_vs_Non-intubated-patients-with-non-incubation-viral-pneumonia-or-non-incubation-non-infectious-diseases_DOWN	NA	1654	724	482	838	1301	29465
bsdb:459/1/1_COVID-19:COVID-19-positive-patients_vs_COVID-19-negative-controls_DOWN	NA	1283313	165779	38501	580596	194	1016	59732	150022	237	1378	57493	1269	475	162289	836	838	32207	970	29465	662
bsdb:459/1/2_COVID-19:COVID-19-positive-patients_vs_COVID-19-negative-controls_UP	NA	432330	397456
bsdb:462/1/1_Type-I-diabetes-mellitus:Individuals-diagnosed-with-Type-1-Diabetes-Mellitus_vs_Healthy-controls_DOWN	NA	165440	4930
bsdb:462/1/2_Type-I-diabetes-mellitus:Individuals-diagnosed-with-Type-1-Diabetes-Mellitus_vs_Healthy-controls_UP	NA	4855	42658	1124675
bsdb:464/1/1_COVID-19:Confirmed-COVID-19-patients_vs_Healthy-controls_DOWN	NA	1331051	2717	43996	1716	44259	848	1378	724	86331	265975	543311	1257	836	123375	1301
bsdb:464/1/2_COVID-19:Confirmed-COVID-19-patients_vs_Healthy-controls_UP	NA	194	117563	32067	906	970	146	195950
bsdb:465/1/1_Diabetic-neuropathy:Individuals-diagnosed-with-peripheral-neuropathy-associated-with-type-2-diabetes_vs_Healthy-controls_UP	NA	572511	561	1506553	906
bsdb:465/1/2_Diabetic-neuropathy:Individuals-diagnosed-with-peripheral-neuropathy-associated-with-type-2-diabetes_vs_Healthy-controls_DOWN	NA	816	216851
bsdb:466/1/1_Chewing-tobacco-behavior:smokeless-tobacco-users_vs_age-matched-controls_UP	NA	43996	1434006
bsdb:467/1/1_HER2-Positive-Breast-Carcinoma:Her2-positive-tumor_vs_Her2-negative-tumor_UP	NA	904
bsdb:467/1/2_HER2-Positive-Breast-Carcinoma:Her2-positive-tumor_vs_Her2-negative-tumor_DOWN	NA	872	1263
bsdb:468/1/1_Endometriosis:Stage-3/4-endometriosis-patients_vs_Healthy-controls_UP	NA	2701	1283313	1301	2129
bsdb:468/1/2_Endometriosis:Stage-3/4-endometriosis-patients_vs_Healthy-controls_DOWN	NA	168808	838	39948	906	2701	397864
bsdb:470/1/1_Colorectal-cancer:colorectal-cancer_vs_controls_UP	NA	165779	1730	848	1378	1649459	1506553	32067	543311	1257	836	123375	292632
bsdb:470/1/2_Colorectal-cancer:colorectal-cancer_vs_controls_UP	NA	165779	1730	848	1378	1649459	1506553	32067	543311	1257	836	123375	292632
bsdb:472/1/2_Gestational-diabetes:Pregnant-individuals-with-gestational-diabetes_vs_Pregnant-individuals-who-are-normal-glucose-tolerance-(NGT)]_DOWN	NA	140625
bsdb:473/1/1_COVID-19:COVID-19-positive-patients_vs_COVID-19-negative-controls_DOWN	NA	848	724	32067
bsdb:476/1/1_COVID-19:Recovered-COVID-19-patients_vs_Healthy-controls_UP	NA	343821	41949	32207	1505663
bsdb:476/1/2_COVID-19:Recovered-COVID-19-patients_vs_Healthy-controls_DOWN	NA	102106	216851	119852	1263
bsdb:477/1/1_COVID-19:Severe-COVID-19-patients_vs_COVID-19-negative-controls_UP	NA	1283313	43996	1164882	265975	838
bsdb:478/1/1_COVID-19:COVID-19-patients_vs_Healthy-controls_DOWN	NA	2801844	2050	265975	32207	84108
bsdb:478/1/2_COVID-19:COVID-19-patients_vs_Healthy-controls_UP	NA	29465
bsdb:479/1/1_COVID-19:ICU-COVID-19-patients_vs_Healthy-controls_DOWN	NA	469	642	1663	59735	1678	32008	830	1485	1298	44259	397456	43994	33882	745	335058	48736	42255	1193515	203470	1754	28895	261684	34072
bsdb:479/1/2_COVID-19:ICU-COVID-19-patients_vs_Healthy-controls_UP	NA	547	561	570	1506553	1847725	1269	133925	44249	53335	1827	590	196081	613	40323
bsdb:480/1/1_Endometriosis:Vaginal-Fluid_vs_Control-group_UP	NA	1378	1301
bsdb:480/1/2_Endometriosis:Vaginal-Fluid_vs_Control-group_DOWN	NA	1375	1380
bsdb:481/1/1_COVID-19:COVID-19-patients_vs_Healthy-controls_UP	NA	84111	100883
bsdb:482/1/1_COVID-19:Severe-COVID-19-patients_vs_Mild-COVID-19-patients_DOWN	NA	29465	482	1301	838
bsdb:482/1/2_COVID-19:Severe-COVID-19-patients_vs_Mild-COVID-19-patients_UP	NA	1279	561
bsdb:485/1/1_COVID-19:COVID-19-patients-with-fever_vs_COVID-19-patients-without-fever_UP	NA	4930	1350
bsdb:485/1/2_COVID-19:COVID-19-patients-with-fever_vs_COVID-19-patients-without-fever_DOWN	NA	207244	838	375288	33024	84111
bsdb:486/1/1_COVID-19:Asymptomatic-COVID-19-patients_vs_Healthy-controls_UP	NA	84111	547	1350	666060	1263	620	46255	1485
bsdb:486/1/2_COVID-19:Asymptomatic-COVID-19-patients_vs_Healthy-controls_DOWN	NA	904	207244	194	28050	906	52225	133925	841	83770
bsdb:488/1/1_Irritable-bowel-syndrome:IBS-D_vs_Healthy-Control_UP	NA	1283313	1678	216851	1263
bsdb:488/1/2_Irritable-bowel-syndrome:IBS-D_vs_Healthy-Control_DOWN	NA	1301
bsdb:489/1/1_COVID-19:COVID-positive-patients-admitted-to-ICU-(i-COVID-19)_vs_Pneumonia-control-patients-(COVID-negative)_UP	NA	1663	909928	2737	84108	1269	1827	57493	1883	33926	1763	86331	1935176	404402	1434004	724	1926667	1696	1350	1716	66831	44249	1386	1935461	577310
bsdb:489/1/2_COVID-19:COVID-positive-patients-admitted-to-ICU-(i-COVID-19)_vs_Pneumonia-control-patients-(COVID-negative)_DOWN	NA	35829	244127	544	102106	1348911	872	1432051	216851	1686313	946234	1407607	117563	2330	1243	2093	265975	2740	1017280	638847	588605	590	292632	662	1653174	1980689	2005359	1738645	1649459	574697	1508657	1506577	207244	570
bsdb:490/1/1_Irritable-bowel-syndrome:IBS_vs_Healthy-Control_UP	NA	29465	1578
bsdb:490/1/2_Irritable-bowel-syndrome:IBS_vs_Healthy-Control_DOWN	NA	1485
bsdb:491/1/1_Irritable-bowel-syndrome:IBS_vs_Healthy-Control_UP	NA	2740
bsdb:492/1/1_Type-II-diabetes-mellitus:Individuals-having-Type-2-Diabetes-Mellitus-without-Diabetic-Retinopathy_vs_Healthy-controls_DOWN	NA	207244	572511	283	33042	724	28050	33024	841	40544	191303
bsdb:492/1/2_Type-II-diabetes-mellitus:Individuals-having-Type-2-Diabetes-Mellitus-without-Diabetic-Retinopathy_vs_Healthy-controls_UP	NA	904	574697	547	561	140625	2172	157	46255
bsdb:494/1/1_Type-II-diabetes-mellitus:Individuals-diagnosed-with-Type-2-Diabetes-Mellitus_vs_Healthy-controls_DOWN	NA	239934	1678	375288	216851
bsdb:494/1/2_Type-II-diabetes-mellitus:Individuals-diagnosed-with-Type-2-Diabetes-Mellitus_vs_Healthy-controls_UP	NA	189330	848	1301
bsdb:495/1/1_Type-II-diabetes-mellitus:Individuals-diagnosed-with-Type-2-Diabetes-Mellitus_vs_Healthy-controls_UP	NA	1283313	906	838
bsdb:495/1/2_Type-II-diabetes-mellitus:Individuals-diagnosed-with-Type-2-Diabetes-Mellitus_vs_Healthy-controls_DOWN	NA	816	577309
bsdb:496/1/1_COVID-19:COVID-19-patients_vs_Healthy-controls_UP	NA	1654	174708	165779	1380	1678	118747	1485	1716	84111	1350	561	209	1578	437755	265975	583	32207	196081	177971	1301	29465
bsdb:496/1/2_COVID-19:COVID-19-patients_vs_Healthy-controls_DOWN	NA	239759	207244	32008	574697	1485	283	33042	106589	189330	216851	61170	28050	482	283168	119852	375288	838	48736	841	1263	40544	172900	629
bsdb:497/1/1_Acute-myeloid-leukemia:Febrile-neutropenia_vs_Pretreatment_UP	NA	1350
bsdb:497/1/2_Acute-myeloid-leukemia:Febrile-neutropenia_vs_Pretreatment_DOWN	NA	561
bsdb:498/1/1_COVID-19:Symptomatic,-mild-to-moderate-COVID-19-patients_vs_Asymptomatic-uninfected-controls_UP	NA	1582879
bsdb:499/1/1_Irritable-bowel-syndrome:IBS-A_vs_Healthy-Control_DOWN	NA	239759	216851	283168	375288	195950
bsdb:499/1/2_Irritable-bowel-syndrome:IBS-A_vs_Healthy-Control_UP	NA	572511	39948	189330	248744	100175	1263
bsdb:500/1/1_COVID-19:COVID-19-patients_vs_COVID-19-negative-patients-with-pneumonia_UP	NA	469	28453
bsdb:500/1/2_COVID-19:COVID-19-patients_vs_COVID-19-negative-patients-with-pneumonia_DOWN	NA	1654	1380	194	1016	43996	1378	117563	32067	906	437755	482	265975	836	838	970	1301	195950	29465
bsdb:501/1/1_Endometriosis:One-(1)-Stage-III-Endometriosis-patient_vs_Women-scheduled-for-laparoscopic-surgery-for-benign-uterine/-ovarian-conditions-as-well-as-women-with-Stage-I-or-Stage-II-endometriosis_UP	NA	35829	222	1193324	174708	244127	816	580596	100883	33042	946234	1578	375288	1743	168808	1279	191303
bsdb:502/1/1_Irritable-bowel-syndrome:IBS_vs_Healthy-Control_UP	NA	194
bsdb:502/1/2_Irritable-bowel-syndrome:IBS_vs_Healthy-Control_DOWN	NA	816	29465	838
bsdb:503/1/1_Amoxicillin:Amoxicillin-exposed_vs_Control(Unexposed-to-Amoxicillin)_UP	NA	848
bsdb:505/1/2_Irritable-bowel-syndrome:IBS_vs_Healthy-Control_DOWN	NA	1678
bsdb:506/1/2_Irritable-bowel-syndrome:IBS-D_vs_Healthy-Control_DOWN	NA	1678
bsdb:507/1/1_Antimicrobial-agent:Patients-after-Rifaximin-treatment_vs_Patients-before-Rifaximin-treatment_DOWN	NA	724	841	29465
bsdb:508/1/1_Parkinson's-disease:Parkinson's-Disease-Patients_vs_Healthy-Controls_UP	NA	239934	1678	561	119852	375288	33024
bsdb:508/1/2_Parkinson's-disease:Parkinson's-Disease-Patients_vs_Healthy-Controls_DOWN	NA	848
bsdb:509/1/1_Smoking-behavior:Smoking_vs_Non-smoking_UP	NA	1283313	1281902	120831	1357	84567	162291	836	583	475230	292632	82802
bsdb:509/1/2_Smoking-behavior:Smoking_vs_Non-smoking_DOWN	NA	43668	55080	238749	547	28231	579	1578	68287	57494	33024	48736	160674
bsdb:511/1/1_COVID-19:COVID-19-patients_vs_Healthy-controls_UP	NA	29465	194	117563	32257	44259
bsdb:511/1/2_COVID-19:COVID-19-patients_vs_Healthy-controls_DOWN	NA	482	1716	713	437755	416916	157	286
bsdb:512/1/1_COVID-19:COVID-19-positive-patients_vs_COVID-19-negative-controls-and-healthcare-workers_UP	NA	469	1269	475	286	32207
bsdb:513/1/1_COVID-19:COVID-19-positive-patients_vs_COVID-19-negative-controls_UP	NA	613	29465
bsdb:514/1/1_Endometriosis:Stage-3/4-endometriosis-patients_vs_Women-scheduled-for-laparoscopic-surgery-for-benign-uterine/-ovarian-conditions_UP	NA	1301
bsdb:516/1/1_Endometriosis:Mice-who-were-injected-with-endometrial-tissues_vs_Healthy-mice_UP	NA	1678	577310
bsdb:518/1/1_Endometriosis:Stage-3/4-endometriosis-patients_vs_Healthy-controls_UP	NA	1654	572511	180162	1716	189330	84111	1350	117563	1578	1357	1763	1742993	1508657	1301	1485
bsdb:518/1/2_Endometriosis:Stage-3/4-endometriosis-patients_vs_Healthy-controls_DOWN	NA	28050	283168	577310	1508657
bsdb:519/1/1_Endometriosis:Endo-mice_vs_Non-endo-mice_UP	NA	816
bsdb:521/1/1_Endometriosis:Stage-3/4-endometriosis-patients_vs_Surgical-controls_DOWN	NA	1654	1743	32207
bsdb:521/1/2_Endometriosis:Stage-3/4-endometriosis-patients_vs_Surgical-controls_UP	NA	469	212791	286	1301
bsdb:522/1/1_Endometriosis:Endometriosis-patients_vs_Controls-Subject-undergoing-laparoscopic-surgery-for-benign-tumors_UP	NA	2737	1663	165695	80865	156973	265	22	469	1350	55968	44249	286	81
bsdb:522/1/2_Endometriosis:Endometriosis-patients_vs_Controls-Subject-undergoing-laparoscopic-surgery-for-benign-tumors_UP	NA	1375	1578	838	2050	39948	906	543311	119852	1663	469	953	33877	40544
bsdb:523/1/1_Endometriosis:Endo-mice_vs_Non-endo-mice_DOWN	NA	207244	816	572511	1432051	1573534	644652	1578	841	1506577
bsdb:523/1/2_Endometriosis:Endo-mice_vs_Non-endo-mice_UP	NA	239934	174708	544	375288	577310	28138
bsdb:524/1/1_Non-alcoholic-steatohepatitis:Individuals-diagnosed-with--Nonalcoholic-steatohepatitis-(without-cirrhosis)_vs_Healthy-controls_UP	NA	1654	102106	84111	1407607	1649459	1506553
bsdb:524/1/2_Non-alcoholic-steatohepatitis:Individuals-diagnosed-with--Nonalcoholic-steatohepatitis-(without-cirrhosis)_vs_Healthy-controls_DOWN	NA	239759	816	397864	872	283168	375288	577309	577310	1481960	1505652
bsdb:525/1/1_Endometriosis:Women-with-EM-associated-CPPS_vs_Women-without-CPPS-presenting-for-routine-examinations_DOWN	NA	1578
bsdb:526/1/1_Adenomyosis,Endometriosis:Endometriosis/-adenomyosis-patients-(AMEM)_vs_Endometriosis-patients-(EM)-and-Patients-without-endometriosis(Control-CT)_UP	NA	1380	194	1582879	216851
bsdb:527/1/1_Endometriosis:Endometriosis-patients_vs_Healthy-controls-taken-from-a-larger-cohort-study_DOWN	NA	447020	28050	577309	191303
bsdb:527/1/2_Endometriosis:Endometriosis-patients_vs_Healthy-controls-taken-from-a-larger-cohort-study_UP	NA	119852	816	375288	33042
bsdb:529/1/1_Rheumatoid-arthritis,Osteoarthritis:arthritis-patient_vs_healthy-controls_UP	NA	848	47670	32067	117563	1654	1301	32207	724	29465	836	482	838
bsdb:529/1/2_Rheumatoid-arthritis,Osteoarthritis:arthritis-patient_vs_healthy-controls_DOWN	NA	469	59732	286	212791	40323	13687	343873	816	283	13159
bsdb:530/1/1_Smoking-status-measurement:Current-Smokers_vs_Never-Smokers_UP	NA	1678	1578	1654	32207	1380	906
bsdb:530/1/2_Smoking-status-measurement:Current-Smokers_vs_Never-Smokers_DOWN	NA	2717	1350	32257	47670	482	416916	724	1378
bsdb:531/1/1_Rheumatoid-arthritis:Pre---High-risk-Patients_vs_Healthy-controls_UP	NA	1378
bsdb:531/1/2_Rheumatoid-arthritis:Pre---High-risk-Patients_vs_Healthy-controls_DOWN	NA	44259	724	482	836	146
bsdb:532/1/1_Rheumatoid-arthritis:rheumatoid-arthritis-patients_vs_healthy-controls_UP	NA	1654	84111	551	1730	1301	191303
bsdb:532/1/2_Rheumatoid-arthritis:rheumatoid-arthritis-patients_vs_healthy-controls_DOWN	NA	216851
bsdb:533/1/1_Parkinson's-disease:Patients-with-Parkinson's-disease_vs_Healthy-control_UP	NA	239934	561	1678	29465	1301	1485	613	206664	547	84108	48463	33951	207244	872	44000
bsdb:533/1/2_Parkinson's-disease:Patients-with-Parkinson's-disease_vs_Healthy-control_DOWN	NA	830	1696	283168	46205	375288	33042	748770	40544	28050	841	570	203804	572511	816
bsdb:534/1/1_Exercise:obese-subjects_vs_lean-subjects_UP	NA	816	102106
bsdb:534/1/2_Exercise:obese-subjects_vs_lean-subjects_DOWN	NA	216851	28050
bsdb:535/1/1_Antimicrobial-agent:Antibiotic-treated_vs_Antibiotic-untreated_DOWN	NA	904	830	28050
bsdb:535/1/2_Antimicrobial-agent:Antibiotic-treated_vs_Antibiotic-untreated_UP	NA	165779	420345	1578	906	5073	583
bsdb:536/1/2_Azithromycin:The-group-given-an-azithromycin-oral-solution_vs_The-group-given-a-placebo_UP	NA	946234
bsdb:537/1/1_Parkinson's-disease:patients-with-idiopathic-parkinson's-disease_vs_healthy-controls-without-any-form-of-Parkinson's-Disease_UP	NA	239934	1678	561
bsdb:537/1/2_Parkinson's-disease:patients-with-idiopathic-parkinson's-disease_vs_healthy-controls-without-any-form-of-Parkinson's-Disease_DOWN	NA	841	216851
bsdb:538/1/1_Antimicrobial-agent:ciprofloxacin-treated_vs_baseline-of-the-ciprofloxacin-treated_DOWN	NA	216851	119852	1263
bsdb:538/1/2_Antimicrobial-agent:ciprofloxacin-treated_vs_baseline-of-the-ciprofloxacin-treated_UP	NA	572511	1485	1730	841
bsdb:540/1/1_Smoking-behavior:Smokers_vs_Non-smokers_UP	NA	838	1301	29465
bsdb:540/1/2_Smoking-behavior:Smokers_vs_Non-smokers_DOWN	NA	482
bsdb:542/1/1_Hidradenitis-suppurativa:Hidradenitis-suppurativa-patients_vs_Healthy-controls_UP	NA	1654	39948	1582879	150022	162289	836	13687
bsdb:542/1/2_Hidradenitis-suppurativa:Hidradenitis-suppurativa-patients_vs_Healthy-controls_DOWN	NA	283	1743	162289
bsdb:543/1/1_HIV-infection:Persons-with-HIV-(PWH)_vs_HIV-seronegative-controls_DOWN	NA	342658	459786	1501226	44748
bsdb:543/1/2_HIV-infection:Persons-with-HIV-(PWH)_vs_HIV-seronegative-controls_UP	NA	1485
bsdb:545/1/1_Antimicrobial-agent:7-week-old-(young)-mice-10-days-after-antibiotic-treatments_vs_7-week-old-(young)-mice-before-antibiotic-treatment_UP	NA	1350
bsdb:545/1/2_Antimicrobial-agent:7-week-old-(young)-mice-10-days-after-antibiotic-treatments_vs_7-week-old-(young)-mice-before-antibiotic-treatment_DOWN	NA	1470349	1729679	1501226
bsdb:546/1/2_COVID-19:COVID-19-cases_vs_Non-infected-controls_DOWN	NA	848	724	482	1301	838
bsdb:547/1/1_COVID-19:Recovered-COVID-19-patients_vs_Healthy-controls_UP	NA	561	946234	1505657
bsdb:547/1/2_COVID-19:Recovered-COVID-19-patients_vs_Healthy-controls_DOWN	NA	35832	580596	189330	216851	1407607	1392389	1501226	841	1263
bsdb:548/1/1_COVID-19:COVID-19-cases_vs_Healthy-controls_UP	NA	2745	117563	32067	1301
bsdb:548/1/2_COVID-19:COVID-19-cases_vs_Healthy-controls_DOWN	NA	482	838	1283313	848	724
bsdb:549/1/1_Keratoconjunctivitis:Atopic-keratoconjunctivitis-(AKC)_vs_Healthy-controls_UP	NA	286	1279	724
bsdb:549/1/2_Keratoconjunctivitis:Atopic-keratoconjunctivitis-(AKC)_vs_Healthy-controls_DOWN	NA	48736	1678	583
bsdb:550/1/1_Juvenile-idiopathic-arthritis:JIA-patients_vs_healthy-controls_UP	NA	123375	86331
bsdb:550/1/2_Juvenile-idiopathic-arthritis:JIA-patients_vs_healthy-controls_DOWN	NA	724	1386	133925
bsdb:551/1/1_High-fat-diet:High-fat-diet-(HFD:200-Inul-)_vs_High-fat-diet-(HFD:-50-cell)_UP	NA	1678
bsdb:551/1/2_High-fat-diet:High-fat-diet-(HFD:200-Inul-)_vs_High-fat-diet-(HFD:-50-cell)_DOWN	NA	816	1485	51514	1350	1578	1357	1301
bsdb:552/1/1_Gestational-age:Week-36_vs_Week-24_UP	NA	475	1301	1279	1350	1716	1378
bsdb:552/1/2_Gestational-age:Week-36_vs_Week-24_UP	NA	1578
bsdb:554/1/1_Parkinson's-disease:patients-with-parkinson's-disease_vs_Healthy-Controls(HC)_UP	NA	838
bsdb:554/1/2_Parkinson's-disease:patients-with-parkinson's-disease_vs_Healthy-Controls(HC)_DOWN	NA	1578
bsdb:555/1/1_Rheumatoid-arthritis:Rheumatoid-arthritis-patient_vs_Healthy-controls_UP	NA	572511	84111	1573535	286	1301	32207
bsdb:555/1/2_Rheumatoid-arthritis:Rheumatoid-arthritis-patient_vs_Healthy-controls_DOWN	NA	1506553	841	41949	2093	162290	1274351
bsdb:556/1/1_Dry-eye-syndrome:Dry-Eye_vs_Normal-Control-(NC)_UP	NA	1301	1186	184869	508215	724	65551	39948	57495	838	216851	357
bsdb:556/1/2_Dry-eye-syndrome:Dry-Eye_vs_Normal-Control-(NC)_DOWN	NA	286	209	434	374	40323	37914	57739	191	261933	263370	295418	561	67575
bsdb:557/1/1_Urinary-tract-infection:Day-5-(end-of-dosing-or-post-dose)_vs_Day-1-(pre-dose)_UP	NA	713	1654	1283313	165779	207244	816	572511	150022	946234	1940255	1434006	2701	1164882	1578	1847725	32067	906	2050	482	265975	459786	543311	1257	33024	286	1501226	841	508215	1508657	970	1301	40544
bsdb:557/1/2_Urinary-tract-infection:Day-5-(end-of-dosing-or-post-dose)_vs_Day-1-(pre-dose)_DOWN	NA	39948	1350	848	375288	970	157	1506577	29465
bsdb:558/1/1_Antimicrobial-agent:received-oral-i.v.-administered-GSK1322322-(end-of-study)_vs_received-oral-i.v.-administered-GSK1322322-(prestudy)_UP	NA	1678	40544
bsdb:558/1/2_Antimicrobial-agent:received-oral-i.v.-administered-GSK1322322-(end-of-study)_vs_received-oral-i.v.-administered-GSK1322322-(prestudy)_DOWN	NA	207244	572511	574697	216851	283168
bsdb:558/1/3_Antimicrobial-agent:received-oral-i.v.-administered-GSK1322322-(end-of-study)_vs_received-oral-i.v.-administered-GSK1322322-(prestudy)_UP	NA	40323
bsdb:561/1/1_Parkinson's-disease:Participants-with-early-stage-Parkinson's-Disease._vs_Healthy-age-sex-matched-controls-without-Parkinson's-disease._UP	NA	157920	407	1827	234	5475	1678	1573	2701	1578	196082
bsdb:561/1/2_Parkinson's-disease:Participants-with-early-stage-Parkinson's-Disease._vs_Healthy-age-sex-matched-controls-without-Parkinson's-disease._DOWN	NA	32199	511434	1518147
bsdb:562/1/1_Health-study-participation:healthy-adult-vagina-50%-up_vs_NA_NA	NA	1578
bsdb:563/1/1_Chlamydia-trachomatis:Controls-aged->-10-years_vs_Controls-aged-<-=-0-years_UP	NA	1716	253183	265	1743
bsdb:563/1/2_Chlamydia-trachomatis:Controls-aged->-10-years_vs_Controls-aged-<-=-0-years_DOWN	NA	43668	57493	1269	1279	1301
bsdb:565/1/1_Arthritis:dogs-with-hip-or-elbow-arthritis_vs_healthy-dogs_DOWN	NA	13334	375288	2740	33024	86331
bsdb:565/1/2_Arthritis:dogs-with-hip-or-elbow-arthritis_vs_healthy-dogs_UP	NA	158846
bsdb:566/1/1_Juvenile-idiopathic-arthritis:HLAB27+_vs_HLAB27-_DOWN	NA	724	84111
bsdb:566/1/2_Juvenile-idiopathic-arthritis:HLAB27+_vs_HLAB27-_UP	NA	35832	39948	596767	1578	459786	543311
bsdb:567/1/1_Colorectal-adenoma:Advanced-colorectal-adenoma-group-(A-CRA)_vs_Healthy-control-group-(HC)_UP	NA	816	1301	1350
bsdb:567/1/2_Colorectal-adenoma:Advanced-colorectal-adenoma-group-(A-CRA)_vs_Healthy-control-group-(HC)_DOWN	NA	1730	841	1485
bsdb:568/1/1_Parkinson's-disease:NPD-group:-patients-suffering-with-suffering-with-with-PD-for-less-than-1-year-and-before-treatment._vs_healthy-controls-without-any-form-of-Parkinson's-Disease_UP	NA	191303
bsdb:568/1/2_Parkinson's-disease:NPD-group:-patients-suffering-with-suffering-with-with-PD-for-less-than-1-year-and-before-treatment._vs_healthy-controls-without-any-form-of-Parkinson's-Disease_DOWN	NA	577309	1263	1301
bsdb:570/1/1_Rheumatoid-arthritis:female-with-early-RA_vs_female-healthy-control_DOWN	NA	102106	1730	1243
bsdb:571/1/1_Osteoarthritis,-knee:Knee-osteroarthritis_vs_Normal-Vitamin-D-status_DOWN	NA	52784
bsdb:571/1/2_Osteoarthritis,-knee:Knee-osteroarthritis_vs_Normal-Vitamin-D-status_UP	NA	1392389	543311	2740	1743	1335483
bsdb:572/1/1_Arthritis:New-onset-rheumatoid-arthritis---NORA_vs_Healthy-controls_UP	NA	135858	838	29465
bsdb:572/1/2_Arthritis:New-onset-rheumatoid-arthritis---NORA_vs_Healthy-controls_DOWN	NA	816	572511	33024
bsdb:574/1/1_Antimicrobial-agent:azithromycin-lactulose-treated-(day-18)_vs_azithromycin-lactulose-treated-(day-0)_DOWN	NA	547	838
bsdb:574/1/2_Antimicrobial-agent:azithromycin-lactulose-treated-(day-18)_vs_azithromycin-lactulose-treated-(day-0)_UP	NA	207244	1350	1578	841	1263
bsdb:575/1/1_Antimicrobial-agent:perinatal-antibiotics_vs_Control-group_UP	NA	1485	216851	838
bsdb:575/1/2_Antimicrobial-agent:perinatal-antibiotics_vs_Control-group_DOWN	NA	816
bsdb:576/1/1_Colorectal-cancer:patients-with-adenocarcinoma_vs_controls-with-no-cancer_DOWN	NA	33042
bsdb:579/1/2_Major-depressive-disorder:Middle-aged-HC-(aged-30-59-years)_vs_Young-Healthy-Controls(aged-18-29-years)_DOWN	NA	102106	117563	158846	1301	29465
bsdb:580/1/1_HIV-infection:HIV+-individuals_vs_HIV-uninfected-individuals_DOWN	NA	194	1016	848	482	265975	838	195950
bsdb:580/1/2_HIV-infection:HIV+-individuals_vs_HIV-uninfected-individuals_UP	NA	1678	1578	32207	1301	29465
bsdb:581/1/1_Epilepsy:Drug-resistant-epilepsy_vs_Drug-sensitive-epilepsy_DOWN	NA	816	397864
bsdb:581/1/2_Epilepsy:Drug-resistant-epilepsy_vs_Drug-sensitive-epilepsy_UP	NA	841	33024	2172	848	33042	482	239934	204475	1263	577309	100883	80865	189330	61170	1380
bsdb:582/1/1_Colorectal-cancer:CRC-patients_vs_healthy-controls_UP	NA	848	543311	1279
bsdb:582/1/2_Colorectal-cancer:CRC-patients_vs_healthy-controls_DOWN	NA	572511	1485	33042	1301
bsdb:583/1/1_HIV-infection:PLWH->50-years-old-with-severe-periodontitis_vs_PLWH->50-years-old-with-no/mild-periodontitis_UP	NA	838	848	32207	32257	29465	437755	1301	724
bsdb:583/1/2_HIV-infection:PLWH->50-years-old-with-severe-periodontitis_vs_PLWH->50-years-old-with-no/mild-periodontitis_DOWN	NA	906	29465
bsdb:584/1/1_Colorectal-adenoma:cra-patients_vs_normal-participants_UP	NA	613	620	590	53335	581	158851	561
bsdb:585/1/1_Colorectal-cancer:CRC-tumor-biopsy_vs_Healthy-tumor-adjacent-biopsy_UP	NA	848	32067	543311	1257	1301
bsdb:585/1/2_Colorectal-cancer:CRC-tumor-biopsy_vs_Healthy-tumor-adjacent-biopsy_DOWN	NA	189330	216851	375288
bsdb:587/1/1_Nicotine-dependence,Smoking-behavior:Current-Smokers_vs_Never-smokers_UP	NA	135858
bsdb:588/1/1_Colorectal-cancer:colorectal-cancer-patients_vs_healthy-subjects_UP	NA	46123	469	33870	776	1243	131079	2172	32207	100132	674963	574899
bsdb:588/1/2_Colorectal-cancer:colorectal-cancer-patients_vs_healthy-subjects_DOWN	NA	119852
bsdb:589/1/1_Colorectal-cancer:CRC-patients_vs_healthy-control_UP	NA	33024	65402
bsdb:590/1/1_HIV-infection:Recently-HIV-1-infected-individuals_vs_HIV-1-negative-individuals_DOWN	NA	189330
bsdb:590/1/2_HIV-infection:Recently-HIV-1-infected-individuals_vs_HIV-1-negative-individuals_UP	NA	29465
bsdb:591/1/1_HIV-infection:HIV+-individuals_vs_HIV–-individuals_UP	NA	572511	118747	580596	544	1716	872	1350	561	1730	848	117563	158846	906	52225	86331	543311	1257	33024	838	113286	1279	191303
bsdb:591/1/2_HIV-infection:HIV+-individuals_vs_HIV–-individuals_DOWN	NA	447020	357	207244	816	1678	830	1485	33042	189330	216851	61170	140625	28050	119852	841	1263	168808	1301
bsdb:592/1/1_HIV-infection:HIV-Patients_vs_Healthy-controls_UP	NA	265975	123375	1578	1926663	133925	580024	86331	2082587	83770	906	1473205	84108	1573535	102106	135858	838	158846	39948
bsdb:592/1/2_HIV-infection:HIV-Patients_vs_Healthy-controls_DOWN	NA	816	207244	2039302	239759	1407607	547	117563	724
bsdb:593/1/1_Polycystic-ovary-syndrome:Obese-women-with-PCOS_vs_Obese-women-without-PCOS_UP	NA	33042	848	1506553	1506577
bsdb:593/1/2_Polycystic-ovary-syndrome:Obese-women-with-PCOS_vs_Obese-women-without-PCOS_DOWN	NA	239759	574697	283	33042	1892380	61170	283168	1508657	123375	292632
bsdb:594/1/1_Periodontitis:HIV+_vs_HIV–_UP	NA	416916	32257	482	32207	46123
bsdb:594/1/2_Periodontitis:HIV+_vs_HIV–_DOWN	NA	82202	195950	32067	970	157	838
bsdb:595/1/1_Colorectal-carcinoma:CRC-patients_vs_Neoplasia-free_UP	NA	816	35832	872	848	32067	543311	1257	836	1017280	970	482
bsdb:595/1/2_Colorectal-carcinoma:CRC-patients_vs_Neoplasia-free_DOWN	NA	469	194	1730	1263
bsdb:596/1/1_HIV-infection:HIV-infected-men_vs_HIV-uninfected-men_DOWN	NA	1678	212791	1847	149698	551	110932	12916	53387	469	1386	34072	99479	89966	28065
bsdb:596/1/2_HIV-infection:HIV-infected-men_vs_HIV-uninfected-men_UP	NA	29465	402649
bsdb:598/1/1_HIV-infection:HIV-seroconverted_vs_HIV-seronegative_UP	NA	39948	2050	1257
bsdb:598/1/2_HIV-infection:HIV-seroconverted_vs_HIV-seronegative_DOWN	NA	838	1161127
bsdb:600/1/1_Parkinson's-disease:Participants-with-Parkinson's-Disease_vs_Healthy-controls_UP	NA	469	239759	92793	580596	1485	872	570	577309	13687	497726
bsdb:600/1/2_Parkinson's-disease:Participants-with-Parkinson's-Disease_vs_Healthy-controls_DOWN	NA	1578	504481
bsdb:603/1/1_Colorectal-cancer:CRC-patients_vs_Non-disease-controls_DOWN	NA	292632	158846
bsdb:603/1/2_Colorectal-cancer:CRC-patients_vs_Non-disease-controls_UP	NA	1263	29465	906	2753
bsdb:604/1/1_Parkinson's-disease:Participants-with-Parkinson's-Disease_vs_Healthy-controls-free-of-neurological-disease_UP	NA	1678	1716	1578	836	838
bsdb:604/1/2_Parkinson's-disease:Participants-with-Parkinson's-Disease_vs_Healthy-controls-free-of-neurological-disease_DOWN	NA	1766253	572511	580596	216851	1407607	28050	119852	841
bsdb:605/1/1_Parkinson's-disease:Participants-with-Parkinson's-Disease_vs_Healthy-controls-without-Parkinson's-disease_UP	NA	375288	239934	574697	29465	283168	248038	35832	1350	1578
bsdb:605/1/2_Parkinson's-disease:Participants-with-Parkinson's-Disease_vs_Healthy-controls-without-Parkinson's-disease_DOWN	NA	216851	838
bsdb:607/1/1_Parkinson's-disease:Participants-with-typical-PD_vs_Healthy-controls_UP	NA	239934	244127	35832	990721	1578	1301	904
bsdb:607/1/2_Parkinson's-disease:Participants-with-typical-PD_vs_Healthy-controls_DOWN	NA	191303
bsdb:608/1/1_Health-study-participation:healthy-child-oral-50%-up_vs_none_NA	NA	1301	32207	29465	838	1378	482	724
bsdb:609/1/1_Colorectal-cancer:CRC_vs_Healthy-Controls-(HC)_UP	NA	239934	207244	1716	84111	1350	1578	906	375288	577310	543311	1257	836	970	40544	547
bsdb:609/1/2_Colorectal-cancer:CRC_vs_Healthy-Controls-(HC)_DOWN	NA	52784	553372	572511	580596	102106	216851	1407607	848	204475	1501226	841	1506577	28050
bsdb:610/1/1_Irritable-bowel-syndrome:constipated-IBS_vs_Healthy-Control_DOWN	NA	1678	1730	841
bsdb:610/1/3_Irritable-bowel-syndrome:constipated-IBS_vs_Healthy-Control_DOWN	NA	1578	1678
bsdb:611/1/1_Colorectal-cancer:Colorectal-Cancer-patients_vs_healthy-controls_UP	NA	239934	848	256846	543311	836
bsdb:611/1/2_Colorectal-cancer:Colorectal-Cancer-patients_vs_healthy-controls_DOWN	NA	1678	572511	216851	28050	158846	577310	33024	46205	1501226	648800	292632
bsdb:612/1/1_Colorectal-cancer:CRC-cases_vs_control-subjects_DOWN	NA	33042
bsdb:613/1/1_Colorectal-cancer:CRC-patients_vs_healthy-individuals_DOWN	NA	713	207244	544	1485	33042	189330	551	216851	724	28050	32067	482	265975	33024	838	841	970	1301	40544	29465
bsdb:614/1/1_Colorectal-cancer:CRC_vs_Healthy-Controls_UP	NA	838	102106	283168	1257	1164882
bsdb:614/1/2_Colorectal-cancer:CRC_vs_Healthy-Controls_DOWN	NA	413496	44748
bsdb:615/1/1_Rheumatoid-arthritis:rheumatoid-arthritis_vs_healthy-controls_UP	NA	2701
bsdb:617/1/1_Microbiome:Neonatal-samples-taken-at-delivery_vs_Maternal-samples-taken-at-delivery._UP	NA	1716	1743	13687	2701	838	1578
bsdb:617/1/2_Microbiome:Neonatal-samples-taken-at-delivery_vs_Maternal-samples-taken-at-delivery._DOWN	NA	1716	1654	836	1283313	482	724	29465	1301	165779	1279	1743	1263	119852	375288	216851	838	816	2701	1578
bsdb:618/1/1_Dementia:Severe-dementia_vs_Control,-mild,-and-moderate-dementia_UP	NA	244127	1432051	1649459	459786	1769710	84036
bsdb:620/1/1_Colorectal-cancer:Invasive-cancer-group_vs_Early-cancer-group_UP	NA	848
bsdb:621/1/1_Colorectal-cancer:Aspirin_vs_Placebo_UP	NA	838
bsdb:621/1/2_Colorectal-cancer:Aspirin_vs_Placebo_DOWN	NA	29465
bsdb:622/1/1_Colorectal-cancer:CRA-and-CRC-groups_vs_Negative-control-group_DOWN	NA	1654	1678	572511	1485	189330	1730	1578	841
bsdb:622/1/2_Colorectal-cancer:CRA-and-CRC-groups_vs_Negative-control-group_UP	NA	33042	1350	848	1301
bsdb:623/1/1_Colorectal-cancer:Patients-with-CRC-recurrence_vs_Patients-without-CRC-recurrence_UP	NA	848	543311	1486725	1257	838
bsdb:623/1/2_Colorectal-cancer:Patients-with-CRC-recurrence_vs_Patients-without-CRC-recurrence_DOWN	NA	40323	29465
bsdb:625/1/1_Socioeconomic-status:Increasing-socioeconomic-status_vs_lower-socioeconomic-status_UP	NA	207244	1730	216851
bsdb:625/1/2_Socioeconomic-status:Increasing-socioeconomic-status_vs_lower-socioeconomic-status_DOWN	NA	816
bsdb:628/1/1_Socioeconomic-status:Low-SES_vs_High-SES_UP	NA	838
bsdb:628/1/2_Socioeconomic-status:Low-SES_vs_High-SES_DOWN	NA	816
bsdb:632/1/1_Gut-microbiome-measurement:Infants-(median-age = 6.6-months)_vs_Neonates-(median-age = 1.2-months)_UP	NA	239934	1678	572511	1485	33042	1730	1578	1357	838	841	1263	1279	375288	216851	189330	158846	577309	162289	1350	2383	816	156973	29465
bsdb:632/1/2_Gut-microbiome-measurement:Infants-(median-age = 6.6-months)_vs_Neonates-(median-age = 1.2-months)_DOWN	NA	239934	1678	572511	1485	33042	1730	1578	1357	838	841	1263	1279	906	184869	119852	1301
bsdb:633/1/1_Colorectal-cancer:Colorectal-Cancer-Patients_vs_Healthy-controls_UP	NA	848	1357	1257	838	1378	22	543311	39948
bsdb:633/1/2_Colorectal-cancer:Colorectal-Cancer-Patients_vs_Healthy-controls_DOWN	NA	12916	469	41275	82976	75	2782229	237	29580	84567	1743	286	497	34037	28453	13687	40323	2755
bsdb:634/1/2_Smoking-behavior:smokers_vs_non-smokers_DOWN	NA	970
bsdb:635/1/1_Smoking-behavior:Less-than-High-school-diploma_vs_College-graduate-or-more_DOWN	NA	1283313
bsdb:635/1/2_Smoking-behavior:Less-than-High-school-diploma_vs_College-graduate-or-more_UP	NA	836	194	838	29465	44259	196081	1301
bsdb:636/1/1_Smoking-behavior:Tobacco-smokers_vs_Non-Smokers_UP	NA	836
bsdb:637/1/1_Colorectal-cancer:CRC_vs_Healthy-Individuals_UP	NA	165779	207244	43668	374	501783	1378	1269	482	53335	286	497	1301	292636
bsdb:637/1/2_Colorectal-cancer:CRC_vs_Healthy-Individuals_DOWN	NA	29465	1654	838	848	68
bsdb:638/1/1_Ankylosing-spondylitis:Ankylosing-spondylitis-patients_vs_Healthy-controls_UP	NA	1654	1678	102106	1716	84111	216851	158846	906	482	838	32207	40544
bsdb:638/1/2_Ankylosing-spondylitis:Ankylosing-spondylitis-patients_vs_Healthy-controls_DOWN	NA	830	544	1485	547	1730	848	570	283168	375288	841	194	1350
bsdb:639/1/1_Socioeconomic-status:underdeveloped-cities-vs-developed-cities_vs_NA_UP	NA	816	375288	1263
bsdb:639/1/2_Socioeconomic-status:underdeveloped-cities-vs-developed-cities_vs_NA_DOWN	NA	838	1263
bsdb:640/1/1_Rheumatoid-arthritis:Rheumatoid-Arthritis_vs_Non-Rheumatoid-Arthritis_UP	NA	1301	32207	32067
bsdb:640/1/2_Rheumatoid-arthritis:Rheumatoid-Arthritis_vs_Non-Rheumatoid-Arthritis_DOWN	NA	1016	416916	836	848
bsdb:641/1/1_Arthritis:Early-Rheumatoid-Arthritis_vs_healthy-control_DOWN	NA	29465	1283313	117563
bsdb:641/1/2_Arthritis:Early-Rheumatoid-Arthritis_vs_healthy-control_UP	NA	1301	970
bsdb:643/1/1_Colorectal-cancer:yCRC_vs_yControl_UP	NA	1654	946234	848	283168	29465
bsdb:643/1/2_Colorectal-cancer:yCRC_vs_yControl_DOWN	NA	1766253	207244	572511	580596	1485	39948	561	724	570	158846	577310	1501226	620
bsdb:645/1/1_Maternal-milk:MOM-(Mother's-own-milk)_vs_DM-(Donor's-Milk)_UP	NA	816	1678	1350
bsdb:645/1/2_Maternal-milk:MOM-(Mother's-own-milk)_vs_DM-(Donor's-Milk)_DOWN	NA	1279
bsdb:646/1/1_Colorectal-adenoma:Adenoma_vs_Non-Adenoma_UP	NA	35832	86331	40544
bsdb:646/1/2_Colorectal-adenoma:Adenoma_vs_Non-Adenoma_DOWN	NA	1485	724	29465
bsdb:647/1/1_Ethnic-group:Black-Women_vs_White-Women_UP	NA	816
bsdb:648/1/1_Ethnic-group,Gut-microbiome-measurement:Gut-microbiome-of-African-American-children-(AA)_vs_Gut-microbiome-of-European-American-children-(EA)_UP	NA	244127	872	248744	846	838	1473205	84108
bsdb:649/1/1_Huntington-disease:R6/2_vs_Wild-type_UP	NA	816	100883	1578	375288
bsdb:649/1/2_Huntington-disease:R6/2_vs_Wild-type_DOWN	NA	447020	872
bsdb:650/1/1_Gut-microbiome-measurement:Children-of-high-SES_vs_Children-of-low-SES_UP	NA	1263	1407607	572511	207244	1730	1678
bsdb:650/1/2_Gut-microbiome-measurement:Children-of-high-SES_vs_Children-of-low-SES_DOWN	NA	216851	86331	838	580024	2082587
bsdb:651/1/1_Colorectal-cancer:CRC-patients-(swp)_vs_Healthy-volunteers-(swc)_DOWN	NA	207244	135858	216851	572511	2701	1678	28050
bsdb:651/1/2_Colorectal-cancer:CRC-patients-(swp)_vs_Healthy-volunteers-(swc)_UP	NA	43996	848	1378	570	86331	1257	836	970	44259
bsdb:652/1/1_Colorectal-cancer:Intramucosal-CRC_vs_Healthy_DOWN	NA	158846	165695
bsdb:652/1/2_Colorectal-cancer:Intramucosal-CRC_vs_Healthy_UP	NA	713	848	543311	1257	1654
bsdb:653/1/1_Colorectal-cancer:Individuals-with-CRC_vs_Healthy-Controls_UP	NA	39948	848	1378	543311	1257	123375	1301
bsdb:653/1/2_Colorectal-cancer:Individuals-with-CRC_vs_Healthy-Controls_DOWN	NA	1654	724	29465
bsdb:654/1/1_Ethnic-group:Asian-Pacific_vs_Caucasians_UP	NA	29465
bsdb:654/1/2_Ethnic-group:Asian-Pacific_vs_Caucasians_DOWN	NA	283168
bsdb:655/1/1_Ethnic-group:African-Americans-(AA)_vs_European-Americans-(EA)_UP	NA	836
bsdb:655/1/2_Ethnic-group:African-Americans-(AA)_vs_European-Americans-(EA)_DOWN	NA	117563	32207
bsdb:656/1/1_Socioeconomic-status:Children-living-in-slum-(Low-SES)_vs_Private-school-children-(High-SES)_UP	NA	1730
bsdb:658/1/1_Colorectal-cancer:Responders-(Partial-Response-or-Stable-Disease)_vs_Non-responders-(Progressive-Disease)_UP	NA	577309
bsdb:658/1/2_Colorectal-cancer:Responders-(Partial-Response-or-Stable-Disease)_vs_Non-responders-(Progressive-Disease)_DOWN	NA	904	239759	35832	848	1506553
bsdb:660/1/1_Smoking-behavior:Smokers_vs_Never-smokers_UP	NA	1654	1380	118747	194	906	437755	265975	838	29465
bsdb:660/1/2_Smoking-behavior:Smokers_vs_Never-smokers_DOWN	NA	416916	2717	538	724	32257	47670	475	482	2740
bsdb:661/1/2_Meningeal-tuberculosis:Tuberculosis-Meningitis-(TBM)_vs_Healthy-Control-(HC)_DOWN	NA	572511	1678	1407607	375288	841	1501226
bsdb:662/1/1_Socioeconomic-status:Low-SES-(high-land-region)_vs_High-SES-(low-land-region)_UP	NA	1578
bsdb:663/1/1_Ethnic-group:Malay_vs_Chinese_UP	NA	838
bsdb:663/1/2_Ethnic-group:Malay_vs_Chinese_DOWN	NA	816
bsdb:666/1/1_Socioeconomic-status:Low-income-country-(Malawi)_vs_High-Income-country-(Finland)_UP	NA	1678
bsdb:667/1/1_Response-to-immunochemotherapy:Responders_vs_Non-responders_UP	NA	216851	162289	33024	32207	1263
bsdb:667/1/2_Response-to-immunochemotherapy:Responders_vs_Non-responders_DOWN	NA	2701
bsdb:669/1/1_Ethnic-group,Place-of-residence-measurement:Rural-African-Children-in-Burkina-Faso_vs_European-Children-in-Italy_UP	NA	203861	52784	82978	830	194	1485	33870	978	1350	52228	140625	1243	52225	581	346096	866	1266	84108	83768	83770	157	299568	46255
bsdb:669/1/2_Ethnic-group,Place-of-residence-measurement:Rural-African-Children-in-Burkina-Faso_vs_European-Children-in-Italy_DOWN	NA	244127	342658	228923	158846	44261	84034	113286	292637	76632	848	84111	35832	158483	230666	544	547	579	41707	149698	69474	146805	590	620	40544	34069	266808
bsdb:670/1/1_Ethnic-group,Socioeconomic-status:Bangladesh-Children-(Household-income-<-$61)_vs_US-children_UP	NA	830
bsdb:671/1/1_Seasonal-gut-microbiome-measurement:samples-taken-in-dry/cold-season_vs_samples-taken-in-dry/hot-or-rainy-season_UP	NA	838	1485	216851
bsdb:671/1/2_Seasonal-gut-microbiome-measurement:samples-taken-in-dry/cold-season_vs_samples-taken-in-dry/hot-or-rainy-season_DOWN	NA	547	1485	482	1263
bsdb:673/1/2_Ethnic-group:Colombia-data_vs_USA-data_DOWN	NA	816
bsdb:674/1/1_Socioeconomic-status:High-SES_vs_Low-SES_UP	NA	80865	1485	375288	283168	1263
bsdb:674/1/2_Socioeconomic-status:High-SES_vs_Low-SES_DOWN	NA	135858	118747	86331	838	1730	189330	447020
bsdb:675/1/1_Socioeconomic-status:higher-monthly-household-income_vs_lower-monthly-household-income_UP	NA	61170	119852
bsdb:675/1/2_Socioeconomic-status:higher-monthly-household-income_vs_lower-monthly-household-income_DOWN	NA	838
bsdb:676/1/1_Response-to-immunochemotherapy:Responders_vs_Non-responders_UP	NA	140625	620
bsdb:676/1/2_Response-to-immunochemotherapy:Responders_vs_Non-responders_DOWN	NA	1263
bsdb:677/1/1_Survival-time:Short-term-surviviors_vs_Long-term-survivors_UP	NA	194	724	1578	1506577	29465
bsdb:677/1/2_Survival-time:Short-term-surviviors_vs_Long-term-survivors_DOWN	NA	39948	836
bsdb:678/1/1_Smoking-behavior:Cigarette-Smokers_vs_Nonsmokers_UP	NA	1380	1678	194	39948	212791	906	2093	346096	838	157
bsdb:678/1/2_Smoking-behavior:Cigarette-Smokers_vs_Nonsmokers_DOWN	NA	836	1016	1378	2737	1257	848	32067	47670	538	482	2717	713	416916	724
bsdb:680/1/1_Response-to-immunochemotherapy:responders-(patients-treated-with-metronomic-dose-of-capecitabine)_vs_non-responders-(patients-treated-with-conventional-dose)_UP	NA	158846	29465
bsdb:680/1/2_Response-to-immunochemotherapy:responders-(patients-treated-with-metronomic-dose-of-capecitabine)_vs_non-responders-(patients-treated-with-conventional-dose)_DOWN	NA	572511
bsdb:681/1/1_Colorectal-cancer:Colorectal-cancer_vs_Healthy-Controls(HC)_UP	NA	1578	32207
bsdb:682/1/1_Small-intestine-enteropathy:IBS.sibo+_vs_IBS.sibo-_UP	NA	1663	2747	1243	374	64001	1357	286
bsdb:682/1/2_Small-intestine-enteropathy:IBS.sibo+_vs_IBS.sibo-_DOWN	NA	222	357	1696	41275	33882	1269	528	44249	1743	379	28453	165695	1716
bsdb:683/1/1_Colorectal-adenoma:adenoma-group_vs_non-adenoma-group_UP	NA	574697	135858	40544
bsdb:683/1/2_Colorectal-adenoma:adenoma-group_vs_non-adenoma-group_DOWN	NA	207244	1678	1573534
bsdb:685/1/1_Colorectal-cancer:CRC_vs_Control_UP	NA	848	816	572511
bsdb:686/1/1_Colorectal-cancer:Colorectal-cancer-(CRC)_vs_Healthy-controls_DOWN	NA	292632
bsdb:687/1/1_Colorectal-adenocarcinoma:colorectal-cancer-patients_vs_healthy-controls_UP	NA	816	1678	620	561
bsdb:687/1/2_Colorectal-adenocarcinoma:colorectal-cancer-patients_vs_healthy-controls_DOWN	NA	102106	100883	216851	1501226	1301	1766253
bsdb:689/1/2_Response-to-immunochemotherapy:Responders_vs_Non-responders-(Progressive-disease)_DOWN	NA	162289	1380	194	1654	1578
bsdb:690/1/1_Response-to-immunochemotherapy:Responders_vs_Non-responders_UP	NA	1485	1578	84036
bsdb:690/1/2_Response-to-immunochemotherapy:Responders_vs_Non-responders_DOWN	NA	35832	375288	40544
bsdb:691/1/1_Response-to-immunochemotherapy:Responders_vs_Non-responders_UP	NA	35832	561	39948	33024
bsdb:691/1/2_Response-to-immunochemotherapy:Responders_vs_Non-responders_DOWN	NA	84111	133925	29465	1301	838
bsdb:692/1/1_Nutraceutical,Colorectal-cancer:colorectal-cancer-patients-who-took-prebiotics-(preoperative-fecal-sample)_vs_colorectal-cancer-patients-who-didn't-take-prebiotics-(preoperative-fecal-sample)_DOWN	NA	816	1350
bsdb:692/1/2_Nutraceutical,Colorectal-cancer:colorectal-cancer-patients-who-took-prebiotics-(preoperative-fecal-sample)_vs_colorectal-cancer-patients-who-didn't-take-prebiotics-(preoperative-fecal-sample)_UP	NA	1678
bsdb:693/1/1_Response-to-immunochemotherapy:Responders_vs_Non-responders_UP	NA	146918	292632	1578	1678	1263	239934	39948	196081
bsdb:693/1/2_Response-to-immunochemotherapy:Responders_vs_Non-responders_DOWN	NA	773	517	191303	10
bsdb:694/1/1_Colorectal-cancer:low-dose-GQD-(300-mg/kg)_vs_non-GQD_UP	NA	1470349	1578	577310	841	1331051
bsdb:694/1/2_Colorectal-cancer:low-dose-GQD-(300-mg/kg)_vs_non-GQD_DOWN	NA	1331051	191303	1506577
bsdb:695/1/1_Antimicrobial-agent:Coli_vs_control_UP	NA	816	1508657	375288
bsdb:695/1/2_Antimicrobial-agent:Coli_vs_control_DOWN	NA	872	577310
bsdb:696/1/1_Nutraceutical:PGT-group---colorectal-cancer-patients-perioperative-probiotics_vs_CGT-group---colorectal-cancer-patients-perioperative-placebo_UP	NA	379	1350
bsdb:696/1/2_Nutraceutical:PGT-group---colorectal-cancer-patients-perioperative-probiotics_vs_CGT-group---colorectal-cancer-patients-perioperative-placebo_DOWN	NA	848	1378	1257	653683
bsdb:697/1/1_Hepatocellular-carcinoma:Responders-to-Immune-checkpoint-inhibitors_vs_Non-responders-to-Immune-checkpoint-inhibitors_UP	NA	83770	1506577
bsdb:697/1/2_Hepatocellular-carcinoma:Responders-to-Immune-checkpoint-inhibitors_vs_Non-responders-to-Immune-checkpoint-inhibitors_DOWN	NA	239934
bsdb:698/1/1_Crohn's-disease:Patients-with-Crohn's-disease_vs_Healthy-controls_UP	NA	46123	561	113286
bsdb:698/1/2_Crohn's-disease:Patients-with-Crohn's-disease_vs_Healthy-controls_DOWN	NA	580596	52225	724	172900
bsdb:699/1/1_Ulcerative-colitis:Patients-with-ulcerative-colitis_vs_Healthy-controls_DOWN	NA	447020	239934	1263	244127	397864	1870884	2172	84108	195950
bsdb:699/1/2_Ulcerative-colitis:Patients-with-ulcerative-colitis_vs_Healthy-controls_UP	NA	836	1301	1506553	1870884	1257	165779	29465	848	538	724
bsdb:700/1/1_Ulcerative-colitis:children-with-ulcerative-colitis_vs_healthy-controls_DOWN	NA	256846
bsdb:701/1/1_Crohn's-disease:CD_vs_Non-IBD_UP	NA	713	180162	1485	1350	561	1164882
bsdb:701/1/2_Crohn's-disease:CD_vs_Non-IBD_DOWN	NA	239759	33042	216851	204475	838	841	286
bsdb:702/1/1_Rheumatoid-arthritis:Active-(RA)-Rheumatoid-Arthritis_vs_Rheumatoid-Arthritis-(RA)-Remission_UP	NA	1654	1716	838	1301	29465
bsdb:702/1/2_Rheumatoid-arthritis:Active-(RA)-Rheumatoid-Arthritis_vs_Rheumatoid-Arthritis-(RA)-Remission_DOWN	NA	1380	848	265975	838	970
bsdb:703/1/1_Rheumatoid-arthritis:All-Matched-(AM)-Rheumatoid-Arthritis_vs_Healthy-Controls_UP	NA	848
bsdb:704/1/2_Arthritis:Rheumatoid-Arthritis_vs_Healthy-Non-RA-Controls_UP	NA	32067
bsdb:705/1/1_Arthritis:Rheumatoid-Arthritis-(RA)_vs_Osteoarthritis-(OA)_DOWN	NA	43996	836	970
bsdb:706/1/2_Rheumatoid-arthritis:Early-Rheumatoid-Arthritis_vs_Healthy-Controls_DOWN	NA	1578
bsdb:707/1/1_Rheumatoid-arthritis:NORA---[New-Onset-Rheumatoid-Arthritis]-Patient_vs_Healthy-controls_UP	NA	156454	909656	32067	838	970	482	836
bsdb:707/1/2_Rheumatoid-arthritis:NORA---[New-Onset-Rheumatoid-Arthritis]-Patient_vs_Healthy-controls_DOWN	NA	1716	52225	1301	32067
bsdb:708/1/1_Rheumatoid-arthritis:rheumatoid-arthritis-patients_vs_healthy-controls_UP	NA	157	836	838
bsdb:708/1/2_Rheumatoid-arthritis:rheumatoid-arthritis-patients_vs_healthy-controls_DOWN	NA	1301	195950
bsdb:709/1/1_Rheumatoid-arthritis:Early-Rheumatoid-Arthritis_vs_Healthy-Controls_UP	NA	1016	157	1578	39948	44259	1434006	118747
bsdb:709/1/2_Rheumatoid-arthritis:Early-Rheumatoid-Arthritis_vs_Healthy-Controls_DOWN	NA	1654	43996	47670	265975	1213720	29465
bsdb:711/1/1_Systemic-lupus-erythematosus:SLE_vs_HC_UP	NA	1649459	570	579	1506553	886360	13687	1301	3025755
bsdb:711/1/2_Systemic-lupus-erythematosus:SLE_vs_HC_DOWN	NA	1766253	239934	39948	189330	216851	1407607	283168	292632
bsdb:712/1/1_Rheumatoid-arthritis:Rheumatoid-Arthritis_vs_healthy-controls_UP	NA	893	872	43994	906	52225	437755	133925
bsdb:713/1/1_Arthritis:Juvenile-Idiopathic-Arthritis_vs_healthy-controls_DOWN	NA	1654	1716	32067
bsdb:713/1/2_Arthritis:Juvenile-Idiopathic-Arthritis_vs_healthy-controls_UP	NA	1301	32067	724	32257
bsdb:714/1/1_Response-to-ketogenic-diet:Overweight/Obese-Men-on-Ketogenic-Diet-(KD)_vs_Overweight/Obese-Men-on-Baseline-Diet-(BD)_UP	NA	1573534	946234	848	1505657	1392389	158846	1980693	577310	3025755
bsdb:714/1/2_Response-to-ketogenic-diet:Overweight/Obese-Men-on-Ketogenic-Diet-(KD)_vs_Overweight/Obese-Men-on-Baseline-Diet-(BD)_DOWN	NA	1766253	207244	1678	39948	1301
bsdb:715/1/1_Acute-respiratory-distress-syndrome:Mortality_vs_Hyper-inflammatory-subphenotype-and-ventilation-free-days(VFDs)_DOWN	NA	838
bsdb:717/1/1_Parkinson's-disease:Participants-with-Parkinson's-Disease-at-baseline_vs_Healthy-controls-at-baseline_UP	NA	239759	1678	1501226
bsdb:717/1/2_Parkinson's-disease:Participants-with-Parkinson's-Disease-at-baseline_vs_Healthy-controls-at-baseline_DOWN	NA	572511	574697	838	39948
bsdb:718/1/1_Polycystic-ovary-syndrome:Letrozole-treated_vs_Placebo-treated_UP	NA	174708	572511	33042	841
bsdb:718/1/2_Polycystic-ovary-syndrome:Letrozole-treated_vs_Placebo-treated_DOWN	NA	239759	51514
bsdb:720/1/1_Chlamydia-trachomatis-infectious-disease:Chlamydia-trachomatis_vs_Healthy-Controls_UP	NA	1375	419014	1380	572511	1485	39948	561	216851	906	841	168808	1301	2129	1678
bsdb:721/1/1_HIV-mother-to-child-transmission:HIV-exposed-uninfected-infants-(HEU)-at-6-weeks_vs_HIV-unexposed-infants-(HUU)-at-6-weeks_UP	NA	397864	572511	84111	283168	168808
bsdb:721/1/2_HIV-mother-to-child-transmission:HIV-exposed-uninfected-infants-(HEU)-at-6-weeks_vs_HIV-unexposed-infants-(HUU)-at-6-weeks_DOWN	NA	135858	547	158846
bsdb:722/1/1_Parkinson's-disease:Parkinson's-Disease-Patients_vs_Healthy-Controls_UP	NA	239934	574697	1432051	61170	596767	1392389	283168	577310	292632
bsdb:722/1/2_Parkinson's-disease:Parkinson's-Disease-Patients_vs_Healthy-Controls_DOWN	NA	209879	816	1485	102106	1573535	1506577
bsdb:723/1/2_Parkinson's-disease:Idiopathic-Parkinson's-Disease-Patients_vs_Healthy-Controls_DOWN	NA	1380	1562	117563	841	577309
bsdb:724/1/1_Parkinson's-disease:Parkinson's-disease-patients-with-normal-cognition_vs_Healthy-spouses-and-Parkinson's-disease-patients-with-mild-cognitive-impairment_UP	NA	1263	572511
bsdb:725/1/1_Eczema:Atopic-dermatitis-case-group_vs_Healthy-controls_DOWN	NA	1378	724	1301	29465
bsdb:725/1/2_Eczema:Atopic-dermatitis-case-group_vs_Healthy-controls_UP	NA	57495	407	1298
bsdb:726/1/1_Aging:Group-2_vs_Group-1-(18–35-years-old)_UP	NA	713	816	561	1578
bsdb:727/1/1_Tobacco-smoke-exposure-measurement:Current-cigarette-smokers_vs_Never-smokers_DOWN	NA	713	59735	1678	2717	1378	724	1164882	1357	47670	482	836	1301
bsdb:727/1/2_Tobacco-smoke-exposure-measurement:Current-cigarette-smokers_vs_Never-smokers_UP	NA	1283313	156454	194	1434006	1578	32067	906	838	286	32207	157	29465
bsdb:728/1/1_Diarrhea:Diarrhea-Group_vs_Controls-(No-Diarrhea-Group)_DOWN	NA	207244	816	1678	572511	100883	189330	1730	216851	1407607	459786	1501226	1508657	1263	33042
bsdb:728/1/2_Diarrhea:Diarrhea-Group_vs_Controls-(No-Diarrhea-Group)_UP	NA	1350	561	1506553
bsdb:729/1/1_Schizophrenia:Elderly-Schizophrenia-Patients_vs_healthy-control_UP	NA	239934	1283313	1678	35832	135858	872	848	1573535	158846	52225	1501226	1473205	84108	1301	83770	40544
bsdb:729/1/2_Schizophrenia:Elderly-Schizophrenia-Patients_vs_healthy-control_DOWN	NA	207244	580596	544	33042	1432051	216851	1407607	204475	570	577310	841	1263	191303
bsdb:730/1/1_Spinal-cord-injury:SCI-(spinal-cord-injury)_vs_healthy-control-(without-SCI)_DOWN	NA	1766253	397864	572511	580596	102106	33042	189330	216851	1686313	1407607	1573535	248744	577310	841	1263	84108	40544
bsdb:730/1/2_Spinal-cord-injury:SCI-(spinal-cord-injury)_vs_healthy-control-(without-SCI)_UP	NA	52784	2383	990721	156973	84111	1350	946234	1505657	1578	459786	1769710	3025755
bsdb:731/1/2_Parkinson's-disease:Parkinson's-Disease-subjects_vs_Healthy-controls_DOWN	NA	1506553	841
bsdb:732/1/1_Obesity:Obese-individuals_vs_Individuals-with-a-healthy-body-mass-index_DOWN	NA	508459	1263	244127	119852	84111	572511	239934
bsdb:732/1/2_Obesity:Obese-individuals_vs_Individuals-with-a-healthy-body-mass-index_UP	NA	904	906	135858	838	1301
bsdb:733/1/1_Sampling-site:duodenal-microbiota_vs_biliary-microbiota_UP	NA	1301
bsdb:735/1/1_Crohn's-disease:Crohn's-disease_vs_Healthy-control_UP	NA	482	713	416916	724
bsdb:735/1/2_Crohn's-disease:Crohn's-disease_vs_Healthy-control_DOWN	NA	216851	375288	841	33042	572511	1263	1730	1678	1485
bsdb:736/1/1_Alzheimer's-disease:Alzheimer’s-disease-patients_vs_healthy-controls_UP	NA	239934	1678	1716	1350	1730	1578	292632	2735
bsdb:736/1/2_Alzheimer's-disease:Alzheimer’s-disease-patients_vs_healthy-controls_DOWN	NA	207244	580596	33042	39948	216851	1407607	204475	838	1501226	841	29465
bsdb:737/1/1_Smoking-behavior:Healthy-current-smokers_vs_Healthy-non-smokers_DOWN	NA	1378	117563	724	482	836	838	1301	848
bsdb:737/1/2_Smoking-behavior:Healthy-current-smokers_vs_Healthy-non-smokers_UP	NA	1654	848	1301	29465	838
bsdb:738/1/1_Crohn's-disease:pediatric-crohn's-disease_vs_healthy-adults_DOWN	NA	158846
bsdb:739/1/1_Treatment:Bacillus-clausii-UBBC-07-group-after-intervention/treatment_vs_Placebo-group-before-intervention/treatment_UP	NA	216851	1578	1678
bsdb:740/1/1_Alzheimer's-disease:Alzheimer’s-disease_vs_healthy-controls_DOWN	NA	572511	1263
bsdb:742/1/1_Parkinson's-disease:Parkinson's-Disease-Patients_vs_Healthy-spouses_UP	NA	239759	244127	35832	574697	830	872	846	196081	292632	133925
bsdb:742/1/2_Parkinson's-disease:Parkinson's-Disease-Patients_vs_Healthy-spouses_DOWN	NA	816	1279384
bsdb:743/1/1_Parkinson's-disease:Parkinson's-Disease-subjects_vs_Healthy-control-volunteers_UP	NA	239934	816	119852
bsdb:743/1/2_Parkinson's-disease:Parkinson's-Disease-subjects_vs_Healthy-control-volunteers_DOWN	NA	572511	33042	189330	841
bsdb:744/1/1_Parkinson's-disease:Parkinson's-Disease-Patients_vs_Healthy-controls._UP	NA	239934	1350	1649459
bsdb:745/1/1_Fasting:Adults-after-fasting_vs_Adults-before-fasting_UP	NA	239934	174708	816	580596	39948	1730	216851	906	841
bsdb:745/1/2_Fasting:Adults-after-fasting_vs_Adults-before-fasting_DOWN	NA	1350	561
bsdb:746/1/1_Parkinson's-disease:Parkinson's-Disease-subjects._vs_Healthy-controls._UP	NA	1654
bsdb:750/1/1_Sex-design:Females_vs_Males_DOWN	NA	59735	195950
bsdb:750/1/2_Sex-design:Females_vs_Males_UP	NA	157	2093	1716
bsdb:751/1/1_Alcohol-drinking:Moderate-drinkers_vs_Non-drinkers_UP	NA	1301	838	59735	1716	848	32067	416916	2717	538	32257	482
bsdb:752/1/1_Smoking-behavior:Smokers_vs_Non-smokers_UP	NA	713	1651	118747	59732	1647	848	1378	82980	908284	613	40544
bsdb:752/1/2_Smoking-behavior:Smokers_vs_Non-smokers_DOWN	NA	46123	1654	1016	1716	44259	117563	32067	86331	53370	970	1279	1301	195950	469
bsdb:753/1/1_Smoking-behavior:Smokers_vs_Nonsmokers_UP	NA	970	157
bsdb:753/1/2_Smoking-behavior:Smokers_vs_Nonsmokers_DOWN	NA	1016	2717
bsdb:754/1/1_Smoking-behavior:Smokers_vs_Non-smokers_UP	NA	816	1716	893	1730	44259	1434006	848	1378	117563	47670	86331	543311	32207	1301	195950	29465	43996	32067	157
bsdb:754/1/2_Smoking-behavior:Smokers_vs_Non-smokers_DOWN	NA	416916	194	2717	724	838	1434006	482	836	970	157
bsdb:756/1/1_Smoking-behavior:Smokers-(S)_vs_Controls-(C)_DOWN	NA	46123	416916	292480	1386	59735	28219	1378	117563	32257	86331	437755	482	196079	265975	162289	1257	67572	75309	42255	1279	265570	933
bsdb:756/1/2_Smoking-behavior:Smokers-(S)_vs_Controls-(C)_UP	NA	222	110934	507	28263	1663	1016	308865	848	32636	110932	33882	838	48736	13687	40323	195950	34072	84567	46466
bsdb:758/1/1_Nasopharyngeal-squamous-cell-carcinoma:Nasopharyngeal-carcinoma-patients-at-baseline_vs_Healthy-controls-at-Baseline_UP	NA	32067	482	286
bsdb:758/1/2_Nasopharyngeal-squamous-cell-carcinoma:Nasopharyngeal-carcinoma-patients-at-baseline_vs_Healthy-controls-at-Baseline_DOWN	NA	1301
bsdb:759/1/1_Dry-eye-syndrome:Dry-Eye_vs_control_DOWN	NA	1716	237	848	724	149698	33882	219181	32207	13687	270	29465
bsdb:760/1/1_Colorectal-cancer:Probio-group_vs_Placebo-control-group_UP	NA	32207	42255	283168	239759	191303	1485	572511	420345	2740	244127	724
bsdb:760/1/2_Colorectal-cancer:Probio-group_vs_Placebo-control-group_DOWN	NA	46123	713	239934	580596	227979	28050	581	375288	651554	577309	497	1263
bsdb:761/1/1_Breast-cancer:Breast-Health-Condition_vs_Control_UP	NA	1161127	543311	836	838	196081	195950
bsdb:762/1/2_Dry-eye-syndrome:Dry-Eye_vs_healthy-controls_UP	NA	286
bsdb:763/1/2_Age-at-assessment:Old_vs_Young_DOWN	NA	336809
bsdb:764/1/1_Type-II-diabetes-mellitus:diabetic_vs_healthy-controls_UP	NA	469	1375	357	1663	76890	191	1696	32008	1562	2745	2742	1269	13159	57494	28100	67575	1060	1835	235888	343873
bsdb:764/1/2_Type-II-diabetes-mellitus:diabetic_vs_healthy-controls_DOWN	NA	165696	1279
bsdb:765/1/1_Adenomyosis:adenomyosis-patients_vs_Healthy-controls_UP	NA	419014	212791	216851	158846	119852	292632
bsdb:765/1/2_Adenomyosis:adenomyosis-patients_vs_Healthy-controls_DOWN	NA	236752	906
bsdb:766/1/1_Stevens-Johnson-syndrome:Stevens-Johnson-Syndrome_vs_healthy-controls_UP	NA	816	216851	51366	239934	838	33042	1301	1578	848	1678	572511	1386	33024	577309	469	1263	158846	283168	1279	53246	551	286	102106	2172	29465	141948	841	191303
bsdb:766/1/2_Stevens-Johnson-syndrome:Stevens-Johnson-Syndrome_vs_healthy-controls_DOWN	NA	22	655352	1485	76008	104267	40222	180162	28196	662
bsdb:767/1/1_Alzheimer's-disease:Alzheimer's-disease-patients_vs_Non-demented-Controls_UP	NA	816	102106	283168	375288	577309	838
bsdb:767/1/2_Alzheimer's-disease:Alzheimer's-disease-patients_vs_Non-demented-Controls_DOWN	NA	580596	216851	577310	838	841
bsdb:771/1/2_Health-study-participation:Bejing-healthy-volunteers_vs_Guangzhou-healthy-volunteers_DOWN	NA	336809
bsdb:774/1/1_Irritable-bowel-syndrome:IBS-C-(IBS-Constipation)_vs_Non-IBS1-(Non-irritable-bowel-syndrome-1)_DOWN	NA	1766253	653683	207244	1678	572511	580596	33042	1716	189330	216851	1407607	724	28050	2039302	838	841	1263	292632	83770	40544	29465
bsdb:774/1/2_Irritable-bowel-syndrome:IBS-C-(IBS-Constipation)_vs_Non-IBS1-(Non-irritable-bowel-syndrome-1)_UP	NA	239934	397864	990721	80865	872	1472649	1432051	1730	1573534	150022	946234	1918511	1649459	596767	1392389	1980693	459786	119852	375288	1508657	2918511
bsdb:775/1/1_Breast-cancer:Breast-cancer-(BC)_vs_Healthy-controls-(HC)_UP	NA	1654	572511	84111	1573534
bsdb:776/1/1_Overactive-bladder:Overactive-Bladder-(OAB)-patients_vs_Asymptomatic-controls_UP	NA	1279	168808	583	31983	1378	2093	1375
bsdb:776/1/2_Overactive-bladder:Overactive-Bladder-(OAB)-patients_vs_Asymptomatic-controls_DOWN	NA	165779	194	39948	1350	150022	848	428711	1578	1357	165696	838	638847	2129
bsdb:778/1/1_Gastric-cancer:Gastric-cancer-(GC)_vs_Superficial-gastritis_UP	NA	642	194	39948	209	1578	838	1827	886360	504481	1301
bsdb:778/1/2_Gastric-cancer:Gastric-cancer-(GC)_vs_Superficial-gastritis_DOWN	NA	1654	1283313	1663	374	41275	194	848	724	32067	482	28100	836	838	508215	29465
bsdb:780/1/1_Exercise:Meditation-group_vs_Control-group_UP	NA	216851	158846	838	816
bsdb:780/1/2_Exercise:Meditation-group_vs_Control-group_DOWN	NA	1678	102106	39948	906	841
bsdb:782/1/1_COVID-19:Pharyngeal-samples-from-COVID-19-patients_vs_samples-from-Healthy-patients_DOWN	NA	32008	194	561	848	724	1269	482	970	195950	157
bsdb:782/1/2_COVID-19:Pharyngeal-samples-from-COVID-19-patients_vs_samples-from-Healthy-patients_UP	NA	1654	508215	1301
bsdb:784/1/2_Gut-microbiome-measurement:Severe-COVID-19_vs_Moderate-COVID-19_DOWN	NA	459786
bsdb:785/1/1_Ulcerative-colitis:Ulcerative-colitis-patient_vs_Healthy-control-individual_UP	NA	375288
bsdb:786/1/1_Type-II-diabetes-mellitus:Pre-Type-2-Diabetes_vs_Healthy-controls---based-on-GA--map_UP	NA	189330
bsdb:786/1/2_Type-II-diabetes-mellitus:Pre-Type-2-Diabetes_vs_Healthy-controls---based-on-GA--map_DOWN	NA	841	29465
bsdb:789/1/1_Breast-cancer:Prediagnostic-(PD)_vs_Healthy-(H)_UP	NA	196013	848	53335	1501226	13687	1279
bsdb:789/1/2_Breast-cancer:Prediagnostic-(PD)_vs_Healthy-(H)_DOWN	NA	1716
bsdb:791/1/1_Spontaneous-preterm-birth:Preterm-Birth_vs_Full-term-Birth_UP	NA	1213720
bsdb:792/1/1_Root:Test-group-(Roots)_vs_Control-group-(Leaves)_UP	NA	149698	4855	164535
bsdb:792/1/2_Root:Test-group-(Roots)_vs_Control-group-(Leaves)_DOWN	NA	29580	286	5598	253308	5498	40657
bsdb:793/1/1_Cerebral-small-vessel-disease:High-burden-(Unhealthy)_vs_Lower-burden-(Healthy)_UP	NA	270497	119852
bsdb:793/1/2_Cerebral-small-vessel-disease:High-burden-(Unhealthy)_vs_Lower-burden-(Healthy)_DOWN	NA	1485	2172	172900
bsdb:794/1/1_Colorectal-cancer:EOCRC-(Early-onset-Colorectal-cancer)-patients_vs_Healthy-controls_UP	NA	848	158846	543311	1257	836
bsdb:795/1/2_Streptococcus-pneumoniae:Pneumococcal-carriers_vs_Pneumococcal-non-carriers._DOWN	NA	165779
bsdb:796/1/1_Aging:Group-4--oldest-age-group-(66-to-80-years-old.-elderly-people)_vs_Group-1--youngest-age-group-(18-to-35-years-old)_UP	NA	570	1578	561
bsdb:796/1/2_Aging:Group-4--oldest-age-group-(66-to-80-years-old.-elderly-people)_vs_Group-1--youngest-age-group-(18-to-35-years-old)_DOWN	NA	577309	86331
bsdb:797/1/1_Smoking-status-measurement:Active-smokers_vs_Never-smokers_DOWN	NA	848	724	407	1301
bsdb:797/1/2_Smoking-status-measurement:Active-smokers_vs_Never-smokers_UP	NA	335058	40323
bsdb:798/1/1_Urinary-tract-infection:Recurrent-Urinary-Tract-Infection-(RUTI)-patients_vs_Asymptomatic-controls_UP	NA	165779	1716	39948	906	836	838	48736	1653174	162289	194	848	212791
bsdb:798/1/2_Urinary-tract-infection:Recurrent-Urinary-Tract-Infection-(RUTI)-patients_vs_Asymptomatic-controls_DOWN	NA	469	239759	1582879	2701	1578	168808	1301
bsdb:799/1/1_Chronic-obstructive-pulmonary-disease:HIV-positive-individuals-diagnosed-with-COPD_vs_HIV-negative-individuals-with-COPD_UP	NA	416916	2801844	1386	2717	1716	1730	44259	848	1378	1840214	32067	2742598	475	543311	838	1743	508215	970	1301	195950
bsdb:799/1/2_Chronic-obstructive-pulmonary-disease:HIV-positive-individuals-diagnosed-with-COPD_vs_HIV-negative-individuals-with-COPD_DOWN	NA	46123	2147	713	1654	1283313	156454	1380	59735	194	1331051	1016	39948	1434006	117563	724	1164882	47670	482	265975	2740	1257	836	71	123375	1213720	34104	195950	157	29465
bsdb:800/1/1_Health-study-participation:pandemic-group-with-covariates-controlled-for_vs_pre-pandemic-group-with-covariates-controlled-for_DOWN	NA	724
bsdb:801/1/1_Respiratory-system-disease:Diseased-individuals-(D)_vs_Non-diseased/-healthy-individuals-(ND)_UP	NA	2801844	1678	1716	561	724	570	44249	286	497	195950
bsdb:801/1/2_Respiratory-system-disease:Diseased-individuals-(D)_vs_Non-diseased/-healthy-individuals-(ND)_DOWN	NA	543311	2093	970	39948	32067	86331	1380	416916	123375	133925	43996	47670	76833	194	1164882	1257	1283313	1485	898	848	157	838
bsdb:802/1/1_Cachexia:cachexia-induced-mice_vs_Healthy-controls_UP	NA	248744	49082	1301	1485	1926677
bsdb:802/1/2_Cachexia:cachexia-induced-mice_vs_Healthy-controls_DOWN	NA	1501226	1357	191303	1678	1263	1980681
bsdb:803/1/1_Colorectal-cancer:Egyptian-Samples-with-Colorectal-Cancer_vs_Normal-samples-free-from-Colorectal-Cancer_UP	NA	57493
bsdb:803/1/2_Colorectal-cancer:Egyptian-Samples-with-Colorectal-Cancer_vs_Normal-samples-free-from-Colorectal-Cancer_DOWN	NA	33986	1269	482
bsdb:804/1/1_Response-to-transplant:CON-FMT:-receiving-control-microbiota-FMT-mice_vs_SD-FMT-AND-SD+MEL-FMT_UP	NA	248038	1508657	1918598
bsdb:806/1/1_Mood-disorder:bipolar-disorder-(BD)_vs_healthy-controls-(HCs)_UP	NA	816	102106	84111	848	1506553	1578	286	1301	292632	3025755	1485
bsdb:807/1/1_Microbiome-measurement:Nasopharyngeal-swab-samples-from-workplaces_vs_Indoor-dust-samples_UP	NA	1716	1279
bsdb:808/1/1_Response-to-diet:mice-on-ketogenic-diet_vs_mice-on-American-diet_UP	NA	35832	28138	1508657
bsdb:808/1/2_Response-to-diet:mice-on-ketogenic-diet_vs_mice-on-American-diet_DOWN	NA	375288
bsdb:809/1/1_Retinopathy:diabetes-mellitus-(DM)_vs_healthy-controls-(HC)_UP	NA	724	906	375288	29465
bsdb:811/1/1_Psoriasis:Psoriasis-patients_vs_Healthy-controls_UP	NA	135858	39948
bsdb:811/1/2_Psoriasis:Psoriasis-patients_vs_Healthy-controls_DOWN	NA	264995	572511	990721	28050	1263
bsdb:812/1/1_Urinary-tract-infection:rUTI-History,-UTI-(-)_vs_No-UTI-History_UP	NA	1375	1578
bsdb:812/1/2_Urinary-tract-infection:rUTI-History,-UTI-(-)_vs_No-UTI-History_UP	NA	816	84111	561	1378	570	1301	2129
bsdb:813/1/1_Body-weight:Aging_vs_Adult_UP	NA	51514	40544	35832
bsdb:814/1/1_Diet-measurement:Adult-Systemic-Sclerosis-patients-on-a-non-low-fermentable-oligosaccharides,-disaccharides,-monosaccharides,-and-polyols-(FODMAP)-diet._vs_Adult-Systemic-Sclerosis-patients-on-a-low-fermentable-oligosaccharides,-disaccharides,-monosaccharides,-and-polyols-(FODMAP)-diet._UP	NA	1350	570	906
bsdb:814/1/2_Diet-measurement:Adult-Systemic-Sclerosis-patients-on-a-non-low-fermentable-oligosaccharides,-disaccharides,-monosaccharides,-and-polyols-(FODMAP)-diet._vs_Adult-Systemic-Sclerosis-patients-on-a-low-fermentable-oligosaccharides,-disaccharides,-monosaccharides,-and-polyols-(FODMAP)-diet._DOWN	NA	1649459	265975	1481960	1505652
bsdb:815/1/1_Ulcerative-proctosigmoiditis:Infants-diagnosed-with-food-protein-induced-allergic-proctocolitis-(FPIAP)_vs_Infants-diagnosed-without-food-protein-induced-allergic-proctocolitis-(FPIAP)_UP	NA	572511
bsdb:815/1/2_Ulcerative-proctosigmoiditis:Infants-diagnosed-with-food-protein-induced-allergic-proctocolitis-(FPIAP)_vs_Infants-diagnosed-without-food-protein-induced-allergic-proctocolitis-(FPIAP)_DOWN	NA	1578
bsdb:817/1/2_Granulomatosis-with-Polyangiitis:Kidneys-with-calcification_vs_Healthy/Healthy-with-no-visible-granuloma_DOWN	NA	150247	57495	1269	265
bsdb:820/1/2_Antimicrobial-agent,Amoxicillin:mouse--after-antibiotic-treatment_vs_mouse-before-antibiotic-treatment_UP	NA	5052	5498	83174
bsdb:821/1/1_Temperature:Warm-Gut_vs_Cool-Gut_UP	NA	239934	244127	100883	375288	168934
bsdb:821/1/2_Temperature:Warm-Gut_vs_Cool-Gut_DOWN	NA	544	150247	653683	1501226	469	29580
bsdb:822/1/1_Azithromycin:Azithromycin(AZM)-at-48-weeks_vs_Placebo-at-48-Weeks_UP	NA	47670	475	32207	157
bsdb:823/1/1_Dry-eye-syndrome:Meibomian-Gland-Dysfunction-(MGD)-Groups_vs_Healthy-controls_UP	NA	1279	13687
bsdb:823/1/2_Dry-eye-syndrome:Meibomian-Gland-Dysfunction-(MGD)-Groups_vs_Healthy-controls_DOWN	NA	1716
bsdb:824/1/1_Gastric-cancer:Gastric-cancer-patients-(Post-gastrectomy)_vs_Gastric-cancer-patients-(Pre-gastrectomy)_UP	NA	404402	1578
bsdb:824/1/2_Gastric-cancer:Gastric-cancer-patients-(Post-gastrectomy)_vs_Gastric-cancer-patients-(Pre-gastrectomy)_DOWN	NA	1654	1766253	239759	2060094	207244	2801844	830	1331051	848	2740	40544
bsdb:825/1/1_Urolithiasis:urinary-stone-disease-patients_vs_healthy-controls_UP	NA	1654	239759	209879	1283313	244127	816	1678	572511	574697	135858	1980681	102106	1348911	1716	872	39948	848	596767	1392389	1506553	1578	248744	158846	906	52225	86331	2039302	283168	459786	375288	577310	838	1263	1301	40544	157	191303	29465
bsdb:827/1/1_Disease-progression-measurement:Advanced-cholangiocarcinoma_vs_Early-cholangiocarcinoma_UP	NA	194	544	32067
bsdb:829/1/1_Breastfeeding-duration:Low-Total-Time-Breastfeeding_vs_Medium-Total-Time-Breastfeeding_DOWN	NA	110934	1678	84567	40323	212744
bsdb:831/1/1_COVID-19:COVID-19-Patients_vs_Non-Covid-19-Patients---pneumonia-patients_UP	NA	816	1017280	1905344
bsdb:831/1/2_COVID-19:COVID-19-Patients_vs_Non-Covid-19-Patients---pneumonia-patients_DOWN	NA	1686313	150022	836	1716	40544	165779	909928
bsdb:832/1/1_Atrial-fibrillation:Individuals-with-Prevalent-Atrial-Fibrillation-(AF)_vs_Individuals-without-Prevalent-Atrial-Fibrillation-(AF)_UP	NA	1432051	1472762	547	579
bsdb:832/1/2_Atrial-fibrillation:Individuals-with-Prevalent-Atrial-Fibrillation-(AF)_vs_Individuals-without-Prevalent-Atrial-Fibrillation-(AF)_DOWN	NA	816	1678	1573535	375288	191303
bsdb:833/1/1_Irritable-bowel-syndrome:Irritable-Bowel-Syndrome_vs_Healthy-controls_UP	NA	1654
bsdb:835/1/1_Response-to-vaccine,Timepoint:Mothers-at-post-vaccination-timepoints_vs_Mothers-at-pre-vaccination-timepoint_UP	NA	41275	2053
bsdb:835/1/2_Response-to-vaccine,Timepoint:Mothers-at-post-vaccination-timepoints_vs_Mothers-at-pre-vaccination-timepoint_DOWN	NA	174708	48736	191303
bsdb:836/1/1_Food-allergy:food-allergy-(FA)-group_vs_non-allergy-(NA)-group_UP	NA	469	286	1696
bsdb:836/1/2_Food-allergy:food-allergy-(FA)-group_vs_non-allergy-(NA)-group_DOWN	NA	239934	239759	1283313	1678	1485	158846	33024	838	1501226	841	1263	29465	204475	572511	459786	1380	848	397864	577309	191303	66831	499551	336260	1017280	580596	43773	53457	423604	906	580024	1184396	283168	2172	2740	1860
bsdb:837/1/1_Cardiovascular-disease:Women-with-coronary-heart-disease-(CHD)_vs_Men-with-coronary-heart-disease-(CHD)_DOWN	NA	28050	838	841
bsdb:837/1/2_Cardiovascular-disease:Women-with-coronary-heart-disease-(CHD)_vs_Men-with-coronary-heart-disease-(CHD)_UP	NA	397864	1678	35832	375288
bsdb:839/1/3_Epilepsy:pre-treatment-(focal-epilepsy)_vs_healthy-control-(HC)_UP	NA	102106	1378
bsdb:840/1/2_Microbiome-measurement:2015-sampling-period_vs_2013-sampling-period_DOWN	NA	1187078
bsdb:841/1/1_Breastfeeding-duration:Calves-without-dam-on-day-35_vs_Calves-with-dam-on-day-35_UP	NA	76831	651554	1257
bsdb:841/1/2_Breastfeeding-duration:Calves-without-dam-on-day-35_vs_Calves-with-dam-on-day-35_DOWN	NA	816	375288
bsdb:842/1/1_Food-allergy:Food-Allergy_vs_Control-group_UP	NA	816
bsdb:844/1/1_Response-to-metformin:metformin-treated-T2D-patients_vs_metformin-naive-type-2-diabetes-(T2D)-patients_UP	NA	1506553
bsdb:845/1/1_Smoking-status-measurement:Current-smokers_vs_Never-smokers_UP	NA	1654	419014	1380	1678	118747	84162	39948	44259	1434006	1578	906	52225	2093	508215	1213720	157	29465
bsdb:845/1/2_Smoking-status-measurement:Current-smokers_vs_Never-smokers_DOWN	NA	46123	416916	1283313	59735	1016	2717	43996	848	724	32257	47670	32067	482	219181	2740	1257	836
bsdb:846/1/1_Diet:Base-Diet---B_vs_Home-Made-Diet---H_UP	NA	816	848	1263	174708	13334	572511	135858	1485	102106	100883	561	209	28050	1578	158846	2740	841	84108
bsdb:846/1/2_Diet:Base-Diet---B_vs_Home-Made-Diet---H_DOWN	NA	1730	577309	447020	572511	580596	100883	33042	189330	1350	2383	216851	119852	375288	33024	838	1301	40544	191303
bsdb:847/1/1_Obesity:Obese-Volunteers-(O)_vs_Normal-weight-volunteers-(N)_UP	NA	46123	135858	102106	100883	84108	123375
bsdb:847/1/2_Obesity:Obese-Volunteers-(O)_vs_Normal-weight-volunteers-(N)_DOWN	NA	239759	244127	397864	194	1485	1582879	596767	459786	577310	162289	836	1501226	44748	292632	191303
bsdb:848/1/1_Autism-spectrum-disorder:Constipated-autism-spectrum-disorder-(C-ASD)-group_vs_Typically-developing-(TD)-group_UP	NA	397864	1470349	283	1348911	33042	872	1472762	848	158846	283168	375288	577309	1481960	2740	33024	1508657	172900
bsdb:848/1/2_Autism-spectrum-disorder:Constipated-autism-spectrum-disorder-(C-ASD)-group_vs_Typically-developing-(TD)-group_DOWN	NA	1375	207244	1716	1506553	1578	1637	475961	248744	407	33882	838	286	48736	1263	399320	1279	3025755	157	1506577
bsdb:849/1/1_Age:type-2-diabetes-(T2D)_vs_Non-T2D(prediabetes)_UP	NA	816	1578	29465
bsdb:849/1/2_Age:type-2-diabetes-(T2D)_vs_Non-T2D(prediabetes)_DOWN	NA	1485	216851
bsdb:851/1/1_Crohn's-disease:non-inflamed-crohn's-disease_vs_non-inflammatory-bowel-disease-who-were-undergoing-colonoscopy-either-for-screening-or-for-other-gastrointestinal-complaints-unrelated-to-IBD_DOWN	NA	33042	459786
bsdb:852/1/1_Acne:Acne-group_vs_Healthy-group_UP	NA	1716	40323
bsdb:852/1/2_Acne:Acne-group_vs_Healthy-group_DOWN	NA	1654	37914	150022	32067	437755	836	838
bsdb:854/1/1_Dry-eye-syndrome:Sjogrens-Syndrome-Dry-Eye-(SSDE)_vs_Normal-Control-(NC)_UP	NA	469	1485	1716
bsdb:854/1/2_Dry-eye-syndrome:Sjogrens-Syndrome-Dry-Eye-(SSDE)_vs_Normal-Control-(NC)_DOWN	NA	1386
bsdb:855/1/1_Dry-eye-syndrome:Dry-Eye-Disease-patients_vs_Healthy-Controls_UP	NA	547	1350	1582879	236752	2701	724	47670	83614	1370	1817	543311	1632780	286	1060	84108	165695	34104	1883	2060	349
bsdb:855/1/2_Dry-eye-syndrome:Dry-Eye-Disease-patients_vs_Healthy-Controls_DOWN	NA	12916	469	642	111142	1283313	1663	414371	1386	59735	1678	43668	1696	10	59732	1716	1912216	80865	82800	37914	1433999	59734	212791	2053	117563	366614	2745	53457	570	57493	57499	1578	1847725	32067	68	149698	407	33882	1269	1763	44249	265	28100	985001	1085622	83618	1855416	32207	613	22	204447	40323
bsdb:857/1/1_Parkinson's-disease:Parkinson's-disease_vs_Healthy-controls_UP	NA	904	469	1350	158846	906	583	1301
bsdb:857/1/2_Parkinson's-disease:Parkinson's-disease_vs_Healthy-controls_DOWN	NA	572511	216851	1263
bsdb:858/1/1_Social-anxiety-disorder:Patients-with-Social-Anxiety-Disorder-(SAD)_vs_Healthy-controls_UP	NA	1924093	644652
bsdb:858/1/2_Social-anxiety-disorder:Patients-with-Social-Anxiety-Disorder-(SAD)_vs_Healthy-controls_DOWN	NA	577310
bsdb:862/1/1_Bronchiectasis:Severe-bronchiectasis_vs_Less-severe-bronchiectasis_UP	NA	286	40323
bsdb:862/1/2_Bronchiectasis:Severe-bronchiectasis_vs_Less-severe-bronchiectasis_DOWN	NA	1654	1380	118747	194	1016	848	117563	32257	32067	906	437755	482	265975	346096	836	838	970	1279	1301	29465	32207
bsdb:863/1/1_Eczema,Urticaria:Atopic-dermatitis-(eczema)_vs_Chronic-urticaria-(hives)_UP	NA	1501226	40544
bsdb:863/1/2_Eczema,Urticaria:Atopic-dermatitis-(eczema)_vs_Chronic-urticaria-(hives)_DOWN	NA	838
bsdb:864/1/1_Diet:Post-fed-group-at-1230-h_vs_Pre-fed-group-at-1100-h_UP	NA	150247	28196	12960	1386	180162	544	551	129337	47420	227979	1578	1357	1243	58050	265	1257	657	838	583	2800384	623282	497	67572	119541	165812	1569	1279	1301	285105	270	160795	2737	84406	629
bsdb:865/1/1_Colorectal-cancer-cell-line:azoxymethane/dextran-sodiumsulfate-(AOM/DSS)-group-at-week-10-(AD10-group)_vs_control-group-at-week-10-(C10-group)_DOWN	NA	239759	1485	872	283168
bsdb:865/1/2_Colorectal-cancer-cell-line:azoxymethane/dextran-sodiumsulfate-(AOM/DSS)-group-at-week-10-(AD10-group)_vs_control-group-at-week-10-(C10-group)_UP	NA	816	1730	209	1392389	375288	1301
bsdb:866/1/1_Intestinal-polyp:Patients-with-low-grade-colorectal-polyps-cohort_vs_Polyp-free-control-patients_UP	NA	816	1263
bsdb:866/1/2_Intestinal-polyp:Patients-with-low-grade-colorectal-polyps-cohort_vs_Polyp-free-control-patients_DOWN	NA	572511	2676048	2678884
bsdb:867/1/1_Breast-cancer:Breast-cancer-patients_vs_Healthy-controls_UP	NA	904	1649459	1506577
bsdb:867/1/2_Breast-cancer:Breast-cancer-patients_vs_Healthy-controls_DOWN	NA	52784	2840511	39948	1501226
bsdb:868/1/1_Ulcerative-colitis:Ulcerative-colitis_vs_Healthy-controls_UP	NA	830	158483	216851	724	28050	1980693	133925	1257	838
bsdb:868/1/2_Ulcerative-colitis:Ulcerative-colitis_vs_Healthy-controls_DOWN	NA	41275	574697	1348911	1912216	1432051	1649292	1407607	1357	1243	629
bsdb:869/1/1_Ulcerative-colitis:quiescent-ulcerative-colitis-patients_vs_healthy-controls_UP	NA	1678
bsdb:870/1/1_Postmenopausal-osteoporosis:Postmenopausal-osteoporosis-(PMOP)-patients_vs_Healthy-controls_UP	NA	1578
bsdb:872/1/1_NA:spinal-cord-injury-patient_vs_typically-healthy-control-group_UP	NA	84111
bsdb:872/1/2_NA:spinal-cord-injury-patient_vs_typically-healthy-control-group_DOWN	NA	1766253	572511	102106	189330	216851	1407607	1573535	841	1263
bsdb:875/1/2_Acne:Acne-vulgaris-group_vs_Healthy-control-group_DOWN	NA	1375	114627	1386	35832	572511	580596	2747	212791	1407607	204475	117563	1357	400634	182709	846	44249	577309	1263
bsdb:876/1/1_Male-homosexuality:Men-with->3-sexual-partners_vs_Men-with-0-3-sexual-partners_DOWN	NA	459786
bsdb:878/1/1_Colorectal-carcinoma:Colon-Tumor_vs_Adjacent-normal-colonic-tissue_UP	NA	416916
bsdb:878/1/2_Colorectal-carcinoma:Colon-Tumor_vs_Adjacent-normal-colonic-tissue_DOWN	NA	547	469
bsdb:879/1/1_Oral-ulcer:Covid-19-with-oral-lesions_vs_Covid-19-patients-without-oral-lesions_UP	NA	1279
bsdb:885/1/1_COVID-19:Moderate-severity_vs_Mild-severity_UP	NA	2039240	189330
bsdb:885/1/2_COVID-19:Moderate-severity_vs_Mild-severity_DOWN	NA	1980693	1485	33042	1263
bsdb:886/1/1_Ascariasis:Ascaris-suum-infected-piglets_vs_Uninfected-piglets_DOWN	NA	1375	1386	1485	1716	51514	832	375288	577309	838	1279	1301	82802	46255
bsdb:886/1/2_Ascariasis:Ascaris-suum-infected-piglets_vs_Uninfected-piglets_UP	NA	1578	838
bsdb:889/1/1_Cervix-erosion:Short-Cervix-Length_vs_Control_UP	NA	41275	286	83618	1279	1443919
bsdb:889/1/2_Cervix-erosion:Short-Cervix-Length_vs_Control_DOWN	NA	265	836	2050
bsdb:890/1/1_Premature-birth:Preterm-birth-(PTB)_vs_Term-birth-(TB)_UP	NA	1016	29465
bsdb:890/1/2_Premature-birth:Preterm-birth-(PTB)_vs_Term-birth-(TB)_DOWN	NA	1716	1654	1164882	194	1283313	836	43996	32067	29465	482	1301	32207	1378	724
bsdb:893/1/1_Prostate-carcinoma:Prostate-Cancer-(PCa),--Cohort-1-(Discovery-Cohort)_vs_Benign-prostatic-hyperplasia-(BPH),--Cohort-1-(Discovery-Cohort)_UP	NA	374
bsdb:893/1/2_Prostate-carcinoma:Prostate-Cancer-(PCa),--Cohort-1-(Discovery-Cohort)_vs_Benign-prostatic-hyperplasia-(BPH),--Cohort-1-(Discovery-Cohort)_UP	NA	2040	165779	43668	1696	10	59732	283	1716	59734	57493	68	186650	265	286	83618	1060	265976	1279	40323
bsdb:894/1/1_Seasonal-gut-microbiome-measurement:Day-180_vs_Day-0_UP	NA	174708	43996	150022	1573535	702	174951	46255
bsdb:894/1/2_Seasonal-gut-microbiome-measurement:Day-180_vs_Day-0_DOWN	NA	3025755	35832	1573534	1506553	33024
bsdb:896/1/1_Health-study-participation:Day-7-participants_vs_Day-1-participants_UP	NA	43994	1301	29465	547
bsdb:897/1/1_Neonatal-death:Unsuccessful-breeders_vs_Successful-breeders_UP	NA	286	570	1330546	53416
bsdb:897/1/2_Neonatal-death:Unsuccessful-breeders_vs_Successful-breeders_DOWN	NA	1918540
bsdb:898/1/1_Bladder-carcinoma:Bladder-cancer_vs_Non-neoplastic-(controls)_UP	NA	469	165779	292480	507002	129337	508215	42255	28453
bsdb:898/1/2_Bladder-carcinoma:Bladder-cancer_vs_Non-neoplastic-(controls)_DOWN	NA	583	125216	613
bsdb:901/1/1_Allergic-asthma:Allergic-asthma_vs_Healthy-control_UP	NA	1678	84111	1301	5475
bsdb:901/1/2_Allergic-asthma:Allergic-asthma_vs_Healthy-control_DOWN	NA	906	816	1348911	239759	904
bsdb:902/1/1_SAPHO-syndrome:SAPHO-syndrome-Patients_vs_Healthy-control-group_UP	NA	1378
bsdb:902/1/2_SAPHO-syndrome:SAPHO-syndrome-Patients_vs_Healthy-control-group_DOWN	NA	1508657
bsdb:903/1/1_Hypercholesterolemia:hypercholesterolemic-(cases)_vs_normocholesterolemic-individuals-(controls)_DOWN	NA	216851	970	172900
bsdb:903/1/2_Hypercholesterolemia:hypercholesterolemic-(cases)_vs_normocholesterolemic-individuals-(controls)_UP	NA	2316	508215
bsdb:904/1/1_Response-to-allogeneic-hematopoietic-stem-cell-transplant:Engraftment-(Patients-After-Allogeneic-Hematopoietic-Stem-Cell-Transplantation)_vs_Preconditioning-(Patients-Before-Allogeneic-Hematopoietic-Stem-Cell-Transplantation)_UP	NA	1350	1578	1243	2093	1279
bsdb:904/1/2_Response-to-allogeneic-hematopoietic-stem-cell-transplant:Engraftment-(Patients-After-Allogeneic-Hematopoietic-Stem-Cell-Transplantation)_vs_Preconditioning-(Patients-Before-Allogeneic-Hematopoietic-Stem-Cell-Transplantation)_DOWN	NA	1654	1378	1164882	32067	1301
bsdb:905/1/1_Parkinson's-disease:Parkinson's-Disease-Patients_vs_Controls_UP	NA	239934	1678	1578	375288	838
bsdb:905/1/2_Parkinson's-disease:Parkinson's-Disease-Patients_vs_Controls_DOWN	NA	572511	33042	216851	841
bsdb:906/1/1_Developmental-stage:Mature-hen-magnum-sample_vs_Immature-hen-magnum-sample-(23-weeks-old)_UP	NA	237	158846
bsdb:906/1/2_Developmental-stage:Mature-hen-magnum-sample_vs_Immature-hen-magnum-sample-(23-weeks-old)_DOWN	NA	374
bsdb:907/1/1_Colorectal-cancer:Colorectal-Cancer-Patients_vs_Advanced-Adenoma-Patients_UP	NA	1765964	504090	1330545	543311
bsdb:907/1/2_Colorectal-cancer:Colorectal-Cancer-Patients_vs_Advanced-Adenoma-Patients_DOWN	NA	572511	1485	1263	841	1407607	724	28050	1501226	189330	459786	1980693	1730	1935176	990721	2005359	2023266	1392389	1935927	207244	1935200	61170	906	35829	1715798	1164882	1940255	244127	191303	588605	1213720
bsdb:908/1/1_Chronic-kidney-disease:Chronic-kidney-disease_vs_Healthy-Controls_UP	NA	46123	469	1654	1380	990721	1485	102106	100883	1348911	1716	84111	1350	1730	204475	117563	1578	32067	581	482	133925	577309	1257	286	638847	32207	1263	196081	177971	123375	1279	1301
bsdb:908/1/2_Chronic-kidney-disease:Chronic-kidney-disease_vs_Healthy-Controls_DOWN	NA	838	216851	841	33024	1263	33042	39948	239759	459786	577310	553372	724	580596	846	84108	189330	1407607	1573535	1485	397864	1501226	207244	574697	283168	904	209879
bsdb:910/1/1_Parkinson's-disease:Wild-type-(WT)-mice-with-fecal-microbes-from-Parkinson’s-disease-patients-(PD)_vs_Wild-type-(WT)-mice-with-fecal-microbes-from-healthy-controls-(HC)_UP	NA	1350	113286
bsdb:910/1/2_Parkinson's-disease:Wild-type-(WT)-mice-with-fecal-microbes-from-Parkinson’s-disease-patients-(PD)_vs_Wild-type-(WT)-mice-with-fecal-microbes-from-healthy-controls-(HC)_DOWN	NA	574697	841
bsdb:911/1/1_Response-to-glucocorticoid:Early-pregnancy-glucocorticoid-(Early-preGC)-exposure-in-2.3years-(mean-age--1SD)_vs_Early-pregnancy-glucocorticoid(Early-preGC)-exposure-in-4.7years-(mean-age)_UP	NA	2039240	1678	574697	715222	1980681	102106	423604	46238	946234	1505657	1392389	133925	119852	33024	84108	123375	83770	35829
bsdb:911/1/2_Response-to-glucocorticoid:Early-pregnancy-glucocorticoid-(Early-preGC)-exposure-in-2.3years-(mean-age--1SD)_vs_Early-pregnancy-glucocorticoid(Early-preGC)-exposure-in-4.7years-(mean-age)_DOWN	NA	419014	189330	216851	832	848	1378	117563	459786	1960084	1506577	3025755
bsdb:912/1/1_Diet:Test-diet_vs_Reference-diet_UP	NA	2093
bsdb:912/1/2_Diet:Test-diet_vs_Reference-diet_DOWN	NA	1578	1357	1243
bsdb:913/1/1_Myopia:L-group----Ok-Lens-group_vs_N-group----Non-wearer-group_UP	NA	41275	469	583	1279	1716	1301	547	1350	572511	1912216
bsdb:913/1/2_Myopia:L-group----Ok-Lens-group_vs_N-group----Non-wearer-group_DOWN	NA	1386
bsdb:914/1/1_Celiac-disease:First-degree-relatives-(FDRs)-of-celiac-disease-(CeD)-patients_vs_Disease-Control-(DC)_UP	NA	1301	1263	838	543311	1080709	906	1578	1505657	209	117563	1378	1730	135858	1678	816	207244	1654
bsdb:914/1/2_Celiac-disease:First-degree-relatives-(FDRs)-of-celiac-disease-(CeD)-patients_vs_Disease-Control-(DC)_DOWN	NA	191303	1301	1263	475	1080709	1578	1505657	1730	572511	397864
bsdb:915/1/1_Breast-carcinoma:premenopausal-breast-cancer-patients-(Pre-BC)_vs_Premenopausal-female-controls-(Pre-C)_UP	NA	816	848	724	40544
bsdb:915/1/2_Breast-carcinoma:premenopausal-breast-cancer-patients-(Pre-BC)_vs_Premenopausal-female-controls-(Pre-C)_DOWN	NA	239934	239759	1678	102106	33042	39948	547	1350	906	52225	846	375288	508215	1301
bsdb:916/1/2_Vaginitis:Recurrent-vaginitis-(RV)_vs_Healthy-women-(control)_DOWN	NA	1578
bsdb:917/1/1_Gut-microbiome-measurement:Antiretroviral-therapy-(ART)-Naïve-at-baseline_vs_Healthy-controls-(HC)_DOWN	NA	1485
bsdb:918/1/1_Constipation,Parkinson's-disease:Parkinson's-disease-patients-(PD)-before-Fecal-microbiota-transplant-(FMT)_vs_Healthy-Control-group_UP	NA	816
bsdb:922/1/1_Parkinson's-disease:Parkinson’s-disease_vs_Healthy-controls_UP	NA	239934
bsdb:923/1/1_Response-to-exercise:Aerobic-exercise-training-group-(AET)_vs_Sham-group-and-parkison's-disease-(PD)-group_UP	NA	1578	1357	400634	93681	216851	1060
bsdb:924/1/1_Parkinson's-disease:Parkinson's-disease-(PD)_vs_Healthy-controls-(HC)_UP	NA	544	1350	570	1357	590	620
bsdb:924/1/2_Parkinson's-disease:Parkinson's-disease-(PD)_vs_Healthy-controls-(HC)_DOWN	NA	841
bsdb:925/1/1_Treatment:Dopamine-treatment-group-(D)_vs_Vehicle-group-(VH)_UP	NA	1350
bsdb:925/1/2_Treatment:Dopamine-treatment-group-(D)_vs_Vehicle-group-(VH)_DOWN	NA	572511	209	1937007
bsdb:927/1/1_Behcet's-syndrome:Untreated-active-Behcet's-disease-(BD)-patients_vs_Healthy-Control_UP	NA	816
bsdb:928/1/1_Chronic-granulomatous-disease:Chronic-granulomatous-disease_vs_Healthy-controls_UP	NA	1506553	1769710	3025755	29465
bsdb:928/1/2_Chronic-granulomatous-disease:Chronic-granulomatous-disease_vs_Healthy-controls_DOWN	NA	207244	1485	102106	33042	189330	28050	191303
bsdb:930/1/1_Gut-microbiome-measurement:Low-litter-performance-sows-at-G109_vs_High-litter-performance-sows-at-G109_UP	NA	33024	191303
bsdb:930/1/2_Gut-microbiome-measurement:Low-litter-performance-sows-at-G109_vs_High-litter-performance-sows-at-G109_DOWN	NA	816
bsdb:931/1/1_Essential-tremor:Essential-Tremor_vs_Healthy-Control_UP	NA	40323
bsdb:931/1/2_Essential-tremor:Essential-Tremor_vs_Healthy-Control_DOWN	NA	49082	135858	216851	404402	1578	160674
bsdb:932/1/1_Delivery-method:Elective-Cesarean-Section-(ECS)_vs_Vaginally-Delivered(VD)_UP	NA	1485
bsdb:932/1/2_Delivery-method:Elective-Cesarean-Section-(ECS)_vs_Vaginally-Delivered(VD)_DOWN	NA	39948	2701	375288
bsdb:933/1/1_Cholestasis:Infantile--cholestasis-(IC)_vs_Healthy-Control-(CON)_UP	NA	156973	1506553	1301
bsdb:933/1/2_Cholestasis:Infantile--cholestasis-(IC)_vs_Healthy-Control-(CON)_DOWN	NA	1501226	75	3025755	580880
bsdb:935/1/1_Parkinson's-disease:Patients-with-Parkinson's-Disease_vs_Healthy-controls_UP	NA	239934	816	2172	1508657	1905344	1392389	990721
bsdb:935/1/2_Parkinson's-disease:Patients-with-Parkinson's-Disease_vs_Healthy-controls_DOWN	NA	216851	724	1573535	1506553	841	84108	40544	29465
bsdb:936/1/1_Vulvovaginitis:Vulvovaginal-symptoms_vs_Non-vulvovaginal-symptoms-(control)_UP	NA	419014	236752	2701	168808
bsdb:937/1/1_Pregnancy:Clinical-pregnancy-(FP)_vs_Non-pregnant-(FN)_DOWN	NA	434	216851	848	204475	724	1578	33024	48463	841	46255
bsdb:937/1/2_Pregnancy:Clinical-pregnancy-(FP)_vs_Non-pregnant-(FN)_UP	NA	1427378	239934	1283313	2086	244127	28196	1380	35832	574697	872	39948	2701	209	482	375288	577309	577310	44013	1827	1263	191303	212791
bsdb:939/1/1_Irritable-bowel-syndrome:Irritable-Bowel-Syndrome-positive-(IBS+)_vs_Irritable-Bowel-Syndrome-negative-(IBS-)_DOWN	NA	816	838
bsdb:940/1/1_COVID-19:Covid-19-group_vs_Control-group_UP	NA	1827388	1762950	2875642	63255	405928	1963373	673167	4930	292631	36048	1932873
bsdb:940/1/2_COVID-19:Covid-19-group_vs_Control-group_DOWN	NA	308926	1323519	36922	5094	1666919	5159	45340	5402	5206	34372	241727
bsdb:941/1/1_Abnormal-sperm-morphology:Asthenozoospermia_vs_Healthy-Control_UP	NA	416916	1283313	191	872	61170	1578	577310	33024
bsdb:942/1/1_Stroke:Cerebral-ischemic-stroke-patients_vs_Healthy-individuals_UP	NA	459786	434	283168	102106	872	442430
bsdb:942/1/2_Stroke:Cerebral-ischemic-stroke-patients_vs_Healthy-individuals_DOWN	NA	191
bsdb:943/1/1_Major-depressive-disorder:Major-depressive-disorder-(MDD)_vs_Healthy-controls-(HC)_UP	NA	447020
bsdb:943/1/2_Major-depressive-disorder:Major-depressive-disorder-(MDD)_vs_Healthy-controls-(HC)_DOWN	NA	841	1485	724	191303
bsdb:944/1/2_Parkinson's-disease:Parkinson's-disease-group_vs_Healthy-control-(control-matched--CM)_DOWN	NA	1350	1357
bsdb:945/1/1_Cognitive-impairment:Mild-Cognitive-Impairment_vs_Cognitive-Normal_UP	NA	33042	33024
bsdb:945/1/2_Cognitive-impairment:Mild-Cognitive-Impairment_vs_Cognitive-Normal_DOWN	NA	39948
bsdb:946/1/2_Parkinson's-disease:PD:-individuals-with-Parkinson's-disease_vs_HC:-household-controls_DOWN	NA	841
bsdb:948/1/1_Disease-staging:Deteriorated-Group-at-year-0_vs_Stable-Group-at-year-0_DOWN	NA	1678
bsdb:950/1/1_Diarrhea:Acutely-diarrheic-American-Shorthair-cats-(MD)_vs_Healthy-American-Shorthair-(MH)_UP	NA	838
bsdb:950/1/2_Diarrhea:Acutely-diarrheic-American-Shorthair-cats-(MD)_vs_Healthy-American-Shorthair-(MH)_DOWN	NA	135858	39948	123375
bsdb:951/1/1_Type-II-diabetes-mellitus:Type-2-Diabetes-Mellitus-Patients_vs_Healthy-Control_UP	NA	43996	212742	543311	1257	157
bsdb:951/1/2_Type-II-diabetes-mellitus:Type-2-Diabetes-Mellitus-Patients_vs_Healthy-Control_DOWN	NA	1283313	47670
bsdb:952/1/1_Clinical-treatment:Parkinson's-disease-(PD)-patients-treated-with-both-levodopa-and-Entacapone-(PD_LE)_vs_Parkinson's-disease-(PD)-patients-treated-with-levodopa-only-(PD_L)_UP	NA	1678	1730
bsdb:952/1/2_Clinical-treatment:Parkinson's-disease-(PD)-patients-treated-with-both-levodopa-and-Entacapone-(PD_LE)_vs_Parkinson's-disease-(PD)-patients-treated-with-levodopa-only-(PD_L)_DOWN	NA	572511	189330	216851	1505657	1578	1769710
bsdb:953/1/1_Upper-digestive-tract-disease:Saliva-samples_vs_Esophagus-samples_UP	NA	482	838
bsdb:953/1/2_Upper-digestive-tract-disease:Saliva-samples_vs_Esophagus-samples_DOWN	NA	1301	724
bsdb:954/1/1_Parkinson's-disease:MPTP-treated-mice_vs_Control-mice_UP	NA	1716	283168	1827	28138	1678
bsdb:954/1/2_Parkinson's-disease:MPTP-treated-mice_vs_Control-mice_DOWN	NA	447020	574697	375288	838	577309
bsdb:955/1/1_Parkinson's-disease:Parkinson's-Disease-(PD)-Patients_vs_Healthy-controls_UP	NA	1357	149698	48736
bsdb:956/1/1_Schizophrenia:Schizophrenia-patients-with-prominent-negative-symptoms-(SCH-N)_vs_Healthy-controls_UP	NA	222	100883	1573534	848	1506553	1960084	1266	1279
bsdb:956/1/2_Schizophrenia:Schizophrenia-patients-with-prominent-negative-symptoms-(SCH-N)_vs_Healthy-controls_DOWN	NA	1766253	507	580596	102106	33042	39948	189330	216851	52225	2039302	1263
bsdb:957/1/1_Parkinson's-disease:Patients-with-Parkinson's-Disease-(PD)_vs_Healthy-controls-(HC)_UP	NA	906	52225	419014	1016	1578	86331	133925	113286	196081	84108
bsdb:957/1/2_Parkinson's-disease:Patients-with-Parkinson's-Disease-(PD)_vs_Healthy-controls-(HC)_DOWN	NA	46123	47670	459786	13687
bsdb:958/1/1_Lung-transplantation:Lung-transplant-event-free-group-(EF)_vs_No-lung-transplant-group-(NT)_UP	NA	1386	1350	570	1263	1301	3025755
bsdb:958/1/2_Lung-transplantation:Lung-transplant-event-free-group-(EF)_vs_No-lung-transplant-group-(NT)_DOWN	NA	1766253	816	2383	216851	838
bsdb:959/1/1_Essential-thrombocythemia:Essential-thrombocythemia-(ET)_vs_Healthy-Controls_UP	NA	29465
bsdb:959/1/2_Essential-thrombocythemia:Essential-thrombocythemia-(ET)_vs_Healthy-Controls_DOWN	NA	1766253	216851
bsdb:960/1/1_Curcumin:CUR-L_vs_MPTP_UP	NA	447020	239759	1283313	2086	2039240	1506553	2518497
bsdb:960/1/2_Curcumin:CUR-L_vs_MPTP_DOWN	NA	239934	1331051	1730	1392389
bsdb:961/1/1_Parkinson's-disease:MPTP-(untreated-PD-mice)_vs_Control-(CON-groups)_UP	NA	816	1283313	375288
bsdb:961/1/2_Parkinson's-disease:MPTP-(untreated-PD-mice)_vs_Control-(CON-groups)_DOWN	NA	1331051	283168	2129
bsdb:962/1/1_Antimicrobial-agent:Antibiotic-(Ab)-global-data-set_vs_Non-medicated-control-(CT)-global-data-set_UP	NA	906
bsdb:962/1/2_Antimicrobial-agent:Antibiotic-(Ab)-global-data-set_vs_Non-medicated-control-(CT)-global-data-set_DOWN	NA	561
bsdb:964/1/1_Polycystic-ovary-syndrome:PCOS-patients-at-Zeitgeber-(ZT)-0_vs_Healthy-control-at-Zeitgeber-(ZT)-0_UP	NA	848
bsdb:964/1/2_Polycystic-ovary-syndrome:PCOS-patients-at-Zeitgeber-(ZT)-0_vs_Healthy-control-at-Zeitgeber-(ZT)-0_DOWN	NA	32067
bsdb:965/1/1_COVID-19:COVID-19-patients_vs_healthy-controls_UP	NA	233189	1386	32008	1016	1350	1378	397456	724	32067	475	482	838	32207	1279	1301	29465
bsdb:965/1/2_COVID-19:COVID-19-patients_vs_healthy-controls_DOWN	NA	1766253	239934	239759	816	1678	572511	216851	1918511	33024	1263	292632
bsdb:966/1/1_Parkinson's-disease:Parkinson's-diease-(PD)-patients_vs_Household-Control_DOWN	NA	580596	1407607
bsdb:967/1/1_Parkinson's-disease:Parkinson's-Disease-(PD)-patients_vs_Healthy_UP	NA	447020	239934
bsdb:967/1/2_Parkinson's-disease:Parkinson's-Disease-(PD)-patients_vs_Healthy_DOWN	NA	577309	33024	838	1301	135858	561
bsdb:968/1/1_Alzheimer's-disease:Alzheimer's-group_vs_Healthy-senior-group_UP	NA	239934	1921511	508459	1716	1795363	1730	237	1804994	359407	354354	846	1004302	52972	838	929509	106633	1847386
bsdb:968/1/2_Alzheimer's-disease:Alzheimer's-group_vs_Healthy-senior-group_DOWN	NA	1678	359336	724	2767842	2767885	2767886	2039302	1227	28100	841	1506577	29465
bsdb:969/1/1_Parkinson's-disease:PD-(Parkinson's-Disease)_vs_rHC-(Random-non-household-healthy-controls)_UP	NA	475	40222	36739	80865	48736	37817	469
bsdb:969/1/2_Parkinson's-disease:PD-(Parkinson's-Disease)_vs_rHC-(Random-non-household-healthy-controls)_DOWN	NA	37914	32008	93681	1637	2985502	1386	1041	629	114627	1578	28050	29548	570	43994	158851	73029	290731	168934	665874	635	191303	173479	44675	281915
bsdb:970/1/1_Alzheimer's-disease-biomarker-measurement:Endogenous-melatonin-reduction-(EMR)-mice_vs_Wild-type-(WT)-mice_UP	NA	2749267	1331051	580024	1578	1742992	100175	1508657
bsdb:971/1/1_Parkinson's-disease:Parkinson's-Disease-Patients_vs_Healthy-Controls_UP	NA	162289
bsdb:971/1/2_Parkinson's-disease:Parkinson's-Disease-Patients_vs_Healthy-Controls_DOWN	NA	216851	1407607
bsdb:973/1/2_Parkinson's-disease:People-with-Parkinson's-Disease-(PWP)_vs_Healthy-Controls_DOWN	NA	2048137	1980681	1505657	2163168	841
bsdb:975/1/2_Parkinson's-disease:Parkinson's-disease_vs_Healthy-controls_DOWN	NA	102106	841	1407607	572511	216851
bsdb:976/1/1_Response-to-antiviral-drug:Intestinal-samples-of-HIV-Positive-Patients_vs_Intestinal-samples-of-Healthy-Control_UP	NA	239934	102106	1730	848	906	52225	86331	1257	33024	838	83770	2172
bsdb:976/1/2_Response-to-antiviral-drug:Intestinal-samples-of-HIV-Positive-Patients_vs_Intestinal-samples-of-Healthy-Control_DOWN	NA	572511	1485	1263
bsdb:977/1/1_COVID-19:COVID-19-patients_vs_local-controls_UP	NA	1654	1283313	1380	906	838	123375	13687	29465
bsdb:977/1/2_COVID-19:COVID-19-patients_vs_local-controls_DOWN	NA	713	194195	816	1678	572511	1016	43996	216851	44259	150022	1378	724	1357	47670	1847725	1840214	86331	482	265975	1263	195950	157
bsdb:978/1/1_Digestive-System-Carcinoma:Responders-to-anti–PD-1/PD-L1-immunotherapy_vs_Non-responders-to-anti–PD-1/PD-L1-immunotherapy_UP	NA	39948	28050	375288
bsdb:978/1/2_Digestive-System-Carcinoma:Responders-to-anti–PD-1/PD-L1-immunotherapy_vs_Non-responders-to-anti–PD-1/PD-L1-immunotherapy_DOWN	NA	816	135858	1649459
bsdb:979/1/1_Parkinson's-disease:Male-Parkinson’s-disease-(PD_M)-patients_vs_Female-Parkinson’s-disease-(PD_F)-patients_UP	NA	239934	1502180	1470353	448125	46466	82980	83766	291988
bsdb:979/1/2_Parkinson's-disease:Male-Parkinson’s-disease-(PD_M)-patients_vs_Female-Parkinson’s-disease-(PD_F)-patients_DOWN	NA	33042	561	348581	1263
bsdb:980/1/1_Non-alcoholic-fatty-liver-disease:Non-alcoholic-fatty-liver-disease-(NAFLD)_vs_Healthy-controls_UP	NA	580596	946234	570	1506553	1578	1506577
bsdb:980/1/2_Non-alcoholic-fatty-liver-disease:Non-alcoholic-fatty-liver-disease-(NAFLD)_vs_Healthy-controls_DOWN	NA	207244	397864	283	33042	39948	216851	1407607	724	158846	906	2172	577309	1481960	838	1508657	1263	1301
bsdb:981/1/1_Parkinson's-disease:Participants-with-Parkinson's-Disease_vs_Healthy-controls_UP	NA	1678	574697	946234
bsdb:981/1/2_Parkinson's-disease:Participants-with-Parkinson's-Disease_vs_Healthy-controls_DOWN	NA	1766253	580596	1407607
bsdb:982/1/1_Prion-disease:Prion-infected-mice-(R)_vs_Healthy-Control-(C)_UP	NA	209	1578
bsdb:982/1/2_Prion-disease:Prion-infected-mice-(R)_vs_Healthy-Control-(C)_DOWN	NA	1283313	1331051
bsdb:983/1/1_Colorectal-adenoma:Adenoma_vs_Non-adenoma_UP	NA	848
bsdb:984/1/1_Parkinson's-disease:Parkinson's-Disease_vs_Healthy-Controls_UP	NA	165779	216851	150022	162289	1769710
bsdb:987/1/1_Cesarean-section:Cesarean-section-scar-diverticulum-(CSD)_vs_Control_UP	NA	816	1350	2701	838	48736	13687	1301
bsdb:987/1/2_Cesarean-section:Cesarean-section-scar-diverticulum-(CSD)_vs_Control_DOWN	NA	1729679	1578
bsdb:989/1/2_Colitis:DSS-+-BAC-Group-(Day-7)_vs_DSS-Group-(Day-7)_DOWN	NA	1017280
bsdb:990/1/1_Colorectal-cancer:Living-bacteria-group-(LB)_vs_Tumor-control-group-(CK)_UP	NA	33042	547	561	1578	119852	838	841	191303
bsdb:990/1/2_Colorectal-cancer:Living-bacteria-group-(LB)_vs_Tumor-control-group-(CK)_DOWN	NA	574697	13687
bsdb:991/1/1_Disease-staging:Melanoma-surface-of-pigs-with-Melanoma-progression_vs_Melanoma-surface-of-pigs-with-with-melanoma-regression_UP	NA	1654	816	194	44259	848	13075	31983	543311	162289	1257	836	1069494
bsdb:991/1/2_Disease-staging:Melanoma-surface-of-pigs-with-Melanoma-progression_vs_Melanoma-surface-of-pigs-with-with-melanoma-regression_DOWN	NA	137460	292480	572511	43668	872	37914	1350	66831	216851	89092	1470540	227979	1578	1269	90243	497	1501226	841	1505652	191303	46255
bsdb:993/1/2_Gut-microbiome-measurement:12-months_vs_3-months_DOWN	NA	816
bsdb:994/1/1_Colorectal-adenoma:Adenoma-patients-(cases)_vs_Adenoma-free-(controls)_UP	NA	12916	469	501783	357	239934	92793	146936	73029	80865	209	1578	1357	1243	248744	165695	40323	83770	191303	46255
bsdb:995/1/1_Parkinson's-disease:MPTP-Group_vs_Control-Group_UP	NA	1729679	1892380	375288	577310
bsdb:995/1/2_Parkinson's-disease:MPTP-Group_vs_Control-Group_DOWN	NA	2749267
bsdb:996/1/1_Irritable-bowel-syndrome:IBS-D-patients-(Duodenal-mucosa-samples)_vs_Healthy-controls-(Duodenal-mucosa-samples)_UP	NA	1386	2747	528	1357	1269	1743	407	33882	44249	1716	80865	41275	1763
bsdb:996/1/2_Irritable-bowel-syndrome:IBS-D-patients-(Duodenal-mucosa-samples)_vs_Healthy-controls-(Duodenal-mucosa-samples)_DOWN	NA	469	222
bsdb:997/1/1_Gut-microbiome-measurement:Mild-cognitive-impairment-(MCI)-and-Alzheimer’s-disease-(AD)_vs_Healthy-group_DOWN	NA	239759	816	375288	909656	1263
bsdb:998/1/1_Parkinson's-disease:PD-patients_vs_Controls_UP	NA	904	264995	244127	194	544	100883	51514	1730	150022	162290	2745	2172	1080709	86331	1253	162289	583	1263	2753	191303	184869
bsdb:998/1/2_Parkinson's-disease:PD-patients_vs_Controls_DOWN	NA	207244	816	572511	189330	216851	28050	33024	838	841	40544
bsdb:999/1/1_Iron-biomarker-measurement:Ferrous-sulfate-(FS)-treated-pups-(PD-15)_vs_Vehicle-control-supplemented-(CON)-pups_UP	NA	1427378	1375	2086	580596	189330	1729679	946234	1892380	100175	1508657	1263	1506577
bsdb:999/1/2_Iron-biomarker-measurement:Ferrous-sulfate-(FS)-treated-pups-(PD-15)_vs_Vehicle-control-supplemented-(CON)-pups_DOWN	NA	447020	239759	1678	43668	1696	830	1470353	1350	66831	227979	1578	248744	2895461	577310	1279	1301	191303	225447
bsdb:1000/1/2_Parkinson's-disease:Rapid-eye-movement-sleep-behavior-disorder-(iRBD)-patients_vs_Controls_DOWN	NA	239934	216851	841
bsdb:1001/1/1_Parkinson's-disease:Parkinson's-disease-patients-with-Akinetic-Rigid---AR_vs_Parkinson's-disease-patients-with-Tremor-Dominant----TD_UP	NA	190972	613	561
bsdb:1001/1/2_Parkinson's-disease:Parkinson's-disease-patients-with-Akinetic-Rigid---AR_vs_Parkinson's-disease-patients-with-Tremor-Dominant----TD_DOWN	NA	216851	572511	33042	28050	69894	1378	1696
bsdb:1002/1/1_Colorectal-cancer:Colorectal-Tumor-Samples_vs_Patient-Matched-Normal-Colon-Tissue-Samples_UP	NA	848	586
bsdb:1003/1/1_Gonorrhea:men-who-have-sex-with-men-using-Biotène_vs_men-who-have-sex-with-men-using-Listerine_DOWN	NA	32067	1301	34104
bsdb:1004/1/1_Gut-microbiome-measurement:Infants-who-are-HIV-exposed-but-uninfected-(iHEU)-at-week-1_vs_Infants-who-are-HIV-unexposed-and-uninfected-(iHUU)-at-week-1_UP	NA	40544	1573535	135858	1473205	2082587	572511	292632	158846	216851
bsdb:1004/1/2_Gut-microbiome-measurement:Infants-who-are-HIV-exposed-but-uninfected-(iHEU)-at-week-1_vs_Infants-who-are-HIV-unexposed-and-uninfected-(iHUU)-at-week-1_DOWN	NA	1654
bsdb:1005/1/1_Microbiome-measurement:Vagina_vs_Oral-(saliva)_UP	NA	1350
bsdb:1005/1/2_Microbiome-measurement:Vagina_vs_Oral-(saliva)_DOWN	NA	1378	1301	1716	1578	407	374	1857532
bsdb:1006/1/1_Parkinson's-disease:PD-patients-with--wearing-off_vs_PD-patients-with-dyskinesia_UP	NA	1578
bsdb:1006/1/2_Parkinson's-disease:PD-patients-with--wearing-off_vs_PD-patients-with-dyskinesia_DOWN	NA	572511
bsdb:1007/1/1_Ulcerative-colitis:Ulcerative-colitis-(UC)_vs_Healthy-controls-(HC)_UP	NA	904	816	216851	375288	577310	459786
bsdb:1007/1/2_Ulcerative-colitis:Ulcerative-colitis-(UC)_vs_Healthy-controls-(HC)_DOWN	NA	239759	33042	846	816	459786	207244	216851	40544
bsdb:1008/1/1_Light:Dim-light-at-night-(dLAN)---Control-group_vs_Normal-light‐dark-cycle-(LD)---Control-group_UP	NA	577309	1578
bsdb:1008/1/2_Light:Dim-light-at-night-(dLAN)---Control-group_vs_Normal-light‐dark-cycle-(LD)---Control-group_DOWN	NA	28138	283168
bsdb:1009/1/1_Peutz-Jeghers-Polyp:Peutz-Jeghers-syndrome-(PJS)_vs_healthy-control-(family-members)_UP	NA	239934	848	570	29465
bsdb:1009/1/2_Peutz-Jeghers-Polyp:Peutz-Jeghers-syndrome-(PJS)_vs_healthy-control-(family-members)_DOWN	NA	216851	1505657	1578	158846	52225	292632	40544
bsdb:1010/1/1_Environmental-exposure-measurement:Ferrous-bisglycinate-group_vs_Placebo-group_UP	NA	46255
bsdb:1010/1/2_Environmental-exposure-measurement:Ferrous-bisglycinate-group_vs_Placebo-group_DOWN	NA	1350
bsdb:1011/1/1_Metastatic-colorectal-cancer:Liver-metastasis-(LM)_vs_No-liver-metastasis-(NLM)_UP	NA	106589	270
bsdb:1011/1/2_Metastatic-colorectal-cancer:Liver-metastasis-(LM)_vs_No-liver-metastasis-(NLM)_DOWN	NA	469	13687
bsdb:1015/1/1_Pituitary-Gland-Adenoma:Patients-with-pituitary-adenomas-(PA)_vs_Healthy-controls_UP	NA	1654	2801844	830	2717	1716	2767353	86331	265975	1257	836	508215	2529408	177971	195950
bsdb:1015/1/2_Pituitary-Gland-Adenoma:Patients-with-pituitary-adenomas-(PA)_vs_Healthy-controls_DOWN	NA	416916	1283313	816	59735	194	1715793	82202	39948	848	724	570	906	482	1926672	620	71	29465
bsdb:1016/1/3_Treatment:Post-treatment-(6-months-later)_vs_Pre-treatment-(baseline)_UP	NA	1578	1301	838	32207	286	196081
bsdb:1016/1/4_Treatment:Post-treatment-(6-months-later)_vs_Pre-treatment-(baseline)_DOWN	NA	1716	32067	1016	265975	838	1654	906	836	848	482
bsdb:1018/1/1_Strongylocentrotus-purpuratus:Diseased-sea-urchins_vs_Healthy-sea-urchins_UP	NA	358023	1122284
bsdb:1019/1/2_Sex-design:female_vs_male_DOWN	NA	168470	432330
bsdb:1020/1/1_Esophageal-squamous-cell-carcinoma:EIESC_oral---Early-stage-intramucosal-esophageal-squamous-carcinoma._vs_NC_oral---No-carcinoma._UP	NA	32067	543311	836	638847
bsdb:1020/1/2_Esophageal-squamous-cell-carcinoma:EIESC_oral---Early-stage-intramucosal-esophageal-squamous-carcinoma._vs_NC_oral---No-carcinoma._DOWN	NA	194	1485	68
bsdb:1021/1/1_Smoking-behaviour-measurement:Early-infants-(3-months)-with-maternal-history-of--'YES'-'smoking_vs_Early-infants-(3-months)-with-maternal-history-of--'NO'-'smoking_UP	NA	1870884	946234	1506553	906	40544
bsdb:1021/1/2_Smoking-behaviour-measurement:Early-infants-(3-months)-with-maternal-history-of--'YES'-'smoking_vs_Early-infants-(3-months)-with-maternal-history-of--'NO'-'smoking_DOWN	NA	572511	724	32207
bsdb:1023/1/1_Insulin-sensitivity-measurement:Insulin-Resistant-(IR)-Individuals_vs_Insulin-Sensitive-(IS)-Individuals_UP	NA	1766253	2039240	572511	1350	909656	2719313
bsdb:1023/1/2_Insulin-sensitivity-measurement:Insulin-Resistant-(IR)-Individuals_vs_Insulin-Sensitive-(IS)-Individuals_DOWN	NA	1918385	1987009	1678	580596	990721	1980681	100883	33042	1716	872	2005359	724	1926667	2163168	1763508	1981028	86331	2039302	283168	459786	846	836	191303
bsdb:1024/1/1_Alzheimer's-disease:Alzheimer's-disease_vs_Healthy-controls_UP	NA	244127	33042	838	1266	292632
bsdb:1024/1/2_Alzheimer's-disease:Alzheimer's-disease_vs_Healthy-controls_DOWN	NA	816	572511	1298	946234	1506553	84108	1213720	662	1263
bsdb:1025/1/1_Alcohol-consumption-measurement:Low-to-Moderate-drinking_vs_Non-Drinking_UP	NA	100883	46205	180162	1485	1501226
bsdb:1025/1/2_Alcohol-consumption-measurement:Low-to-Moderate-drinking_vs_Non-Drinking_DOWN	NA	40323	724	72763
bsdb:1026/1/1_SARS-coronavirus:SARS-CoV-2-infected-PLWH-(< 8-days)_vs_SARS-CoV-2-uninfected-PLWH-(< 8-days)_UP	NA	84111	239759	816
bsdb:1026/1/2_SARS-coronavirus:SARS-CoV-2-infected-PLWH-(< 8-days)_vs_SARS-CoV-2-uninfected-PLWH-(< 8-days)_DOWN	NA	1766253	580596	189330	1407607	906	52225
bsdb:1027/1/1_Colorectal-carcinoma:Colorectal-cancer-(CRC)_vs_Healthy_UP	NA	469	1654	642	416916	239934	419014	156454	92793	1663	374	41275	574697	990721	1716	538	547	1350	33986	1434006	1378	117563	570	1506553	1578	158846	52225	86331	581	133925	375288	543311	1257	1743	113286	48736	160674	1827	196081	970	84108	123375	13687	1301
bsdb:1027/1/2_Colorectal-carcinoma:Colorectal-cancer-(CRC)_vs_Healthy_DOWN	NA	816	216851	1766253	292632	1263	33024	207244	580596	841	1407607	189330	33042	239759	2039302	577310	724	168808	1980693	1506577	28050	459786	35832	946234	1980681	1573534	3028852
bsdb:1028/1/1_Menopause:Postmenopausal-women-group_vs_Premenopausal-women-group_UP	NA	1283313	724	482
bsdb:1028/1/2_Menopause:Postmenopausal-women-group_vs_Premenopausal-women-group_DOWN	NA	482
bsdb:1029/1/1_Vaginal-microbiome-measurement:Bacterial-Vaginosis-(BV)-Infected-Women_vs_Normal-Healthy-Women-&-High‑risk-human-papillomavirus(HR-HPV)-Infected-Women-(HPV)_UP	NA	838
bsdb:1032/1/1_Hepatocellular-carcinoma:Patients-with-Hepatocellular-carcinoma-(HCC)_vs_Healthy-controls_UP	NA	816	1301	29465	3025755
bsdb:1032/1/2_Hepatocellular-carcinoma:Patients-with-Hepatocellular-carcinoma-(HCC)_vs_Healthy-controls_DOWN	NA	1501226	35832
bsdb:1033/1/1_Papillary-thyroid-carcinoma:PTC-patients-with-advanced-lesions-(T3_4)_vs_PTC-patients-with-mild-lesions-(T1_2)_UP	NA	1301	117563	724
bsdb:1033/1/2_Papillary-thyroid-carcinoma:PTC-patients-with-advanced-lesions-(T3_4)_vs_PTC-patients-with-mild-lesions-(T1_2)_DOWN	NA	286	1827	13687
bsdb:1034/1/1_Birth-measurement:High-vaginal-sialidase-activity_vs_Low-vaginal-sialidase-activity_UP	NA	1375	1380	1485	39948	2701	1378	906	543311	838
bsdb:1034/1/2_Birth-measurement:High-vaginal-sialidase-activity_vs_Low-vaginal-sialidase-activity_DOWN	NA	32008	80865	963	1578	1007	504481
bsdb:1035/1/1_Urinary-schistosomiasis:Infection-Only_vs_Healthy-Control_UP	NA	469	1375	59732	66831	570	286	22	1279
bsdb:1035/1/2_Urinary-schistosomiasis:Infection-Only_vs_Healthy-Control_DOWN	NA	469	635	547	551	2701	568	131079	13159	29487	497	46255	1279
bsdb:1036/1/1_Behcet's-syndrome:Behcet's-disease-recipient-mice_vs_Healthy-controls-recipient-mice_UP	NA	1357	35832	33042	283	283168	580024	33024	42255	1432051	2129	149698	209879
bsdb:1036/1/2_Behcet's-syndrome:Behcet's-disease-recipient-mice_vs_Healthy-controls-recipient-mice_DOWN	NA	133925	1386	239934	1283313
bsdb:1037/1/1_Chronic-constipation:Constipated-women_vs_Healthy-women_UP	NA	816	1407607	375288	544
bsdb:1037/1/2_Chronic-constipation:Constipated-women_vs_Healthy-women_DOWN	NA	570	841
bsdb:1038/1/1_Response-to-radiation:Premenopausal-Pre-treatment-group_vs_Premenopausal-healthy-controls-(HPV-Negative-women)_UP	NA	165779	1380	118747	194	39948	236752	1686313	848	1378	2050	437755	543311	2740	162289	1257	836	838	123375	1213720
bsdb:1038/1/2_Response-to-radiation:Premenopausal-Pre-treatment-group_vs_Premenopausal-healthy-controls-(HPV-Negative-women)_DOWN	NA	469	31988	1912216	1578	286	67575	1279
bsdb:1039/1/1_Diet:Urban-Xhosa-Cohort_vs_Rural-Xhosa-Cohort_UP	NA	816	33024	848	830	1506553	3025755	239759	35832	946234	283168	397864	459786	1432051	1980693
bsdb:1039/1/2_Diet:Urban-Xhosa-Cohort_vs_Rural-Xhosa-Cohort_DOWN	NA	265975	1470353	423604	970	157	39948	216851	838
bsdb:1040/1/1_COVID-19:RPs-(Recovered-Patients)_vs_HCs-(Healthy-Controls)_UP	NA	28196	36922	44249	5094	270	46255	43994	265975	1213720	118747	29465	848	168808	69278	34019	528	57739	475
bsdb:1040/1/2_COVID-19:RPs-(Recovered-Patients)_vs_HCs-(Healthy-Controls)_DOWN	NA	5475	2801844	1283313	838	308865	59734	2737	407	68287	374	953	1381133	47670	48736	416916	662
bsdb:1041/1/1_Oral-cavity-carcinoma:Tumor-tissue-(TT)-samples_vs_Adjacent-normal-tissue-(AT)_UP	NA	41275
bsdb:1041/1/2_Oral-cavity-carcinoma:Tumor-tissue-(TT)-samples_vs_Adjacent-normal-tissue-(AT)_DOWN	NA	482	528	508215	29465
bsdb:1042/1/1_Insecticide:permethrin-resistant-mosquito_vs_permethrin-susceptible-mosquito_UP	NA	28453	400634	1301	42255
bsdb:1042/1/2_Insecticide:permethrin-resistant-mosquito_vs_permethrin-susceptible-mosquito_DOWN	NA	32
bsdb:1043/1/1_Human-immunodeficiency-virus:Acute-HIV-infected-participants-at-baseline-(A0)_vs_HIV-uninfected-MSM----controls-(D)_UP	NA	838
bsdb:1043/1/2_Human-immunodeficiency-virus:Acute-HIV-infected-participants-at-baseline-(A0)_vs_HIV-uninfected-MSM----controls-(D)_DOWN	NA	32067	1578	32207	47670	195950	1716	191303	841	1501226	816	82202	459786	475	43996
bsdb:1045/1/1_Gut-microbiome-measurement:Workers-after-entry-into-an-underground-tunnel-(Exposed-status-(ES))_vs_Workers-before-entry-into-an-underground-tunnel-(Baseline-status-(BS))_UP	NA	1678	55968	1501226	1485
bsdb:1045/1/2_Gut-microbiome-measurement:Workers-after-entry-into-an-underground-tunnel-(Exposed-status-(ES))_vs_Workers-before-entry-into-an-underground-tunnel-(Baseline-status-(BS))_DOWN	NA	216851	841
bsdb:1046/1/1_Aging:PLWH-on-ART_vs_PLWOH_UP	NA	1283313	135858
bsdb:1046/1/2_Aging:PLWH-on-ART_vs_PLWOH_DOWN	NA	239759	816	216851
bsdb:1047/1/1_Major-depressive-disorder:CUMS-group_vs_Control-group_UP	NA	570	816
bsdb:1047/1/2_Major-depressive-disorder:CUMS-group_vs_Control-group_DOWN	NA	1279
bsdb:1049/1/1_Atopic-eczema:cADtreat-dogs_vs_Healthy-dogs_UP	NA	1663	1716	281915
bsdb:1050/1/1_Taxonomic-microbiome-measurement:Esophagus_vs_Oral-cavity_UP	NA	469	713	174708	572511	374	59732	33042	212791	407	165696	528	119852	20	1743	286	48736	1007	504481	165695	13687	1279	40323	1301
bsdb:1050/1/2_Taxonomic-microbiome-measurement:Esophagus_vs_Oral-cavity_DOWN	NA	1654	2717	482	346096	970
bsdb:1051/1/1_Lung-cancer:Lung-cancer-(L-group)_vs_Benign-pulmonary-diseases-(N-group)_UP	NA	816
bsdb:1051/1/2_Lung-cancer:Lung-cancer-(L-group)_vs_Benign-pulmonary-diseases-(N-group)_DOWN	NA	572511	2747	33042	1407607	1649	1164882	1743	292632
bsdb:1052/1/1_Alzheimer's-disease:Alzheimer’s-Disease-(AD)_vs_Cognitively-normal-control-(NC)_UP	NA	1766253	1283313	1380	508459	33042	216851	543311	286	123375
bsdb:1052/1/2_Alzheimer's-disease:Alzheimer’s-Disease-(AD)_vs_Cognitively-normal-control-(NC)_DOWN	NA	3025755	1506577
bsdb:1053/1/1_Nephrolithiasis:KB-group---Bladder-urine-from-kidney-stone-patients._vs_HB-group---Bladder-urine-from-healthy-controls._UP	NA	838	216851	231454	34037	2740	165697	31988	44249	375288	283168
bsdb:1053/1/2_Nephrolithiasis:KB-group---Bladder-urine-from-kidney-stone-patients._vs_HB-group---Bladder-urine-from-healthy-controls._DOWN	NA	469	848
bsdb:1054/1/1_Streptococcal-infection:GBS-culture-positive-pregnant-women_vs_GBS-culture-negative-pregnant-women_DOWN	NA	1578
bsdb:1054/1/2_Streptococcal-infection:GBS-culture-positive-pregnant-women_vs_GBS-culture-negative-pregnant-women_UP	NA	194	1716	2701	1257	1279	1301	2129
bsdb:1055/1/1_Pregnancy:Amniotic-fluid-derived-extracellular-vesicles-(AM-EVs)_vs_Amniotic-fluid-(AM)_UP	NA	239759	1283313	816	374	1298	57495	29393	1378	117563	1847725	482	162289	836	838	1279	1301	29465
bsdb:1056/1/1_Microbiome-measurement:RNAlater---Day-4_vs_RNAlater---Day-0_UP	NA	102106
bsdb:1057/1/1_Lifestyle-measurement:Female-subjects-situated-in-Soweto_vs_Female-subjects-situated-in-Bushbuckridge_UP	NA	258514
bsdb:1057/1/2_Lifestyle-measurement:Female-subjects-situated-in-Soweto_vs_Female-subjects-situated-in-Bushbuckridge_DOWN	NA	239759	2086	216851	946234	577310	838	1263	40544	213484
bsdb:1058/1/1_Coronary-artery-disease:Patient-with-coronary-artery-disease_vs_Healthy-controls_UP	NA	1980681	102106	1573534	2767881	1980693	162289	123375	40544
bsdb:1058/1/2_Coronary-artery-disease:Patient-with-coronary-artery-disease_vs_Healthy-controls_DOWN	NA	572511	1730	1407607	2039302
bsdb:1060/1/1_Population:Kwepe_vs_Kuvale_UP	NA	118747	177971	158876
bsdb:1061/1/1_Alzheimer's-disease:Alzheimer’s-Disease-(AD)_vs_Cognitively-normal-(CN)-and-amnestic-mild-cognitive-impairment-(aMCI)_UP	NA	838	29465	848	286	1033	156454	2282523	2767358	906	374	2767353	1213720	469322
bsdb:1063/1/1_Oral-lichen-planus:Oral-lichen-planus-(both-erosive-and-non-erosive-)_vs_Healthy-Control_UP	NA	361177	1663	906	2050	265975
bsdb:1063/1/2_Oral-lichen-planus:Oral-lichen-planus-(both-erosive-and-non-erosive-)_vs_Healthy-Control_DOWN	NA	46123	2147	416916	816	538	1582879	332102	32067	482	504481	1054211	195950
bsdb:1064/1/1_Response-to-irinotecan:Colon-cancer-and-Irinotecan-treated-patients_vs_Healthy-individuals_DOWN	NA	1678	204475	1263	33024	872
bsdb:1065/1/1_Breast-cancer:pre-menopausal-breast-cancer-(BC)-patients_vs_pre-menopausal-controls_UP	NA	1924093	1678	204475	1905344
bsdb:1066/1/1_Polycystic-ovary-syndrome:Polycystic-ovary-syndrome-(PCOS)-patients_vs_Healthy-Controls_UP	NA	5352	4930
bsdb:1066/1/2_Polycystic-ovary-syndrome:Polycystic-ovary-syndrome-(PCOS)-patients_vs_Healthy-Controls_DOWN	NA	5052
bsdb:1067/1/1_Acquired-primary-ovarian-failure:Primary-ovarian-failure-(POF)_vs_Healthy-controls_UP	NA	838	2701	1678	168808	836	816	39948	29465	194	162289	165779	1301	31983	586	1716	577310	1485	613	28196	182709	59732	1654	150022	404402	572511	83614	33976	2742	83770	1161127	2745	904	1378	909928	204475	32207	90243	1350	28263	1283313
bsdb:1067/1/2_Acquired-primary-ovarian-failure:Primary-ovarian-failure-(POF)_vs_Healthy-controls_DOWN	NA	1578	41275	543311	841	528	1380
bsdb:1071/1/1_Psoriasis:Psoriasis_vs_Healthy-Control-(HC)_UP	NA	216851	204475	158846	638847	2753
bsdb:1071/1/2_Psoriasis:Psoriasis_vs_Healthy-Control-(HC)_DOWN	NA	848	816
bsdb:1072/1/1_Non-alcoholic-fatty-liver-disease:HIV+-MASLD+_vs_HIV--MASLD+_UP	NA	189330	1506577	86331	123375	1501226	1485	2740	2172	248744	1573535	572511	1506553
bsdb:1072/1/2_Non-alcoholic-fatty-liver-disease:HIV+-MASLD+_vs_HIV--MASLD+_DOWN	NA	1508657	1350	53335	629	1578	1263	1301	1766253	841	239759	292632	46255	207244
bsdb:1073/1/1_Bacterial-disease:Diseased-sea-urchins_vs_Healthy-sea-urchins_UP	NA	1617805	365032	28228	393277	76008	437504	1579315	574899	45247	1649465	449810	1779141	2321187	1122284	156993	265488	1827484	2433
bsdb:1073/1/2_Bacterial-disease:Diseased-sea-urchins_vs_Healthy-sea-urchins_DOWN	NA	261825	93171	1068873	893	109168	46913	1471399	444459	1217416	2038635	188905	1434035	83612	265488	1827484	1147735	22	237444
bsdb:1075/1/2_Puberty:Pubertal_vs_Non-pubertal_DOWN	NA	724	100883
bsdb:1076/1/1_Allergic-rhinitis:Allergic-rhinitis-(AR)_vs_healthy-controls-(HC)_UP	NA	80865	150022	570	838	1279	662
bsdb:1076/1/2_Allergic-rhinitis:Allergic-rhinitis-(AR)_vs_healthy-controls-(HC)_DOWN	NA	93681
bsdb:1077/1/1_Gut-microbiome-measurement:JAX-CH-group_vs_JAX-group_UP	NA	2086	816	51514	1578	248038	375288
bsdb:1077/1/2_Gut-microbiome-measurement:JAX-CH-group_vs_JAX-group_DOWN	NA	174708	1678
bsdb:1079/1/1_Esophageal-adenocarcinoma:Cluster-2_vs_Cluster-1_UP	NA	836	838	1301
bsdb:1079/1/2_Esophageal-adenocarcinoma:Cluster-2_vs_Cluster-1_DOWN	NA	838
bsdb:1080/1/1_Lower-respiratory-tract-disease:Chronic-Otitis-Media-With-Effusion-(COME)-with-asthma-or-bronchiolitis_vs_Chronic-Otitis-Media-With-Effusion-(COME)-without-asthma-or-bronchiolitis_UP	NA	724	1279	475
bsdb:1081/1/1_Taxonomic-microbiome-measurement:Highly-attractive-group_vs_Poorly-attractive-group_UP	NA	73778	13687	1279
bsdb:1081/1/2_Taxonomic-microbiome-measurement:Highly-attractive-group_vs_Poorly-attractive-group_DOWN	NA	41275	1716	665874
bsdb:1082/1/2_Polycystic-ovary-syndrome:polycystic-ovary-syndrome-(PCOS)-like-mice_vs_Controls_DOWN	NA	816	375288	1647175
bsdb:1083/1/1_Age:B-Group-(B25.2)_vs_B-Group-(B15.2)_UP	NA	1234
bsdb:1084/1/1_Recalcitrant-atopic-dermatitis:mild-atopic-dermatitis-(AD)_vs_healthy-controls_UP	NA	1763
bsdb:1085/1/1_Gut-microbiome-measurement:High-Bifidobacterium-group_vs_Low-Bifidobacterium-group_UP	NA	1678	1716	1301
bsdb:1085/1/2_Gut-microbiome-measurement:High-Bifidobacterium-group_vs_Low-Bifidobacterium-group_DOWN	NA	1279	1350	570	1485
bsdb:1086/1/1_Phenylketonuria:Phenylketonuria-(PKU-S)_vs_Control-(CTRL-S)_UP	NA	194	724	1164882	29465
bsdb:1086/1/2_Phenylketonuria:Phenylketonuria-(PKU-S)_vs_Control-(CTRL-S)_DOWN	NA	1654	2801844	2717	43996	1434006	133925	2740	1257	1213720
bsdb:1088/1/1_Schizophrenia:SCZF:-patients-with-schizophrenia_vs_HCF:-healthy-controls-(no-psychiatric-diagnosis-of-schizophrenia)_UP	NA	1654	1663	102106	106589	1730	88	13159	354349	286	113286	620
bsdb:1088/1/2_Schizophrenia:SCZF:-patients-with-schizophrenia_vs_HCF:-healthy-controls-(no-psychiatric-diagnosis-of-schizophrenia)_DOWN	NA	447020	239759	92793	816	33042	1350	216851	724	1159323	119852	375288	838	46205	1263
bsdb:1089/1/1_Treatment:Schizophrenia-patients-after-treatment-(AT)_vs_Schizophrenia-patients-before-treatment-(BT)_UP	NA	580596	216851	119852	838	841	458032
bsdb:1089/1/2_Treatment:Schizophrenia-patients-after-treatment-(AT)_vs_Schizophrenia-patients-before-treatment-(BT)_DOWN	NA	32207
bsdb:1090/1/1_Metabolic-syndrome:Schizophrenia-patients-without-MetS_vs_Schizophrenia-patients-with-MetS_UP	NA	239934	135858	1485	1730	1266	191303	1218
bsdb:1090/1/2_Metabolic-syndrome:Schizophrenia-patients-without-MetS_vs_Schizophrenia-patients-with-MetS_DOWN	NA	816	32008	1485	39948	1578	158846	375288	40544
bsdb:1091/1/1_Chronic-gastritis,Gastric-cancer:Gastric-Cancer_vs_Chronic-gastritis_UP	NA	33042	848	724	1578	459786	375288	33024	40544	29465
bsdb:1091/1/2_Chronic-gastritis,Gastric-cancer:Gastric-Cancer_vs_Chronic-gastritis_DOWN	NA	469	447020	1678	102106	1350	1730	581	286
bsdb:1092/1/1_Cognitive-decline-measurement:Probiotic-group_vs_Placebo-group_UP	NA	838
bsdb:1092/1/2_Cognitive-decline-measurement:Probiotic-group_vs_Placebo-group_UP	NA	816	577310	838	1980693
bsdb:1093/1/1_Schizophrenia:SCZ:-individuals-with-a-psychiatric-diagnosis-of-schizophrenia_vs_HC:-individuals-without-a-psychiatric-diagnosis-of-schizophrenia_UP	NA	816	1380	848	906	29465	239934
bsdb:1093/1/2_Schizophrenia:SCZ:-individuals-with-a-psychiatric-diagnosis-of-schizophrenia_vs_HC:-individuals-without-a-psychiatric-diagnosis-of-schizophrenia_DOWN	NA	816	33024	397864	572511	33042	39948	1407607	570	407	1301
bsdb:1094/1/1_Schizophrenia:SZ:-patients-with-schizophrenia_vs_NC:-normal-controls_UP	NA	904	119977	244127	118747	135858	1485	102106	33870	1716	872	547	1378	1578	52225	86331	583	1266	970	83770	28033	179
bsdb:1094/1/2_Schizophrenia:SZ:-patients-with-schizophrenia_vs_NC:-normal-controls_DOWN	NA	239934	580596	508459	189330	216851	1357	906	482	638847	29465
bsdb:1095/1/1_Metabolite:HF+DI-(High-fat-and-Dimethyl-Itaconate-treated-mice)_vs_HF+Veh-(High-fat-and-Vehicle-treated-mice)_UP	NA	174708	1283313	191	83770
bsdb:1095/1/2_Metabolite:HF+DI-(High-fat-and-Dimethyl-Itaconate-treated-mice)_vs_HF+Veh-(High-fat-and-Vehicle-treated-mice)_DOWN	NA	1392389	1506553	83618	1508657	332162
bsdb:1096/1/1_Gut-microbiome-measurement:Infants_vs_Mothers_UP	NA	258514	447020	239759	244127	109326	397864	572511	580596	1348911	33042	39948	216851	1407607	204475	644652	61170	1392389	86331	459786	841	1263
bsdb:1096/1/2_Gut-microbiome-measurement:Infants_vs_Mothers_DOWN	NA	1654	1380	1678	84111	547	1350	150022	1378	117563	570	1578	68287	32207	13687	1279	29465
bsdb:1099/1/1_Schizophrenia:SCH-patients_vs_healthy-controls_DOWN	NA	1501226
bsdb:1099/1/2_Schizophrenia:SCH-patients_vs_healthy-controls_UP	NA	1506553
bsdb:1100/1/1_Autism-spectrum-disorder:Autistic_vs_Healthy-controls_UP	NA	816	158846	838
bsdb:1100/1/2_Autism-spectrum-disorder:Autistic_vs_Healthy-controls_DOWN	NA	1432051
bsdb:1103/1/1_Dry-eye-syndrome:Mild-Dry-Eye_vs_control_UP	NA	1663	748770	57494	13687	1569
bsdb:1103/1/2_Dry-eye-syndrome:Mild-Dry-Eye_vs_control_DOWN	NA	1578	1716	212791	528	1743
bsdb:1104/1/1_Gut-microbiome-measurement:Paternal-Gut-Microbiome-Depleted-Mice_vs_Male-Mice-with-Normal-Gut-Microbiome_DOWN	NA	816	1578	1485
bsdb:1104/1/2_Gut-microbiome-measurement:Paternal-Gut-Microbiome-Depleted-Mice_vs_Male-Mice-with-Normal-Gut-Microbiome_UP	NA	816	1578
bsdb:1106/1/1_Breastfeeding-duration:Non_Exclusive-Breast-Feeding-(Non-EBF)_vs_Exclusive-Breast-Feeding-(EBF)_UP	NA	1678	1350
bsdb:1106/1/2_Breastfeeding-duration:Non_Exclusive-Breast-Feeding-(Non-EBF)_vs_Exclusive-Breast-Feeding-(EBF)_DOWN	NA	572511	135858	102106	1578	838	1263
bsdb:1108/1/1_HIV-infection,Abnormal-inflammatory-response:HIV-infected_vs_HIV-uninfected_UP	NA	84108	102106
bsdb:1108/1/2_HIV-infection,Abnormal-inflammatory-response:HIV-infected_vs_HIV-uninfected_DOWN	NA	1501226
bsdb:1111/1/1_Relapsing-remitting-multiple-sclerosis:Caucasian-Americans-(CA)_vs_Healthy-Controls_UP	NA	1485	239934
bsdb:1114/1/1_Gestational-diabetes:Gestational-diabetes-mellitus-(GDM)_vs_Healthy-controls_UP	NA	191303	142587
bsdb:1114/1/2_Gestational-diabetes:Gestational-diabetes-mellitus-(GDM)_vs_Healthy-controls_DOWN	NA	253238	906	838	32207	292632	29465
bsdb:1115/1/1_Ischemic-stroke:Patients-with-stroke-associated-pneumonia-(SAP)_vs_Patients-without-stroke-associated-pneumonia-(non-SAP)_UP	NA	830	1716
bsdb:1115/1/2_Ischemic-stroke:Patients-with-stroke-associated-pneumonia-(SAP)_vs_Patients-without-stroke-associated-pneumonia-(non-SAP)_DOWN	NA	580596	1407607
bsdb:1117/1/1_Gestational-diabetes:Gestational-diabetes-mellitus-(GDM)_vs_Healthy-controls_UP	NA	1654	978	279	2985502
bsdb:1117/1/2_Gestational-diabetes:Gestational-diabetes-mellitus-(GDM)_vs_Healthy-controls_DOWN	NA	1375	212791	216851	963	497	93681
bsdb:1118/1/1_HIV-infection:Immunological-Responder-(IR)-HIV-infected-individual_vs_Healthy-HIV-negative-individual_UP	NA	46123	547	848	1506553	906	1827	1301	29465
bsdb:1118/1/2_HIV-infection:Immunological-Responder-(IR)-HIV-infected-individual_vs_Healthy-HIV-negative-individual_DOWN	NA	239759	207244	816	397864	1678	216851	1407607	119852	577309	577310	841	292632	172900
bsdb:1124/1/2_Vaginal-microbiome-measurement:Women-with-varying-vaginal-microbiome-profiles-based-on-their-ancestry._vs_Women-without-any-specific-microbiome-conditions_DOWN	NA	1279
bsdb:1125/1/2_Gut-microbiome-measurement,Glucose-metabolism-measurement:African-citizens_vs_Han-Chinese_DOWN	NA	816
bsdb:1130/1/1_Diarrhea:Diarrhea_vs_healthy-controls_UP	NA	1301
bsdb:1130/1/2_Diarrhea:Diarrhea_vs_healthy-controls_DOWN	NA	1578	52225
bsdb:1139/1/2_Gut-microbiome-measurement:Prebiotic-group_vs_Placebo-group_DOWN	NA	1924093
bsdb:1141/1/1_Postnatal-growth-retardation:Colostrum-deprived-mice_vs_Control_UP	NA	248744	1331051
bsdb:1141/1/2_Postnatal-growth-retardation:Colostrum-deprived-mice_vs_Control_DOWN	NA	1506577
bsdb:1142/1/1_Hypertrophy:Tonsillar-hypertrophy-(TH)_vs_Control_UP	NA	1678	39948	308865	44259	1378	1578	543311	2171988
bsdb:1144/1/1_Autism-spectrum-disorder:Children-with-Autism-Spectrum-Disorder-(ASD)_vs_Healthy-children_UP	NA	216851	838	292632	1263	1766253
bsdb:1144/1/2_Autism-spectrum-disorder:Children-with-Autism-Spectrum-Disorder-(ASD)_vs_Healthy-children_DOWN	NA	1678	1730
